[	0	1	O
Epidemiology	1	13	O
of	14	16	O
respiratory	17	28	B-Anatomical_system
allergy	29	36	O
in	37	39	O
children	40	48	O
]	48	49	O
.	49	50	O

Epidemiology	51	63	O
of	64	66	O
paediatric	67	77	O
respiratory	78	89	B-Anatomical_system
allergic	90	98	O
disorders	99	108	O
allows	109	115	O
the	116	119	O
approach	120	128	O
to	129	131	O
causal	132	138	O
and	139	142	O
preventive	143	153	O
risk	154	158	O
factors	159	166	O
by	167	169	O
studying	170	178	O
groups	179	185	O
or	186	188	O
sub	189	192	O
groups	193	199	O
of	200	202	O
children	203	211	O
in	212	214	O
different	215	224	O
locations	225	234	O
and	235	238	O
under	239	244	O
different	245	254	O
conditions	255	265	O
.	265	266	O

This	267	271	O
is	272	274	O
,	274	275	O
however	276	283	O
,	283	284	O
complicated	285	296	O
by	297	299	O
the	300	303	O
lack	304	308	O
of	309	311	O
consensus	312	321	O
on	322	324	O
disease	325	332	O
definitions	333	344	O
,	344	345	O
which	346	351	O
renders	352	359	O
comparisons	360	371	O
between	372	379	O
studies	380	387	O
difficult	388	397	O
.	397	398	O

Atopy	399	404	O
is	405	407	O
usually	408	415	O
defined	416	423	O
by	424	426	O
the	427	430	O
presence	431	439	O
of	440	442	O
positive	443	451	O
skin	452	456	B-Organ
tests	457	462	O
(	463	464	O
wheal	464	469	O
size	470	474	O
of	475	477	O
at	478	480	O
least	481	486	O
a	487	488	O
mean	489	493	O
diameter	494	502	O
>	503	504	O
or	505	507	O
=	508	509	O
3	510	511	O
mm	512	514	O
)	514	515	O
,	515	516	O
by	517	519	O
the	520	523	O
presence	524	532	O
of	533	535	O
specific	536	544	O
IgE	545	548	O
,	548	549	O
or	550	552	O
by	553	555	O
the	556	559	O
presence	560	568	O
of	569	571	O
increased	572	581	O
total	582	587	O
IgE	588	591	O
(	592	593	O
>	593	594	O
or	595	597	O
=	598	599	O
100	600	603	O
UI	604	606	O
/	606	607	O
mL	607	609	O
)	609	610	O
.	610	611	O

Infantile	612	621	O
asthma	622	628	O
is	629	631	O
not	632	635	O
well	636	640	O
defined	641	648	O
,	648	649	O
complicated	650	661	O
by	662	664	O
the	665	668	O
high	669	673	O
prevalence	674	684	O
of	685	687	O
bronchiolitis	688	701	O
;	701	702	O
one	703	706	O
thus	707	711	O
questions	712	721	O
between	722	729	O
wheezing	730	738	O
or	739	741	O
wheezy	742	748	O
bronchitis	749	759	O
.	759	760	O

Prevalence	761	771	O
is	772	774	O
high	775	779	O
:	779	780	O
among	781	786	O
early	787	792	O
wheezers	793	801	O
,	801	802	O
two	803	806	O
populations	807	818	O
will	819	823	O
be	824	826	O
defined	827	834	O
by	835	837	O
the	838	841	O
medium	842	848	O
term	849	853	O
evolution	854	863	O
:	863	864	O
transient	865	874	O
wheezers	875	883	O
and	884	887	O
persistent	888	898	O
wheezers	899	907	O
.	907	908	O

Risk	909	913	O
factors	914	921	O
for	922	925	O
these	926	931	O
two	932	935	O
conditions	936	946	O
are	947	950	O
different	951	960	O
.	960	961	O

Childhood	962	971	O
asthma	972	978	O
may	979	982	O
be	983	985	O
defined	986	993	O
by	994	996	O
the	997	1000	O
diagnosis	1001	1010	O
of	1011	1013	O
asthma	1014	1020	O
(	1021	1022	O
specific	1022	1030	O
but	1031	1034	O
fairly	1035	1041	O
non	1042	1045	O
-	1045	1046	O
sensitive	1046	1055	O
)	1055	1056	O
,	1056	1057	O
by	1058	1060	O
asthmatic	1061	1070	O
symptoms	1071	1079	O
(	1080	1081	O
wheezing	1081	1089	O
,	1089	1090	O
waking	1091	1097	O
by	1098	1100	O
an	1101	1103	O
attack	1104	1110	O
of	1111	1113	O
shortness	1114	1123	O
of	1124	1126	O
breath	1127	1133	O
)	1133	1134	O
(	1135	1136	O
sensitive	1136	1145	O
but	1146	1149	O
not	1150	1153	O
very	1154	1158	O
specific	1159	1167	O
)	1167	1168	O
,	1168	1169	O
or	1170	1172	O
by	1173	1175	O
the	1176	1179	O
combination	1180	1191	O
of	1192	1194	O
symptoms	1195	1203	O
and	1204	1207	O
airway	1208	1214	B-Multi-tissue_structure
hyperresponsiveness	1215	1234	O
.	1234	1235	O

The	1236	1239	O
ISAAC	1240	1245	O
study	1246	1251	O
has	1252	1255	O
standardised	1256	1268	O
a	1269	1270	O
questionnaire	1271	1284	O
to	1285	1287	O
assess	1288	1294	O
the	1295	1298	O
prevalence	1299	1309	O
of	1310	1312	O
asthma	1313	1319	O
.	1319	1320	O

The	1321	1324	O
preliminary	1325	1336	O
results	1337	1344	O
show	1345	1349	O
that	1350	1354	O
there	1355	1360	O
are	1361	1364	O
wide	1365	1369	O
variations	1370	1380	O
across	1381	1387	O
the	1388	1391	O
world	1392	1397	O
.	1397	1398	O

The	1399	1402	O
prevalence	1403	1413	O
is	1414	1416	O
low	1417	1420	O
in	1421	1423	O
Africa	1424	1430	O
and	1431	1434	O
Asia	1435	1439	O
,	1439	1440	O
intermediate	1441	1453	O
in	1454	1456	O
Europe	1457	1463	O
,	1463	1464	O
and	1465	1468	O
high	1469	1473	O
in	1474	1476	O
Anglo	1477	1482	O
-	1482	1483	O
Saxon	1483	1488	O
countries	1489	1498	O
.	1498	1499	O

The	1500	1503	O
prevalence	1504	1514	O
of	1515	1517	O
asthma	1518	1524	O
has	1525	1528	O
gradually	1529	1538	O
increased	1539	1548	O
over	1549	1553	O
the	1554	1557	O
past	1558	1562	O
20	1563	1565	O
years	1566	1571	O
in	1572	1574	O
developed	1575	1584	O
countries	1585	1594	O
.	1594	1595	O

Asthma	1596	1602	O
and	1603	1606	O
atopy	1607	1612	O
are	1613	1616	O
closely	1617	1624	O
associated	1625	1635	O
in	1636	1638	O
children	1639	1647	O
.	1647	1648	O

Risk	1649	1653	O
factors	1654	1661	O
are	1662	1665	O
genetic	1666	1673	O
,	1673	1674	O
associated	1675	1685	O
with	1686	1690	O
sex	1691	1694	O
and	1695	1698	O
environmental	1699	1712	O
factors	1713	1720	O
.	1720	1721	O

Among	1722	1727	O
these	1728	1733	O
,	1733	1734	O
allergic	1735	1743	O
sensitisation	1744	1757	O
is	1758	1760	O
associated	1761	1771	O
with	1772	1776	O
the	1777	1780	O
degree	1781	1787	O
of	1788	1790	O
exposure	1791	1799	O
to	1800	1802	O
allergens	1803	1812	O
.	1812	1813	O

Westernization	1814	1828	O
of	1829	1831	O
way	1832	1835	O
of	1836	1838	O
life	1839	1843	O
is	1844	1846	O
associated	1847	1857	O
with	1858	1862	O
increased	1863	1872	O
prevalence	1873	1883	O
of	1884	1886	O
atopy	1887	1892	O
,	1892	1893	O
allergic	1894	1902	O
rhinitis	1903	1911	O
and	1912	1915	O
asthma	1916	1922	O
.	1922	1923	O

Atopy	1924	1929	O
seems	1930	1935	O
inversely	1936	1945	O
correlated	1946	1956	O
to	1957	1959	O
certain	1960	1967	O
infections	1968	1978	O
.	1978	1979	O

Passive	1980	1987	O
smoking	1988	1995	O
is	1996	1998	O
clearly	1999	2006	O
associated	2007	2017	O
with	2018	2022	O
early	2023	2028	O
wheezing	2029	2037	O
.	2037	2038	O

This	2039	2043	O
and	2044	2047	O
atmospheric	2048	2059	O
pollution	2060	2069	O
aggravate	2070	2079	O
childhood	2080	2089	O
asthma	2090	2096	O
.	2096	2097	O

However	2098	2105	O
,	2105	2106	O
the	2107	2110	O
inducing	2111	2119	O
role	2120	2124	O
of	2125	2127	O
pollution	2128	2137	O
on	2138	2140	O
asthma	2141	2147	O
is	2148	2150	O
still	2151	2156	O
controversial	2157	2170	O
.	2170	2171	O

Novel	0	5	O
mechanism	6	15	O
for	16	19	O
the	20	23	O
impairment	24	34	O
of	35	37	O
cell	38	42	B-Cell
proliferation	43	56	O
in	57	59	O
HIV	60	63	O
-	63	64	O
1	64	65	O
infection	66	75	O
.	75	76	O

The	77	80	O
synthesis	81	90	O
of	91	93	O
ribonucleotides	94	109	O
is	110	112	O
essential	113	122	O
to	123	125	O
cell	126	130	B-Cell
proliferation	131	144	O
.	144	145	O

Defects	146	153	O
in	154	156	O
the	157	160	O
relevant	161	169	O
metabolic	170	179	O
pathways	180	188	O
have	189	193	O
been	194	198	O
demonstrated	199	211	O
in	212	214	O
stimulated	215	225	O
T	226	227	B-Cell
cells	228	233	I-Cell
from	234	238	O
AIDS	239	243	O
patients	244	252	O
and	253	256	O
are	257	260	O
associated	261	271	O
with	272	276	O
lymphocyte	277	287	B-Cell
necrotic	288	296	O
death	297	302	O
.	302	303	O

Here	304	308	O
,	308	309	O
Margarita	310	319	O
Bofill	320	326	O
and	327	330	O
colleagues	331	341	O
discuss	342	349	O
the	350	353	O
possibility	354	365	O
that	366	370	O
an	371	373	O
impaired	374	382	O
ribonucleotide	383	397	O
metabolism	398	408	O
might	409	414	O
be	415	417	O
common	418	424	O
to	425	427	O
all	428	431	O
rapidly	432	439	O
dividing	440	448	O
cells	449	454	B-Cell
and	455	458	O
thus	459	463	O
contribute	464	474	O
to	475	477	O
other	478	483	O
recognized	484	494	O
symptoms	495	503	O
of	504	506	O
HIV	507	510	O
-	510	511	O
1	511	512	O
infection	513	522	O
.	522	523	O

A	0	1	O
pancreatic	2	12	B-Cell
beta	13	17	I-Cell
-	18	19	I-Cell
cell	19	23	I-Cell
-	23	24	O
specific	24	32	O
enhancer	33	41	O
in	42	44	O
the	45	48	O
human	49	54	O
PDX	55	58	O
-	58	59	O
1	59	60	O
gene	61	65	O
is	66	68	O
regulated	69	78	O
by	79	81	O
hepatocyte	82	92	O
nuclear	93	100	O
factor	101	107	O
3beta	108	113	O
(	114	115	O
HNF	115	118	O
-	118	119	O
3beta	119	124	O
)	125	126	O
,	126	127	O
HNF	128	131	O
-	131	132	O
1alpha	132	138	O
,	138	139	O
and	140	143	O
SPs	144	147	O
transcription	148	161	O
factors	162	169	O
.	169	170	O

The	171	174	O
PDX	175	178	O
-	178	179	O
1	179	180	O
transcription	181	194	O
factor	195	201	O
plays	202	207	O
a	208	209	O
key	210	213	O
role	214	218	O
in	219	221	O
pancreas	222	230	B-Organ
development	231	242	O
.	242	243	O

Although	244	252	O
expressed	253	262	O
in	263	265	O
all	266	269	O
cells	270	275	B-Cell
at	276	278	O
the	279	282	O
early	283	288	O
stages	289	295	O
,	295	296	O
in	297	299	O
the	300	303	O
adult	304	309	O
it	310	312	O
is	313	315	O
mainly	316	322	O
restricted	323	333	O
to	334	336	O
the	337	340	O
beta	341	345	B-Cell
-	345	346	I-Cell
cell	346	350	I-Cell
.	350	351	O

To	352	354	O
characterize	355	367	O
the	368	371	O
regulatory	372	382	O
elements	383	391	O
and	392	395	O
potential	396	405	O
transcription	406	419	O
factors	420	427	O
necessary	428	437	O
for	438	441	O
human	442	447	O
PDX	448	451	O
-	451	452	O
1	452	453	O
gene	454	458	O
expression	459	469	O
in	470	472	O
beta	473	477	B-Cell
-	477	478	I-Cell
cells	478	483	I-Cell
,	483	484	O
we	485	487	O
constructed	488	499	O
a	500	501	O
series	502	508	O
of	509	511	O
5	512	513	O
'	513	514	O
and	515	518	O
3	519	520	O
'	520	521	O
deletion	522	530	O
fragments	531	540	O
of	541	543	O
the	544	547	O
5	548	549	O
'	549	550	O
-	550	551	O
flanking	551	559	O
region	560	566	O
of	567	569	O
the	570	573	O
gene	574	578	O
,	578	579	O
fused	580	585	O
to	586	588	O
the	589	592	O
luciferase	593	603	O
reporter	604	612	O
gene	613	617	O
.	617	618	O

In	619	621	O
this	622	626	O
report	627	633	O
,	633	634	O
we	635	637	O
identify	638	646	O
by	647	649	O
transient	650	659	O
transfections	660	673	O
in	674	676	O
beta	677	681	B-Cell
-	681	682	I-Cell
and	683	686	O
non	687	690	B-Cell
-	690	691	I-Cell
beta	691	695	I-Cell
-	695	696	I-Cell
cells	696	701	I-Cell
a	702	703	O
novel	704	709	O
beta	710	714	B-Cell
-	714	715	I-Cell
cell	715	719	I-Cell
-	719	720	O
specific	720	728	O
distal	729	735	O
enhancer	736	744	O
element	745	752	O
located	753	760	O
between	761	768	O
-	769	770	O
3	770	771	O
.	771	772	O
7	772	773	O
and	774	777	O
-	778	779	O
3	779	780	O
.	780	781	O
45	781	783	O
kilobases	784	793	O
.	793	794	O

DNase	795	800	O
I	801	802	O
footprinting	803	815	O
analysis	816	824	O
revealed	825	833	O
two	834	837	O
protected	838	847	O
regions	848	855	O
,	855	856	O
one	857	860	O
binding	861	868	O
the	869	872	O
transcription	873	886	O
factors	887	894	O
SP1	895	898	O
and	899	902	O
SP3	903	906	O
and	907	910	O
the	911	914	O
other	915	920	O
hepatocyte	921	931	O
nuclear	932	939	O
factor	940	946	O
3beta	947	952	O
(	953	954	O
HNF	954	957	O
-	957	958	O
3beta	958	963	O
)	963	964	O
and	965	968	O
HNF	969	972	O
-	972	973	O
1alpha	973	979	O
.	979	980	O

Cotransfection	981	995	O
experiments	996	1007	O
suggest	1008	1015	O
that	1016	1020	O
HNF	1021	1024	O
-	1024	1025	O
3beta	1025	1030	O
,	1030	1031	O
HNF	1032	1035	O
-	1035	1036	O
1alpha	1036	1042	O
,	1042	1043	O
and	1044	1047	O
SP1	1048	1051	O
are	1052	1055	O
positive	1056	1064	O
regulators	1065	1075	O
of	1076	1078	O
the	1079	1082	O
herein	1083	1089	O
-	1089	1090	O
described	1090	1099	O
human	1100	1105	O
PDX	1106	1109	O
-	1109	1110	O
1	1110	1111	O
enhancer	1112	1120	O
element	1121	1128	O
.	1128	1129	O

Furthermore	1130	1141	O
,	1141	1142	O
mutations	1143	1152	O
within	1153	1159	O
each	1160	1164	O
motif	1165	1170	O
abolished	1171	1180	O
the	1181	1184	O
binding	1185	1192	O
of	1193	1195	O
the	1196	1199	O
corresponding	1200	1213	O
factor	1214	1220	O
(	1220	1221	O
s	1221	1222	O
)	1222	1223	O
and	1224	1227	O
dramatically	1228	1240	O
impaired	1241	1249	O
the	1250	1253	O
enhancer	1254	1262	O
activity	1263	1271	O
,	1271	1272	O
therefore	1273	1282	O
suggesting	1283	1293	O
cooperativity	1294	1307	O
between	1308	1315	O
these	1316	1321	O
factors	1322	1329	O
.	1329	1330	O

[	0	1	O
A	1	2	O
decline	3	10	O
in	11	13	O
the	14	17	O
French	18	24	O
demographic	25	36	O
situation	37	46	O
in	47	49	O
the	50	53	O
context	54	61	O
of	62	64	O
a	65	66	O
Europe	67	73	O
also	74	78	O
in	79	81	O
demographic	82	93	O
decline	94	101	O
]	101	102	O
.	102	103	O

The	104	107	O
author	108	114	O
analyzes	115	123	O
the	124	127	O
decline	128	135	O
in	136	138	O
French	139	145	O
fertility	146	155	O
which	156	161	O
has	162	165	O
occurred	166	174	O
over	175	179	O
the	180	183	O
past	184	188	O
two	189	192	O
years	193	198	O
using	199	204	O
data	205	209	O
from	210	214	O
official	215	223	O
sources	224	231	O
.	231	232	O

Some	234	238	O
comparisons	239	250	O
are	251	254	O
made	255	259	O
with	260	264	O
fertility	265	274	O
trends	275	281	O
in	282	284	O
other	285	290	O
European	291	299	O
countries	300	309	O
.	309	310	O

The	0	3	O
patterns	4	12	O
of	13	15	O
internal	16	24	O
migration	25	34	O
in	35	37	O
Maharashtra	38	49	O
:	49	50	O
an	52	54	O
analysis	55	63	O
of	64	66	O
1971	67	71	O
census	72	78	O
data	79	83	O
.	83	84	O

Patterns	85	93	O
of	94	96	O
internal	97	105	O
migration	106	115	O
in	116	118	O
the	119	122	O
state	123	128	O
of	129	131	O
Maharashtra	132	143	O
,	143	144	O
India	145	150	O
,	150	151	O
for	152	155	O
the	156	159	O
period	160	166	O
1961	167	171	O
-	171	172	O
1971	172	176	O
are	177	180	O
analyzed	181	189	O
using	190	195	O
1971	196	200	O
census	201	207	O
data	208	212	O
.	212	213	O

The	215	218	O
nature	219	225	O
,	225	226	O
volume	227	233	O
,	233	234	O
and	235	238	O
direction	239	248	O
of	249	251	O
migration	252	261	O
are	262	265	O
examined	266	274	O
.	274	275	O

Migrants	277	285	O
are	286	289	O
characterized	290	303	O
according	304	313	O
to	314	316	O
factors	317	324	O
including	325	334	O
age	335	338	O
,	338	339	O
sex	340	343	O
,	343	344	O
marital	345	352	O
status	353	359	O
,	359	360	O
occupation	361	371	O
,	371	372	O
and	373	376	O
areas	377	382	O
of	383	385	O
origin	386	392	O
and	393	396	O
destination	397	408	O
.	408	409	O

Deletion	0	8	O
of	9	11	O
guanine	12	19	O
nucleotide	20	30	O
binding	31	38	O
protein	39	46	O
alpha	47	52	O
z	53	54	O
subunit	55	62	O
in	63	65	O
mice	66	70	O
induces	71	78	O
a	79	80	O
gene	81	85	O
dose	86	90	O
dependent	91	100	O
tolerance	101	110	O
to	111	113	O
morphine	114	122	O
.	122	123	O

The	124	127	O
mechanism	128	137	O
underlying	138	148	O
the	149	152	O
development	153	164	O
of	165	167	O
tolerance	168	177	O
to	178	180	O
morphine	181	189	O
is	190	192	O
still	193	198	O
incompletely	199	211	O
understood	212	222	O
.	222	223	O

Morphine	224	232	O
binds	233	238	O
to	239	241	O
opioid	242	248	O
receptors	249	258	O
,	258	259	O
which	260	265	O
in	266	268	O
turn	269	273	O
activates	274	283	O
downstream	284	294	O
second	295	301	O
messenger	302	311	O
cascades	312	320	O
through	321	328	O
heterotrimeric	329	343	O
guanine	344	351	O
nucleotide	352	362	O
binding	363	370	O
proteins	371	379	O
(	380	381	O
G	381	382	O
proteins	383	391	O
)	391	392	O
.	392	393	O

In	394	396	O
this	397	401	O
paper	402	407	O
,	407	408	O
we	409	411	O
show	412	416	O
that	417	421	O
G	422	423	O
(	423	424	O
z	424	425	O
)	425	426	O
,	426	427	O
a	428	429	O
member	430	436	O
of	437	439	O
the	440	443	O
inhibitory	444	454	O
G	455	456	O
protein	457	464	O
family	465	471	O
,	471	472	O
plays	473	478	O
an	479	481	O
important	482	491	O
role	492	496	O
in	497	499	O
mediating	500	509	O
the	510	513	O
analgesic	514	523	O
and	524	527	O
lethality	528	537	O
effects	538	545	O
of	546	548	O
morphine	549	557	O
after	558	563	O
tolerance	564	573	O
development	574	585	O
.	585	586	O

We	587	589	O
blocked	590	597	O
signaling	598	607	O
through	608	615	O
the	616	619	O
G	620	621	O
(	621	622	O
z	622	623	O
)	623	624	O
second	625	631	O
messenger	632	641	O
cascade	642	649	O
by	650	652	O
genetic	653	660	O
ablation	661	669	O
of	670	672	O
the	673	676	O
alpha	677	682	O
subunit	683	690	O
of	691	693	O
the	694	697	O
G	698	699	O
protein	700	707	O
in	708	710	O
mice	711	715	O
.	715	716	O

The	717	720	O
Galpha	721	727	O
(	727	728	O
z	728	729	O
)	729	730	O
knockout	731	739	O
mouse	740	745	O
develops	746	754	O
significantly	755	768	O
increased	769	778	O
tolerance	779	788	O
to	789	791	O
morphine	792	800	O
,	800	801	O
which	802	807	O
depends	808	815	O
on	816	818	O
Galpha	819	825	O
(	825	826	O
z	826	827	O
)	827	828	O
gene	829	833	O
dosage	834	840	O
.	840	841	O

Further	842	849	O
experiments	850	861	O
demonstrate	862	873	O
that	874	878	O
the	879	882	O
enhanced	883	891	O
morphine	892	900	O
tolerance	901	910	O
is	911	913	O
not	914	917	O
caused	918	924	O
by	925	927	O
pharmacokinetic	928	943	O
and	944	947	O
behavioural	948	959	O
learning	960	968	O
mechanisms	969	979	O
.	979	980	O

The	981	984	O
results	985	992	O
suggest	993	1000	O
that	1001	1005	O
G	1006	1007	O
(	1007	1008	O
z	1008	1009	O
)	1009	1010	O
signaling	1011	1020	O
pathways	1021	1029	O
are	1030	1033	O
involved	1034	1042	O
in	1043	1045	O
transducing	1046	1057	O
the	1058	1061	O
analgesic	1062	1071	O
and	1072	1075	O
lethality	1076	1085	O
effects	1086	1093	O
of	1094	1096	O
morphine	1097	1105	O
following	1106	1115	O
chronic	1116	1123	O
morphine	1124	1132	O
treatment	1133	1142	O
.	1142	1143	O

Effects	0	7	O
of	8	10	O
buffer	11	17	O
properties	18	28	O
on	29	31	O
cyclodextrin	32	44	O
glucanotransferase	45	63	O
reactions	64	73	O
and	74	77	O
cyclodextrin	78	90	O
production	91	101	O
from	102	106	O
raw	107	110	O
sago	111	115	O
(	116	117	O
Cycas	117	122	O
revoluta	123	131	O
)	131	132	O
starch	133	139	B-Organism_substance
.	139	140	O

Results	141	148	O
from	149	153	O
the	154	157	O
present	158	165	O
study	166	171	O
have	172	176	O
shown	177	182	O
that	183	187	O
the	188	191	O
ionic	192	197	O
species	198	205	O
of	206	208	O
buffers	209	216	O
,	216	217	O
pH	218	220	O
values	221	227	O
and	228	231	O
reaction	232	240	O
temperature	241	252	O
can	253	256	O
affect	257	263	O
the	264	267	O
enzyme	268	274	O
unit	275	279	O
activities	280	290	O
and	291	294	O
product	295	302	O
specificity	303	314	O
of	315	317	O
Toruzyme	318	326	O
(	327	328	O
Novo	328	332	O
Nordisk	333	340	O
A	341	342	O
/	342	343	O
S	343	344	O
Bagsvaerd	345	354	O
,	354	355	O
Denmark	356	363	O
)	363	364	O
CGTase	365	371	O
(	372	373	O
cyclodextrin	373	385	O
glucanotransferase	386	404	O
)	404	405	O
.	405	406	O

Applying	407	415	O
a	416	417	O
similar	418	425	O
reaction	426	434	O
environment	435	446	O
(	447	448	O
acetate	448	455	O
buffer	456	462	O
,	462	463	O
pH	464	466	O
6	467	468	O
.	468	469	O
0	469	470	O
;	470	471	O
temperature	472	483	O
,	483	484	O
60	485	487	O
degrees	488	495	O
C	496	497	O
)	497	498	O
,	498	499	O
the	500	503	O
CGTase	504	510	O
was	511	514	O
found	515	520	O
to	521	523	O
be	524	526	O
capable	527	534	O
of	535	537	O
producing	538	547	O
pre	548	551	O
dominantly	552	562	O
beta	563	567	O
-	567	568	O
cyclodextrin	568	580	O
from	581	585	O
either	586	592	O
raw	593	596	O
or	597	599	O
gelatinized	600	611	O
sago	612	616	O
(	617	618	O
Cycas	618	623	O
revoluta	624	632	O
)	632	633	O
starch	634	640	B-Organism_substance
.	640	641	O

Changing	642	650	O
the	651	654	O
buffer	655	661	O
from	662	666	O
acetate	667	674	O
to	675	677	O
phosphate	678	687	O
reduced	688	695	O
the	696	699	O
yield	700	705	O
of	706	708	O
beta	709	713	O
-	713	714	O
cyclodextrin	714	726	O
from	727	731	O
2	732	733	O
.	733	734	O
48	734	736	O
to	737	739	O
1	740	741	O
.	741	742	O
42	742	744	O
mg	745	747	O
/	747	748	O
ml	748	750	O
and	751	754	O
also	755	759	O
affected	760	768	O
the	769	772	O
product	773	780	O
specificity	781	792	O
,	792	793	O
where	794	799	O
production	800	810	O
of	811	813	O
both	814	818	O
alpha	819	824	O
-	824	825	O
and	826	829	O
beta	830	834	O
-	834	835	O
cyclodextrins	835	848	O
were	849	853	O
more	854	858	O
pronounced	859	869	O
.	869	870	O

The	871	874	O
decrease	875	883	O
in	884	886	O
the	887	890	O
production	891	901	O
of	902	904	O
cyclodextrins	905	918	O
in	919	921	O
phosphate	922	931	O
buffer	932	938	O
was	939	942	O
significant	943	954	O
at	955	957	O
both	958	962	O
pH	963	965	O
6	966	967	O
.	967	968	O
0	968	969	O
and	970	973	O
7	974	975	O
.	975	976	O
0	976	977	O
.	977	978	O

However	979	986	O
,	986	987	O
changing	988	996	O
the	997	1000	O
buffer	1001	1007	O
to	1008	1010	O
Tris	1011	1015	O
/	1015	1016	O
HCl	1016	1019	O
(	1020	1021	O
pH	1021	1023	O
7	1024	1025	O
.	1025	1026	O
0	1026	1027	O
)	1027	1028	O
showed	1029	1035	O
a	1036	1037	O
significant	1038	1049	O
increase	1050	1058	O
in	1059	1061	O
beta	1062	1066	O
-	1066	1067	O
cyclodextrin	1067	1079	O
production	1080	1090	O
.	1090	1091	O

Increasing	1092	1102	O
the	1103	1106	O
ionic	1107	1112	O
strength	1113	1121	O
of	1122	1124	O
sodium	1125	1131	O
acetate	1132	1139	O
and	1140	1143	O
Tris	1144	1148	O
/	1148	1149	O
HCl	1149	1152	O
buffers	1153	1160	O
at	1161	1163	O
pH	1164	1166	O
6	1167	1168	O
.	1168	1169	O
0	1169	1170	O
and	1171	1174	O
7	1175	1176	O
.	1176	1177	O
0	1177	1178	O
to	1179	1181	O
equivalent	1182	1192	O
ionic	1193	1198	O
strength	1199	1207	O
of	1208	1210	O
phosphate	1211	1220	O
buffers	1221	1228	O
showed	1229	1235	O
no	1236	1238	O
significant	1239	1250	O
effects	1251	1258	O
on	1259	1261	O
cyclodextrin	1262	1274	O
production	1275	1285	O
.	1285	1286	O

Higher	1287	1293	O
yield	1294	1299	O
of	1300	1302	O
cyclodextrins	1303	1316	O
at	1317	1319	O
pH	1320	1322	O
7	1323	1324	O
.	1324	1325	O
0	1325	1326	O
when	1327	1331	O
Tris	1332	1336	O
/	1336	1337	O
HCl	1337	1340	O
was	1341	1344	O
used	1345	1349	O
might	1350	1355	O
be	1356	1358	O
due	1359	1362	O
to	1363	1365	O
the	1366	1369	O
binding	1370	1377	O
of	1378	1380	O
chloride	1381	1389	O
ions	1390	1394	O
at	1395	1397	O
the	1398	1401	O
calcium	1402	1409	O
-	1409	1410	O
binding	1410	1417	O
sites	1418	1423	O
of	1424	1426	O
the	1427	1430	O
CGTase	1431	1437	O
,	1437	1438	O
resulting	1439	1448	O
in	1449	1451	O
the	1452	1455	O
shift	1456	1461	O
of	1462	1464	O
the	1465	1468	O
optimum	1469	1476	O
pH	1477	1479	O
close	1480	1485	O
to	1486	1488	O
physiological	1489	1502	O
environment	1503	1514	O
,	1514	1515	O
leading	1516	1523	O
to	1524	1526	O
an	1527	1529	O
increase	1530	1538	O
in	1539	1541	O
the	1542	1545	O
activities	1546	1556	O
and	1557	1560	O
specificity	1561	1572	O
.	1572	1573	O

Rational	0	8	O
synthesis	9	18	O
of	19	21	O
multicyclic	22	33	O
bis	34	37	O
[	37	38	O
2	38	39	O
]	39	40	O
catenanes	40	49	O
.	49	50	O

Bis	51	54	O
-	54	55	O
loop	55	59	O
tetraurea	60	69	O
calix	70	75	O
[	75	76	O
4	76	77	O
]	77	78	O
arene	78	83	O
6	84	85	O
has	86	89	O
been	90	94	O
prepared	95	103	O
by	104	106	O
acylation	107	116	O
of	117	119	O
the	120	123	O
wide	124	128	O
-	128	129	O
rim	129	132	O
calix	133	138	O
[	138	139	O
4	139	140	O
]	140	141	O
arene	141	146	O
tetraamine	147	157	O
1	158	159	O
with	160	164	O
the	165	168	O
activated	169	178	O
bis	179	182	O
(	182	183	O
urethane	183	191	O
)	191	192	O
8	193	194	O
under	195	200	O
dilution	201	209	O
conditions	210	220	O
.	220	221	O

Similarly	222	231	O
the	232	235	O
bis	236	239	O
(	239	240	O
Boc	240	243	O
-	243	244	O
protected	244	253	O
)	253	254	O
tetraamine	255	265	O
2	266	267	O
is	268	270	O
converted	271	280	O
into	281	285	O
the	286	289	O
mono	290	294	O
-	294	295	O
loop	295	299	O
derivative	300	310	O
3	311	312	O
which	313	318	O
after	319	324	O
deprotection	325	337	O
and	338	341	O
acylation	342	351	O
gives	352	357	O
the	358	361	O
bisalkenyl	362	372	O
derivative	373	383	O
5	384	385	O
.	385	386	O

In	387	389	O
apolar	390	396	O
solvents	397	405	O
this	406	410	O
tetraurea	411	420	O
calix	421	426	O
[	426	427	O
4	427	428	O
]	428	429	O
arene	429	434	O
5	435	436	O
forms	437	442	O
regioselectively	443	459	O
a	460	461	O
single	462	468	O
hydrogen	469	477	O
-	477	478	O
bonded	478	484	O
homodimer	485	494	O
,	494	495	O
from	496	500	O
which	501	506	O
the	507	510	O
bis	511	514	O
[	514	515	O
2	515	516	O
]	516	517	O
catenane	517	525	O
10a	526	529	O
is	530	532	O
formed	533	539	O
in	540	542	O
49	543	545	O
%	545	546	O
by	547	549	O
a	550	551	O
metathesis	552	562	O
reaction	563	571	O
followed	572	580	O
by	581	583	O
hydrogenation	584	597	O
.	597	598	O

Bis	599	602	O
-	602	603	O
loop	603	607	O
derivative	608	618	O
6	619	620	O
forms	621	626	O
no	627	629	O
homodimers	630	640	O
for	641	644	O
steric	645	651	O
reasons	652	659	O
,	659	660	O
but	661	664	O
a	665	666	O
stoichiometric	667	681	O
mixture	682	689	O
with	690	694	O
the	695	698	O
open	699	703	O
-	703	704	O
chain	704	709	O
tetraalkenyl	710	722	O
derivative	723	733	O
7a	734	736	O
contains	737	745	O
exclusively	746	757	O
the	758	761	O
heterodimer	762	773	O
.	773	774	O

Metathesis	775	785	O
and	786	789	O
subsequent	790	800	O
hydrogenation	801	814	O
now	815	818	O
yields	819	825	O
65	826	828	O
%	829	830	O
of	831	833	O
the	834	837	O
pure	838	842	O
bis	843	846	O
[	846	847	O
2	847	848	O
]	848	849	O
catenane	849	857	O
10a	858	861	O
which	862	867	O
could	868	873	O
not	874	877	O
be	878	880	O
isolated	881	889	O
from	890	894	O
the	895	898	O
complex	899	906	O
reaction	907	915	O
mixture	916	923	O
obtained	924	932	O
from	933	937	O
the	938	941	O
homodimer	942	951	O
7a	952	954	O
.	954	955	O
7a	955	957	O
.	957	958	O

The	959	962	O
chirality	963	972	O
of	973	975	O
10a	976	979	O
(	980	981	O
D	981	982	O
(	982	983	O
2	983	984	O
)	984	985	O
symmetry	986	994	O
)	994	995	O
has	996	999	O
been	1000	1004	O
verified	1005	1013	O
by	1014	1016	O
optical	1017	1024	O
resolution	1025	1035	O
using	1036	1041	O
HPLC	1042	1046	O
on	1047	1049	O
a	1050	1051	O
chiral	1052	1058	O
stationary	1059	1069	O
phase	1070	1075	O
.	1075	1076	O

Sciatic	0	7	B-Multi-tissue_structure
nerve	8	13	I-Multi-tissue_structure
repair	14	20	O
by	21	23	O
microgrooved	24	36	O
nerve	37	42	B-Multi-tissue_structure
conduits	43	51	O
made	52	56	O
of	57	59	O
chitosan	60	68	O
-	68	69	O
gold	69	73	O
nanocomposites	74	88	O
.	88	89	O

BACKGROUND	90	100	O
:	100	101	O

To	102	104	O
better	105	111	O
direct	112	118	O
the	119	122	O
repair	123	129	O
of	130	132	O
peripheral	133	143	B-Multi-tissue_structure
nerve	144	149	I-Multi-tissue_structure
after	150	155	O
injury	156	162	O
,	162	163	O
an	164	166	O
implant	167	174	O
consisting	175	185	O
of	186	188	O
a	189	190	O
multicomponent	191	205	O
micropatterned	206	220	O
conduit	221	228	B-Multi-tissue_structure
seeded	229	235	O
with	236	240	O
NSC	241	244	B-Cell
was	245	248	O
designed	249	257	O
.	257	258	O

METHODS	259	266	O
:	266	267	O

The	268	271	O
mechanical	272	282	O
properties	283	293	O
of	294	296	O
the	297	300	O
chi	301	304	O
-	304	305	O
Au	305	307	O
nanocomposites	308	322	O
were	323	327	O
tested	328	334	O
.	334	335	O

In	336	338	O
vitro	339	344	O
,	344	345	O
the	346	349	O
effect	350	356	O
of	357	359	O
chi	360	363	O
-	363	364	O
Au	364	366	O
on	367	369	O
cell	370	374	B-Cell
behavior	375	383	O
(	384	385	O
NSC	385	388	B-Cell
and	389	392	O
glial	393	398	B-Cell
cell	399	403	I-Cell
line	404	408	I-Cell
C6	409	411	I-Cell
)	411	412	O
and	413	416	O
the	417	420	O
influence	421	430	O
of	431	433	O
micropattern	434	446	O
on	447	449	O
cell	450	454	B-Cell
alignment	455	464	O
were	465	469	O
evaluated	470	479	O
.	479	480	O

In	481	483	O
vivo	484	488	O
,	488	489	O
the	490	493	O
micropatterned	494	508	O
conduits	509	517	O
with	518	522	O
/	522	523	O
without	523	530	O
the	531	534	O
preseeded	535	544	O
NSC	545	548	B-Cell
were	549	553	O
implanted	554	563	O
to	564	566	O
bridge	567	573	O
a	574	575	O
10	576	578	O
-	578	579	O
mm	579	581	O
-	581	582	O
long	582	586	O
defect	587	593	O
of	594	596	O
the	597	600	O
sciatic	601	608	B-Multi-tissue_structure
nerve	609	614	I-Multi-tissue_structure
in	615	617	O
9	618	619	O
male	620	624	O
Sprague	625	632	O
-	632	633	O
Dawley	633	639	O
rats	640	644	O
.	644	645	O

The	646	649	O
repair	650	656	O
outcome	657	664	O
was	665	668	O
investigated	669	681	O
6	682	683	O
weeks	684	689	O
after	690	695	O
the	696	699	O
surgery	700	707	O
.	707	708	O

RESULTS	709	716	O
:	716	717	O

Based	718	723	O
on	724	726	O
the	727	730	O
dynamic	731	738	O
modulus	739	746	O
,	746	747	O
chitosan	748	756	O
with	757	761	O
50	762	764	O
ppm	765	768	O
or	769	771	O
more	772	776	O
gold	777	781	O
was	782	785	O
a	786	787	O
stronger	788	796	O
material	797	805	O
than	806	810	O
others	811	817	O
.	817	818	O

In	819	821	O
vitro	822	827	O
,	827	828	O
gold	829	833	O
at	834	836	O
25	837	839	O
or	840	842	O
50	843	845	O
ppm	846	849	O
led	850	853	O
to	854	856	O
better	857	863	O
cell	864	868	B-Cell
performance	869	880	O
for	881	884	O
NSC	885	888	B-Cell
;	888	889	O
and	890	893	O
gold	894	898	O
at	899	901	O
50	902	904	O
ppm	905	908	O
gave	909	913	O
better	914	920	O
cell	921	925	B-Cell
performance	926	937	O
for	938	941	O
C6	942	944	B-Cell
.	944	945	O

On	946	948	O
the	949	952	O
microgrooved	953	965	O
substrate	966	975	O
,	975	976	O
the	977	980	O
NSC	981	984	B-Cell
had	985	988	O
elongated	989	998	O
processes	999	1008	O
oriented	1009	1017	O
parallel	1018	1026	O
to	1027	1029	O
the	1030	1033	O
grooves	1034	1041	O
,	1041	1042	O
whereas	1043	1050	O
the	1051	1054	O
NSC	1055	1058	B-Cell
on	1059	1061	O
the	1062	1065	O
nonpatterned	1066	1078	O
surfaces	1079	1087	O
did	1088	1091	O
not	1092	1095	O
exhibit	1096	1103	O
a	1104	1105	O
particular	1106	1116	O
bias	1117	1121	O
in	1122	1124	O
alignment	1125	1134	O
.	1134	1135	O

In	1136	1138	O
vivo	1139	1143	O
,	1143	1144	O
the	1145	1148	O
number	1149	1155	O
of	1156	1158	O
regenerated	1159	1170	O
axons	1171	1176	O
,	1176	1177	O
the	1178	1181	O
regenerated	1182	1193	O
area	1194	1198	O
,	1198	1199	O
and	1200	1203	O
the	1204	1207	O
number	1208	1214	O
of	1215	1217	O
blood	1218	1223	B-Multi-tissue_structure
vessels	1224	1231	I-Multi-tissue_structure
were	1232	1236	O
significantly	1237	1250	O
higher	1251	1257	O
in	1258	1260	O
the	1261	1264	O
NSC	1265	1268	B-Cell
-	1268	1269	O
preseeded	1269	1278	O
conduit	1279	1286	O
.	1286	1287	O

CONCLUSION	1288	1298	O
:	1298	1299	O

Modification	1300	1312	O
of	1313	1315	O
the	1316	1319	O
chitosan	1320	1328	O
matrix	1329	1335	O
by	1336	1338	O
gold	1339	1343	O
nanoparticles	1344	1357	O
not	1358	1361	O
only	1362	1366	O
provides	1367	1375	O
the	1376	1379	O
mechanical	1380	1390	O
strength	1391	1399	O
but	1400	1403	O
also	1404	1408	O
affects	1409	1416	O
the	1417	1420	O
cellular	1421	1429	B-Cell
response	1430	1438	O
.	1438	1439	O

The	1440	1443	O
preliminary	1444	1455	O
in	1456	1458	O
vivo	1459	1463	O
data	1464	1468	O
demonstrated	1469	1481	O
that	1482	1486	O
the	1487	1490	O
biodegradable	1491	1504	O
micropatterned	1505	1519	O
conduits	1520	1528	O
preseeded	1529	1538	O
with	1539	1543	O
NSC	1544	1547	B-Cell
provided	1548	1556	O
a	1557	1558	O
combination	1559	1570	O
of	1571	1573	O
physical	1574	1582	O
and	1583	1586	O
biological	1587	1597	O
guidance	1598	1606	O
cues	1607	1611	O
for	1612	1615	O
regenerating	1616	1628	O
axons	1629	1634	B-Cellular_component
at	1635	1637	O
the	1638	1641	O
cellular	1642	1650	B-Cell
level	1651	1656	O
and	1657	1660	O
offered	1661	1668	O
a	1669	1670	O
better	1671	1677	O
alternative	1678	1689	O
for	1690	1693	O
repairing	1694	1703	O
sciatic	1704	1711	B-Multi-tissue_structure
nerve	1712	1717	I-Multi-tissue_structure
transactions	1718	1730	O
.	1730	1731	O

[	0	1	O
The	1	4	O
clinical	5	13	O
and	14	17	O
laboratory	18	28	O
features	29	37	O
of	38	40	O
acute	41	46	O
promyelocytic	47	60	O
leukemia	61	69	O
:	69	70	O
an	71	73	O
analysis	74	82	O
of	83	85	O
513	86	89	O
cases	90	95	O
]	95	96	O
.	96	97	O

OBJECTIVE	98	107	O
:	107	108	O

To	109	111	O
investigate	112	123	O
the	124	127	O
clinical	128	136	O
and	137	140	O
laboratory	141	151	O
features	152	160	O
of	161	163	O
acute	164	169	O
promyelocytic	170	183	O
leukemia	184	192	O
(	193	194	O
APL	194	197	O
)	197	198	O
.	198	199	O

METHODS	200	207	O
:	207	208	O

513	209	212	O
APL	213	216	O
patients	217	225	O
in	226	228	O
the	229	232	O
last	233	237	O
two	238	241	O
decades	242	249	O
were	250	254	O
retrospectively	255	270	O
analyzed	271	279	O
in	280	282	O
this	283	287	O
research	288	296	O
.	296	297	O

We	298	300	O
investigated	301	313	O
the	314	317	O
clinical	318	326	O
features	327	335	O
including	336	345	O
age	346	349	O
,	349	350	O
sex	351	354	O
,	354	355	O
abnormality	356	367	O
of	368	370	O
peripheral	371	381	O
hemogram	382	390	O
before	391	397	O
treatment	398	407	O
,	407	408	O
therapeutic	409	420	O
effect	421	427	O
and	428	431	O
follow	432	438	O
-	438	439	O
up	439	441	O
and	442	445	O
laboratory	446	456	O
data	457	461	O
such	462	466	O
as	467	469	O
morphology	470	480	O
,	480	481	O
immunology	482	492	O
,	492	493	O
cytogenetics	494	506	O
and	507	510	O
molecular	511	520	O
biology	521	528	O
(	529	530	O
MICM	530	534	O
)	534	535	O
.	535	536	O

RESULTS	537	544	O
:	544	545	O

The	546	549	O
median	550	556	O
age	557	560	O
of	561	563	O
the	564	567	O
APL	568	571	O
patients	572	580	O
was	581	584	O
33	585	587	O
years	588	593	O
old	594	597	O
and	598	601	O
the	602	605	O
ratio	606	611	O
of	612	614	O
male	615	619	O
and	620	623	O
female	624	630	O
was	631	634	O
1	635	636	O
.	636	637	O
21	637	639	O
:	639	640	O
1	640	641	O
.	641	642	O

Before	643	649	O
treatment	650	659	O
,	659	660	O
the	661	664	O
median	665	671	O
level	672	677	O
of	678	680	O
WBC	681	684	B-Cell
was	685	688	O
4	689	690	O
.	690	691	O
3	691	692	O
x	693	694	O
10	695	697	O
(	697	698	O
9	698	699	O
)	699	700	O
/	700	701	O
L	701	702	O
and	703	706	O
the	707	710	O
detection	711	720	O
rate	721	725	O
of	726	728	O
abnormal	729	737	O
promyelocyte	738	750	B-Cell
on	751	753	O
blood	754	759	B-Organism_substance
film	760	764	O
was	765	768	O
85	769	771	O
.	771	772	O
8	772	773	O
%	773	774	O
;	774	775	O
with	776	780	O
immunophenotypic	781	797	O
detection	798	807	O
,	807	808	O
the	809	812	O
expression	813	823	O
levels	824	830	O
of	831	833	O
CD117	834	839	O
,	839	840	O
CD34	841	845	O
,	845	846	O
HLA	847	850	O
-	850	851	O
DR	851	853	O
,	853	854	O
CD7	855	858	O
,	858	859	O
CD14	860	864	O
and	865	868	O
CD19	869	873	O
in	874	876	O
APL	877	880	O
were	881	885	O
found	886	891	O
to	892	894	O
be	895	897	O
lower	898	903	O
and	904	907	O
the	908	911	O
expression	912	922	O
levels	923	929	O
of	930	932	O
CD2	933	936	O
,	936	937	O
CD33	938	942	O
and	943	946	O
MPO	947	950	O
higher	951	957	O
than	958	962	O
those	963	968	O
in	969	971	O
other	972	977	O
subtypes	978	986	O
of	987	989	O
acute	990	995	O
myelocytic	996	1006	O
leukemia	1007	1015	O
(	1016	1017	O
AML	1017	1020	O
)	1020	1021	O
(	1022	1023	O
both	1023	1027	O
P	1028	1029	O
<	1030	1031	O
0	1032	1033	O
.	1033	1034	O
01	1034	1036	O
)	1036	1037	O
.	1037	1038	O

Specific	1039	1047	O
abnormal	1048	1056	O
chromosome	1057	1067	B-Cellular_component
t	1068	1069	O
(	1070	1071	O
15	1071	1073	O
;	1073	1074	O
17	1074	1076	O
)	1076	1077	O
was	1078	1081	O
detected	1082	1090	O
in	1091	1093	O
91	1094	1096	O
.	1096	1097	O
7	1097	1098	O
%	1098	1099	O
of	1100	1102	O
the	1103	1106	O
patients	1107	1115	O
,	1115	1116	O
of	1117	1119	O
whom	1120	1124	O
75	1125	1127	O
.	1127	1128	O
9	1128	1129	O
%	1129	1130	O
had	1131	1134	O
standard	1135	1143	O
translocation	1144	1157	O
of	1158	1160	O
t	1161	1162	O
(	1163	1164	O
15	1164	1166	O
;	1166	1167	O
17	1167	1169	O
)	1169	1170	O
,	1170	1171	O
being	1172	1177	O
the	1178	1181	O
most	1182	1186	O
common	1187	1193	O
one	1194	1197	O
and	1198	1201	O
15	1202	1204	O
.	1204	1205	O
8	1205	1206	O
%	1206	1207	O
of	1208	1210	O
the	1211	1214	O
patients	1215	1223	O
had	1224	1227	O
t	1228	1229	O
(	1230	1231	O
15	1231	1233	O
;	1233	1234	O
17	1234	1236	O
)	1236	1237	O
with	1238	1242	O
additional	1243	1253	O
abnormal	1254	1262	O
chromosome	1263	1273	B-Cellular_component
.	1273	1274	O

There	1275	1280	O
was	1281	1284	O
only	1285	1289	O
7	1290	1291	O
.	1291	1292	O
5	1292	1293	O
%	1293	1294	O
of	1295	1297	O
the	1298	1301	O
patients	1302	1310	O
with	1311	1315	O
normal	1316	1322	O
karyotype	1323	1332	O
.	1332	1333	O

However	1334	1341	O
,	1341	1342	O
the	1343	1346	O
presence	1347	1355	O
of	1356	1358	O
both	1359	1363	O
simple	1364	1370	O
translocation	1371	1384	O
and	1385	1388	O
complex	1389	1396	O
translocation	1397	1410	O
was	1411	1414	O
seldom	1415	1421	O
seen	1422	1426	O
.	1426	1427	O

With	1428	1432	O
molecular	1433	1442	O
biological	1443	1453	O
detection	1454	1463	O
,	1463	1464	O
PML	1465	1468	O
/	1468	1469	O
RARalpha	1469	1477	O
fusion	1478	1484	O
gene	1485	1489	O
positive	1490	1498	O
rate	1499	1503	O
was	1504	1507	O
99	1508	1510	O
.	1510	1511	O
6	1511	1512	O
%	1512	1513	O
.	1513	1514	O

In	1515	1517	O
a	1518	1519	O
relatively	1520	1530	O
long	1531	1535	O
clinical	1536	1544	O
follow	1545	1551	O
-	1551	1552	O
up	1552	1554	O
,	1554	1555	O
we	1556	1558	O
found	1559	1564	O
that	1565	1569	O
the	1570	1573	O
complete	1574	1582	O
remission	1583	1592	O
(	1593	1594	O
CR	1594	1596	O
)	1596	1597	O
rate	1598	1602	O
in	1603	1605	O
APL	1606	1609	O
patients	1610	1618	O
was	1619	1622	O
84	1623	1625	O
.	1625	1626	O
7	1626	1627	O
%	1627	1628	O
,	1628	1629	O
incidence	1630	1639	O
of	1640	1642	O
DIC	1643	1646	O
was	1647	1650	O
13	1651	1653	O
.	1653	1654	O
4	1654	1655	O
%	1655	1656	O
and	1657	1660	O
five	1661	1665	O
-	1665	1666	O
year	1666	1670	O
survival	1671	1679	O
rate	1680	1684	O
was	1685	1688	O
30	1689	1691	O
.	1691	1692	O
7	1692	1693	O
%	1693	1694	O
.	1694	1695	O

The	1696	1699	O
median	1700	1706	O
count	1707	1712	O
of	1713	1715	O
WBC	1716	1719	B-Cell
in	1720	1722	O
CR	1723	1725	O
group	1726	1731	O
was	1732	1735	O
lower	1736	1741	O
than	1742	1746	O
that	1747	1751	O
non	1752	1755	O
-	1755	1756	O
remission	1756	1765	O
group	1766	1771	O
(	1772	1773	O
P	1773	1774	O
<	1775	1776	O
0	1777	1778	O
.	1778	1779	O
01	1779	1781	O
)	1781	1782	O
.	1782	1783	O

There	1784	1789	O
were	1790	1794	O
no	1795	1797	O
significant	1798	1809	O
differences	1810	1821	O
on	1822	1824	O
expressions	1825	1836	O
of	1837	1839	O
CD34	1840	1844	O
and	1845	1848	O
CD2	1849	1852	O
and	1853	1856	O
changes	1857	1864	O
of	1865	1867	O
cytogenetics	1868	1880	O
between	1881	1888	O
the	1889	1892	O
two	1893	1896	O
groups	1897	1903	O
(	1904	1905	O
P	1905	1906	O
>	1907	1908	O
0	1909	1910	O
.	1910	1911	O
05	1911	1913	O
)	1913	1914	O
.	1914	1915	O

CONCLUSIONS	1916	1927	O
:	1927	1928	O

Comprehensive	1929	1942	O
evaluation	1943	1953	O
of	1954	1956	O
MICM	1957	1961	O
could	1962	1967	O
be	1968	1970	O
of	1971	1973	O
important	1974	1983	O
significance	1984	1996	O
in	1997	1999	O
the	2000	2003	O
diagnosis	2004	2013	O
and	2014	2017	O
prognosis	2018	2027	O
judgment	2028	2036	O
for	2037	2040	O
APL	2041	2044	O
patients	2045	2053	O
.	2053	2054	O

The	2055	2058	O
CR	2059	2061	O
rate	2062	2066	O
in	2067	2069	O
these	2070	2075	O
patients	2076	2084	O
with	2085	2089	O
high	2090	2094	O
WBC	2095	2098	B-Cell
count	2099	2104	O
was	2105	2108	O
considerable	2109	2121	O
low	2122	2125	O
.	2125	2126	O

Cognitive	0	9	O
function	10	18	O
and	19	22	O
number	23	29	O
of	30	32	O
teeth	33	38	B-Organ
in	39	41	O
a	42	43	O
community	44	53	O
-	53	54	O
dwelling	54	62	O
elderly	63	70	O
population	71	81	O
without	82	89	O
dementia	90	98	O
.	98	99	O

Although	100	108	O
the	109	112	O
number	113	119	O
of	120	122	O
sound	123	128	O
or	129	131	O
decayed	132	139	O
teeth	140	145	B-Organ
has	146	149	O
been	150	154	O
reported	155	163	O
to	164	166	O
be	167	169	O
associated	170	180	O
with	181	185	O
cognitive	186	195	O
function	196	204	O
in	205	207	O
elderly	208	215	O
populations	216	227	O
with	228	232	O
dementia	233	241	O
,	241	242	O
little	243	249	O
is	250	252	O
known	253	258	O
about	259	264	O
this	265	269	O
association	270	281	O
in	282	284	O
elderly	285	292	O
populations	293	304	O
without	305	312	O
dementia	313	321	O
.	321	322	O

We	323	325	O
evaluated	326	335	O
this	336	340	O
relationship	341	353	O
,	353	354	O
with	355	359	O
adjustment	360	370	O
for	371	374	O
confounding	375	386	O
factors	387	394	O
,	394	395	O
in	396	398	O
Japanese	399	407	O
populations	408	419	O
of	420	422	O
60	423	425	O
-	425	426	O
year	426	430	O
-	430	431	O
old	431	434	O
(	435	436	O
n	436	437	O
=	438	439	O
270	440	443	O
;	443	444	O
120	445	448	O
males	449	454	O
and	455	458	O
150	459	462	O
females	463	470	O
)	470	471	O
and	472	475	O
65	476	478	O
-	478	479	O
year	479	483	O
-	483	484	O
old	484	487	O
(	488	489	O
n	489	490	O
=	491	492	O
123	493	496	O
;	496	497	O
57	498	500	O
males	501	506	O
and	507	510	O
66	511	513	O
females	514	521	O
)	521	522	O
individuals	523	534	O
residing	535	543	O
in	544	546	O
Fukuoka	547	554	O
Prefecture	555	565	O
of	566	568	O
Japan	569	574	O
.	574	575	O

Dental	576	582	O
examinations	583	595	O
were	596	600	O
performed	601	610	O
in	611	613	O
all	614	617	O
subjects	618	626	O
,	626	627	O
along	628	633	O
with	634	638	O
the	639	642	O
Mini	643	647	O
-	647	648	O
mental	648	654	O
state	655	660	O
examination	661	672	O
(	673	674	O
MMSE	674	678	O
)	678	679	O
for	680	683	O
assessing	684	693	O
cognitive	694	703	O
function	704	712	O
.	712	713	O

Among	714	719	O
the	720	723	O
total	724	729	O
of	730	732	O
393	733	736	O
subjects	737	745	O
,	745	746	O
the	747	750	O
mean	751	755	O
MMSE	756	760	O
score	761	766	O
was	767	770	O
27	771	773	O
.	773	774	O
9	774	775	O
+	776	777	O
/	777	778	O
-	778	779	O
1	780	781	O
.	781	782	O
9	782	783	O
,	783	784	O
and	785	788	O
391	789	792	O
subjects	793	801	O
scored	802	808	O
24	809	811	O
or	812	814	O
higher	815	821	O
.	821	822	O

The	823	826	O
mean	827	831	O
numbers	832	839	O
of	840	842	O
sound	843	848	O
and	849	852	O
decayed	853	860	O
teeth	861	866	B-Organ
were	867	871	O
12	872	874	O
.	874	875	O
0	875	876	O
+	877	878	O
/	878	879	O
-	879	880	O
6	881	882	O
.	882	883	O
3	883	884	O
and	885	888	O
0	889	890	O
.	890	891	O
5	891	892	O
+	893	894	O
/	894	895	O
-	895	896	O
1	897	898	O
.	898	899	O
2	899	900	O
,	900	901	O
respectively	902	914	O
.	914	915	O

Associations	916	928	O
were	929	933	O
found	934	939	O
between	940	947	O
the	948	951	O
numbers	952	959	O
of	960	962	O
sound	963	968	O
and	969	972	O
decayed	973	980	O
teeth	981	986	B-Organ
and	987	990	O
MMSE	991	995	O
in	996	998	O
total	999	1004	O
subjects	1005	1013	O
and	1014	1017	O
males	1018	1023	O
,	1023	1024	O
but	1025	1028	O
not	1029	1032	O
in	1033	1035	O
females	1036	1043	O
,	1043	1044	O
by	1045	1047	O
multiple	1048	1056	O
regression	1057	1067	O
analysis	1068	1076	O
adjusted	1077	1085	O
for	1086	1089	O
gender	1090	1096	O
,	1096	1097	O
age	1098	1101	O
,	1101	1102	O
level	1103	1108	O
of	1109	1111	O
education	1112	1121	O
,	1121	1122	O
marital	1123	1130	O
status	1131	1137	O
,	1137	1138	O
smoking	1139	1146	O
,	1146	1147	O
alcohol	1148	1155	O
drinking	1156	1164	O
,	1164	1165	O
working	1166	1173	O
status	1174	1180	O
,	1180	1181	O
systolic	1182	1190	O
blood	1191	1196	B-Organism_substance
pressure	1197	1205	O
and	1206	1209	O
blood	1210	1215	B-Organism_substance
glucose	1216	1223	O
.	1223	1224	O

An	1225	1227	O
association	1228	1239	O
was	1240	1243	O
also	1244	1248	O
found	1249	1254	O
between	1255	1262	O
MMSE	1263	1267	O
and	1268	1271	O
the	1272	1275	O
number	1276	1282	O
of	1283	1285	O
sound	1286	1291	O
teeth	1292	1297	B-Organ
in	1298	1300	O
a	1301	1302	O
logistic	1303	1311	O
regression	1312	1322	O
analysis	1323	1331	O
.	1331	1332	O

In	1333	1335	O
conclusion	1336	1346	O
,	1346	1347	O
associations	1348	1360	O
were	1361	1365	O
found	1366	1371	O
between	1372	1379	O
normal	1380	1386	O
-	1386	1387	O
range	1387	1392	O
cognitive	1393	1402	O
function	1403	1411	O
and	1412	1415	O
the	1416	1419	O
numbers	1420	1427	O
of	1428	1430	O
sound	1431	1436	O
and	1437	1440	O
decayed	1441	1448	O
teeth	1449	1454	B-Organ
,	1454	1455	O
after	1456	1461	O
adjustment	1462	1472	O
for	1473	1476	O
various	1477	1484	O
confounding	1485	1496	O
factors	1497	1504	O
,	1504	1505	O
in	1506	1508	O
an	1509	1511	O
elderly	1512	1519	O
Japanese	1520	1528	O
population	1529	1539	O
.	1539	1540	O

Comment	0	7	O
on	8	10	O
"	11	12	O
Why	12	15	O
reduced	16	23	O
-	23	24	O
form	24	28	O
regression	29	39	O
models	40	46	O
of	47	49	O
health	50	56	O
effects	57	64	O
versus	65	71	O
exposures	72	81	O
should	82	88	O
not	89	92	O
replace	93	100	O
QRA	101	104	O
:	104	105	O
livestock	106	115	O
production	116	126	O
and	127	130	O
infant	131	137	O
mortality	138	147	O
as	148	150	O
an	151	153	O
example	154	161	O
,	161	162	O
"	162	163	O
by	164	166	O
Louis	167	172	O
Anthony	173	180	O
(	181	182	O
Tony	182	186	O
)	186	187	O
Cox	188	191	O
,	191	192	O
Jr	193	195	O
.	195	196	O
,	196	197	O
Risk	198	202	O
Analysis	203	211	O
2009	212	216	O
,	216	217	O
Vol	218	221	O
.	221	222	O

29	223	225	O
,	225	226	O
No	227	229	O
.	229	230	O
12	231	233	O
.	233	234	O

While	235	240	O
a	241	242	O
recent	243	249	O
paper	250	255	O
by	256	258	O
Cox	259	262	O
in	263	265	O
this	266	270	O
journal	271	278	O
uses	279	283	O
as	284	286	O
its	287	290	O
motivating	291	301	O
factor	302	308	O
the	309	312	O
benefits	313	321	O
of	322	324	O
quantitative	325	337	O
risk	338	342	O
assessment	343	353	O
,	353	354	O
its	355	358	O
content	359	366	O
is	367	369	O
entirely	370	378	O
devoted	379	386	O
to	387	389	O
critiquing	390	400	O
Sneeringer	401	411	O
'	411	412	O
s	412	413	O
article	414	421	O
in	422	424	O
the	425	428	O
American	429	437	O
Journal	438	445	O
of	446	448	O
Agricultural	449	461	O
Economics	462	471	O
.	471	472	O

Cox	473	476	O
'	476	477	O
s	477	478	O
two	479	482	O
main	483	487	O
critiques	488	497	O
of	498	500	O
Sneeringer	501	511	O
are	512	515	O
fundamentally	516	529	O
flawed	530	536	O
and	537	540	O
misrepresent	541	553	O
the	554	557	O
original	558	566	O
article	567	574	O
.	574	575	O

Cox	576	579	O
posits	580	586	O
that	587	591	O
Sneeringer	592	602	O
did	603	606	O
A	607	608	O
and	609	612	O
B	613	614	O
,	614	615	O
and	616	619	O
then	620	624	O
argues	625	631	O
why	632	635	O
A	636	637	O
and	638	641	O
B	642	643	O
are	644	647	O
incorrect	648	657	O
.	657	658	O

However	659	666	O
,	666	667	O
Sneeringer	668	678	O
in	679	681	O
fact	682	686	O
did	687	690	O
C	691	692	O
and	693	696	O
D	697	698	O
;	698	699	O
thus	700	704	O
critiques	705	714	O
of	715	717	O
A	718	719	O
and	720	723	O
B	724	725	O
are	726	729	O
not	730	733	O
applicable	734	744	O
to	745	747	O
Sneeringer	748	758	O
'	758	759	O
s	759	760	O
analysis	761	769	O
.	769	770	O

Prognostic	0	10	O
significance	11	23	O
of	24	26	O
TRAIL	27	32	O
signaling	33	42	O
molecules	43	52	O
in	53	55	O
stage	56	61	B-Pathological_formation
II	62	64	I-Pathological_formation
and	65	68	I-Pathological_formation
III	69	72	I-Pathological_formation
colorectal	73	83	I-Pathological_formation
cancer	84	90	I-Pathological_formation
.	90	91	O

PURPOSE	92	99	O
:	99	100	O

We	101	103	O
previously	104	114	O
found	115	120	O
that	121	125	O
cellular	126	134	O
FLICE	135	140	O
-	140	141	O
inhibitory	141	151	O
protein	152	159	O
(	160	161	O
c	161	162	O
-	162	163	O
FLIP	163	167	O
)	167	168	O
,	168	169	O
caspase	170	177	O
8	178	179	O
,	179	180	O
and	181	184	O
tumor	185	190	O
necrosis	191	199	O
factor	200	206	O
-	206	207	O
related	207	214	O
apoptosis	215	224	O
-	224	225	O
inducing	225	233	O
ligand	234	240	O
(	241	242	O
TRAIL	242	247	O
)	247	248	O
receptor	249	257	O
2	258	259	O
(	260	261	O
DR5	261	264	O
)	264	265	O
are	266	269	O
major	270	275	O
regulators	276	286	O
of	287	289	O
cell	290	294	B-Cell
viability	295	304	O
and	305	308	O
chemotherapy	309	321	O
-	321	322	O
induced	322	329	O
apoptosis	330	339	O
in	340	342	O
colorectal	343	353	B-Pathological_formation
cancer	354	360	I-Pathological_formation
.	360	361	O

In	362	364	O
this	365	369	O
study	370	375	O
,	375	376	O
we	377	379	O
determined	380	390	O
the	391	394	O
prognostic	395	405	O
significance	406	418	O
of	419	421	O
c	422	423	O
-	423	424	O
FLIP	424	428	O
,	428	429	O
caspase	430	437	O
8	438	439	O
,	439	440	O
TRAIL	441	446	O
and	447	450	O
DR5	451	454	O
expression	455	465	O
in	466	468	O
tissues	469	476	B-Tissue
from	477	481	O
patients	482	490	O
with	491	495	O
stage	496	501	B-Pathological_formation
II	502	504	I-Pathological_formation
and	505	508	I-Pathological_formation
III	509	512	I-Pathological_formation
colorectal	513	523	I-Pathological_formation
cancer	524	530	I-Pathological_formation
.	530	531	O

EXPERIMENTAL	532	544	O
DESIGN	545	551	O
:	551	552	O

Tissue	553	559	B-Tissue
microarrays	560	571	O
were	572	576	O
constructed	577	588	O
from	589	593	O
matched	594	601	O
normal	602	608	B-Tissue
and	609	612	O
tumor	613	618	B-Tissue
tissue	619	625	I-Tissue
derived	626	633	O
from	634	638	O
patients	639	647	O
(	648	649	O
n	649	650	O
=	651	652	O
253	653	656	O
)	656	657	O
enrolled	658	666	O
in	667	669	O
a	670	671	O
phase	672	677	O
III	678	681	O
trial	682	687	O
of	688	690	O
adjuvant	691	699	O
5	700	701	O
-	701	702	O
fluorouracil	702	714	O
-	714	715	O
based	715	720	O
chemotherapy	721	733	O
versus	734	740	O
postoperative	741	754	O
observation	755	766	O
alone	767	772	O
.	772	773	O

TRAIL	774	779	O
,	779	780	O
DR5	781	784	O
,	784	785	O
caspase	786	793	O
8	794	795	O
,	795	796	O
and	797	800	O
c	801	802	O
-	802	803	O
FLIP	803	807	O
expression	808	818	O
levels	819	825	O
were	826	830	O
determined	831	841	O
by	842	844	O
immunohistochemistry	845	865	O
.	865	866	O

RESULTS	867	874	O
:	874	875	O

Colorectal	876	886	B-Pathological_formation
tumors	887	893	I-Pathological_formation
displayed	894	903	O
significantly	904	917	O
higher	918	924	O
expression	925	935	O
levels	936	942	O
of	943	945	O
c	946	947	O
-	947	948	O
FLIP	948	952	O
(	953	954	O
P	954	955	O
<	956	957	O
0	958	959	O
.	959	960	O
001	960	963	O
)	963	964	O
,	964	965	O
caspase	966	973	O
8	974	975	O
(	976	977	O
P	977	978	O
=	979	980	O
0	981	982	O
.	982	983	O
01	983	985	O
)	985	986	O
,	986	987	O
and	988	991	O
DR5	992	995	O
(	996	997	O
P	997	998	O
<	999	1000	O
0	1001	1002	O
.	1002	1003	O
001	1003	1006	O
)	1006	1007	O
,	1007	1008	O
but	1009	1012	O
lower	1013	1018	O
levels	1019	1025	O
of	1026	1028	O
TRAIL	1029	1034	O
(	1035	1036	O
P	1036	1037	O
<	1038	1039	O
0	1040	1041	O
.	1041	1042	O
001	1042	1045	O
)	1045	1046	O
compared	1047	1055	O
with	1056	1060	O
matched	1061	1068	O
normal	1069	1075	B-Tissue
tissue	1076	1082	I-Tissue
.	1082	1083	O

In	1084	1086	O
univariate	1087	1097	O
analysis	1098	1106	O
,	1106	1107	O
higher	1108	1114	O
TRAIL	1115	1120	O
expression	1121	1131	O
in	1132	1134	O
the	1135	1138	O
tumor	1139	1144	B-Pathological_formation
was	1145	1148	O
associated	1149	1159	O
with	1160	1164	O
worse	1165	1170	O
overall	1171	1178	O
survival	1179	1187	O
(	1188	1189	O
P	1189	1190	O
=	1191	1192	O
0	1193	1194	O
.	1194	1195	O
026	1195	1198	O
)	1198	1199	O
,	1199	1200	O
with	1201	1205	O
a	1206	1207	O
trend	1208	1213	O
to	1214	1216	O
decreased	1217	1226	O
relapse	1227	1234	O
-	1234	1235	O
free	1235	1239	O
survival	1240	1248	O
(	1249	1250	O
RFS	1250	1253	O
;	1253	1254	O
P	1255	1256	O
=	1257	1258	O
0	1259	1260	O
.	1260	1261	O
06	1261	1263	O
)	1263	1264	O
,	1264	1265	O
and	1266	1269	O
higher	1270	1276	O
tumor	1277	1282	B-Pathological_formation
c	1283	1284	O
-	1284	1285	O
FLIP	1285	1289	O
expression	1290	1300	O
was	1301	1304	O
associated	1305	1315	O
with	1316	1320	O
a	1321	1322	O
significantly	1323	1336	O
decreased	1337	1346	O
RFS	1347	1350	O
(	1351	1352	O
P	1352	1353	O
=	1354	1355	O
0	1356	1357	O
.	1357	1358	O
015	1358	1361	O
)	1361	1362	O
.	1362	1363	O

Using	1364	1369	O
multivariate	1370	1382	O
predictive	1383	1393	O
modeling	1394	1402	O
for	1403	1406	O
RFS	1407	1410	O
in	1411	1413	O
all	1414	1417	O
patients	1418	1426	O
and	1427	1430	O
including	1431	1440	O
all	1441	1444	O
biomarkers	1445	1455	O
,	1455	1456	O
age	1457	1460	O
,	1460	1461	O
treatment	1462	1471	O
,	1471	1472	O
and	1473	1476	O
stage	1477	1482	O
,	1482	1483	O
we	1484	1486	O
found	1487	1492	O
that	1493	1497	O
the	1498	1501	O
model	1502	1507	O
was	1508	1511	O
significant	1512	1523	O
when	1524	1528	O
the	1529	1532	O
mean	1533	1537	O
tumor	1538	1543	B-Pathological_formation
c	1544	1545	O
-	1545	1546	O
FLIP	1546	1550	O
expression	1551	1561	O
score	1562	1567	O
and	1568	1571	O
disease	1572	1579	O
stage	1580	1585	O
were	1586	1590	O
included	1591	1599	O
(	1600	1601	O
P	1601	1602	O
<	1603	1604	O
0	1605	1606	O
.	1606	1607	O
001	1607	1610	O
)	1610	1611	O
.	1611	1612	O

As	1613	1615	O
regards	1616	1623	O
overall	1624	1631	O
survival	1632	1640	O
,	1640	1641	O
the	1642	1645	O
overall	1646	1653	O
model	1654	1659	O
was	1660	1663	O
predictive	1664	1674	O
when	1675	1679	O
both	1680	1684	O
TRAIL	1685	1690	O
expression	1691	1701	O
and	1702	1705	O
disease	1706	1713	O
stage	1714	1719	O
were	1720	1724	O
included	1725	1733	O
(	1734	1735	O
P	1735	1736	O
<	1737	1738	O
0	1739	1740	O
.	1740	1741	O
001	1741	1744	O
)	1744	1745	O
.	1745	1746	O

CONCLUSIONS	1747	1758	O
:	1758	1759	O

High	1760	1764	O
c	1765	1766	O
-	1766	1767	O
FLIP	1767	1771	O
and	1772	1775	O
TRAIL	1776	1781	O
expression	1782	1792	O
may	1793	1796	O
be	1797	1799	O
independent	1800	1811	O
adverse	1812	1819	O
prognostic	1820	1830	O
markers	1831	1838	O
in	1839	1841	O
stage	1842	1847	B-Pathological_formation
II	1848	1850	I-Pathological_formation
and	1851	1854	I-Pathological_formation
III	1855	1858	I-Pathological_formation
colorectal	1859	1869	I-Pathological_formation
cancer	1870	1876	I-Pathological_formation
and	1877	1880	O
might	1881	1886	O
identify	1887	1895	O
patients	1896	1904	O
most	1905	1909	O
at	1910	1912	O
risk	1913	1917	O
of	1918	1920	O
relapse	1921	1928	O
.	1928	1929	O

Influences	0	10	O
on	11	13	O
the	14	17	O
pharmacokinetics	18	34	O
of	35	37	O
oxycodone	38	47	O
:	47	48	O
a	49	50	O
multicentre	51	62	O
cross	63	68	O
-	68	69	O
sectional	69	78	O
study	79	84	O
in	85	87	O
439	88	91	O
adult	92	97	O
cancer	98	104	B-Pathological_formation
patients	105	113	O
.	113	114	O

OBJECTIVE	115	124	O
:	124	125	O

Oxycodone	126	135	O
is	136	138	O
widely	139	145	O
used	146	150	O
for	151	154	O
the	155	158	O
treatment	159	168	O
of	169	171	O
cancer	172	178	B-Pathological_formation
pain	179	183	O
,	183	184	O
but	185	188	O
little	189	195	O
is	196	198	O
known	199	204	O
of	205	207	O
its	208	211	O
pharmacokinetics	212	228	O
in	229	231	O
cancer	232	238	B-Pathological_formation
pain	239	243	O
patients	244	252	O
.	252	253	O

The	254	257	O
aim	258	261	O
of	262	264	O
this	265	269	O
study	270	275	O
was	276	279	O
to	280	282	O
explore	283	290	O
the	291	294	O
relationships	295	308	O
between	309	316	O
ordinary	317	325	O
patient	326	333	O
characteristics	334	349	O
and	350	353	O
serum	354	359	B-Organism_substance
concentrations	360	374	O
of	375	377	O
oxycodone	378	387	O
and	388	391	O
the	392	395	O
ratios	396	402	O
noroxycodone	403	415	O
or	416	418	O
oxymorphone	419	430	O
/	430	431	O
oxycodone	431	440	O
in	441	443	O
cancer	444	450	B-Pathological_formation
patients	451	459	O
.	459	460	O

METHODS	461	468	O
:	468	469	O

Four	470	474	O
hundred	475	482	O
and	483	486	O
thirty	487	493	O
-	493	494	O
nine	494	498	O
patients	499	507	O
using	508	513	O
oral	514	518	O
oxycodone	519	528	O
for	529	532	O
cancer	533	539	B-Pathological_formation
pain	540	544	O
were	545	549	O
included	550	558	O
.	558	559	O

The	560	563	O
patients	564	572	O
'	572	573	O
characteristics	574	589	O
(	590	591	O
sex	591	594	O
,	594	595	O
age	596	599	O
,	599	600	O
body	601	605	B-Organism_subdivision
mass	606	610	O
index	611	616	O
[	617	618	O
BMI	618	621	O
]	621	622	O
,	622	623	O
Karnofsky	624	633	O
performance	634	645	O
status	646	652	O
,	652	653	O
"	654	655	O
time	655	659	O
since	660	665	O
starting	666	674	O
opioids	675	682	O
"	682	683	O
,	683	684	O
"	685	686	O
oxycodone	686	695	O
total	696	701	O
daily	702	707	O
dose	708	712	O
"	712	713	O
,	713	714	O
"	715	716	O
time	716	720	O
from	721	725	O
last	726	730	O
oxycodone	731	740	O
dose	741	745	O
"	745	746	O
,	746	747	O
use	748	751	O
of	752	754	O
CYP3A4	755	761	O
inducer	762	769	O
/	769	770	O
inhibitor	770	779	O
,	779	780	O
"	781	782	O
use	782	785	O
of	786	788	O
systemic	789	797	O
steroids	798	806	O
"	806	807	O
,	807	808	O
"	809	810	O
number	810	816	O
of	817	819	O
medications	820	831	O
taken	832	837	O
in	838	840	O
the	841	844	O
last	845	849	O
24	850	852	O
h	853	854	O
"	854	855	O
,	855	856	O
glomerular	857	867	B-Multi-tissue_structure
filtration	868	878	O
rate	879	883	O
(	884	885	O
GFR	885	888	O
)	888	889	O
and	890	893	O
albumin	894	901	O
serum	902	907	B-Organism_substance
concentrations	908	922	O
)	922	923	O
influence	924	933	O
on	934	936	O
oxycodone	937	946	O
serum	947	952	B-Organism_substance
concentrations	953	967	O
or	968	970	O
metabolite	971	981	O
/	981	982	O
oxycodone	982	991	O
ratios	992	998	O
were	999	1003	O
explored	1004	1012	O
by	1013	1015	O
multiple	1016	1024	O
regression	1025	1035	O
analyses	1036	1044	O
.	1044	1045	O

RESULTS	1046	1053	O
:	1053	1054	O

Sex	1055	1058	O
,	1058	1059	O
CYP3A4	1060	1066	O
inducers	1067	1075	O
/	1075	1076	O
inhibitors	1076	1086	O
,	1086	1087	O
total	1088	1093	O
daily	1094	1099	O
dose	1100	1104	O
,	1104	1105	O
and	1106	1109	O
"	1110	1111	O
time	1111	1115	O
from	1116	1120	O
last	1121	1125	O
oxycodone	1126	1135	O
dose	1136	1140	O
"	1140	1141	O
predicted	1142	1151	O
oxycodone	1152	1161	O
concentrations	1162	1176	O
.	1176	1177	O

CYP3A4	1178	1184	O
inducers	1185	1193	O
,	1193	1194	O
total	1195	1200	O
daily	1201	1206	O
dose	1207	1211	O
,	1211	1212	O
and	1213	1216	O
"	1217	1218	O
number	1218	1224	O
of	1225	1227	O
medications	1228	1239	O
taken	1240	1245	O
in	1246	1248	O
the	1249	1252	O
last	1253	1257	O
24	1258	1260	O
h	1261	1262	O
"	1262	1263	O
predicted	1264	1273	O
the	1274	1277	O
oxymorphone	1278	1289	O
/	1289	1290	O
oxycodone	1290	1299	O
ratio	1300	1305	O
.	1305	1306	O

Total	1307	1312	O
daily	1313	1318	O
dose	1319	1323	O
,	1323	1324	O
"	1325	1326	O
time	1326	1330	O
from	1331	1335	O
last	1336	1340	O
dose	1341	1345	O
to	1346	1348	O
blood	1349	1354	B-Organism_substance
sample	1355	1361	I-Organism_substance
"	1361	1362	O
,	1362	1363	O
albumin	1364	1371	O
,	1371	1372	O
sex	1373	1376	O
,	1376	1377	O
CYP3A4	1378	1384	O
inducers	1385	1393	O
/	1393	1394	O
inhibitors	1394	1404	O
,	1404	1405	O
steroids	1406	1414	O
,	1414	1415	O
BMI	1416	1419	O
and	1420	1423	O
GFR	1424	1427	O
predicted	1428	1437	O
the	1438	1441	O
noroxycodone	1442	1454	O
/	1454	1455	O
oxycodone	1455	1464	O
ratio	1465	1470	O
.	1470	1471	O

CONCLUSION	1472	1482	O
:	1482	1483	O

Women	1484	1489	O
had	1490	1493	O
lower	1494	1499	O
oxycodone	1500	1509	O
serum	1510	1515	B-Organism_substance
concentrations	1516	1530	O
than	1531	1535	O
men	1536	1539	O
.	1539	1540	O

CYP3A4	1541	1547	O
inducers	1548	1556	O
/	1556	1557	O
inhibitors	1557	1567	O
should	1568	1574	O
be	1575	1577	O
used	1578	1582	O
with	1583	1587	O
caution	1588	1595	O
as	1596	1598	O
these	1599	1604	O
are	1605	1608	O
predicted	1609	1618	O
to	1619	1621	O
have	1622	1626	O
a	1627	1628	O
significant	1629	1640	O
impact	1641	1647	O
on	1648	1650	O
oxycodone	1651	1660	O
pharmacokinetics	1661	1677	O
.	1677	1678	O

Other	1679	1684	O
characteristics	1685	1700	O
explained	1701	1710	O
only	1711	1715	O
minor	1716	1721	O
parts	1722	1727	O
of	1728	1730	O
the	1731	1734	O
variability	1735	1746	O
of	1747	1749	O
the	1750	1753	O
outcomes	1754	1762	O
.	1762	1763	O

Phase	0	5	O
II	6	8	O
trial	9	14	O
with	15	19	O
D	20	21	O
-	21	22	O
Trp	22	25	O
-	25	26	O
6	26	27	O
-	27	28	O
LH	28	30	O
-	30	31	O
RH	31	33	O
in	34	36	O
prostatic	37	46	B-Pathological_formation
carcinoma	47	56	I-Pathological_formation
:	56	57	O
comparison	58	68	O
with	69	73	O
other	74	79	O
hormonal	80	88	O
agents	89	95	O
.	95	96	O

Various	97	104	O
approaches	105	115	O
to	116	118	O
hormonal	119	127	O
treatment	128	137	O
of	138	140	O
prostate	141	149	B-Pathological_formation
carcinoma	150	159	I-Pathological_formation
are	160	163	O
discussed	164	173	O
.	173	174	O

Eighty	175	181	O
-	181	182	O
one	182	185	O
patients	186	194	O
with	195	199	O
prostatic	200	209	B-Pathological_formation
carcinoma	210	219	I-Pathological_formation
,	219	220	O
eight	221	226	O
with	227	231	O
stage	232	237	O
B	238	239	O
,	239	240	O
nine	241	245	O
with	246	250	O
stage	251	256	O
C	257	258	O
,	258	259	O
and	260	263	O
64	264	266	O
with	267	271	O
stage	272	277	O
D	278	279	O
disease	280	287	O
,	287	288	O
were	289	293	O
treated	294	301	O
subcutaneously	302	316	O
daily	317	322	O
for	323	326	O
3	327	328	O
months	329	335	O
with	336	340	O
the	341	344	O
LH	345	347	O
-	347	348	O
RH	348	350	O
agonist	351	358	O
D	359	360	O
-	360	361	O
Trp	361	364	O
-	364	365	O
6	365	366	O
-	366	367	O
LH	367	369	O
-	369	370	O
RH	370	372	O
(	373	374	O
Decapeptyl	374	384	O
)	384	385	O
in	386	388	O
order	389	394	O
to	395	397	O
evaluate	398	406	O
the	407	410	O
incidence	411	420	O
of	421	423	O
remissions	424	434	O
according	435	444	O
to	445	447	O
WHO	448	451	O
recommendations	452	467	O
for	468	471	O
oncologic	472	481	O
trials	482	488	O
.	488	489	O

The	490	493	O
findings	494	502	O
were	503	507	O
compared	508	516	O
to	517	519	O
those	520	525	O
obtained	526	534	O
with	535	539	O
other	540	545	O
hormonal	546	554	O
therapies	555	564	O
of	565	567	O
prostatic	568	577	B-Pathological_formation
carcinoma	578	587	I-Pathological_formation
according	588	597	O
to	598	600	O
the	601	604	O
statistical	605	616	O
method	617	623	O
of	624	626	O
"	627	628	O
expected	628	636	O
response	637	645	O
rate	646	650	O
"	650	651	O
as	652	654	O
adapted	655	662	O
by	663	665	O
Lee	666	669	O
and	670	673	O
Wesley	674	680	O
for	681	684	O
phase	685	690	O
II	691	693	O
trials	694	700	O
.	700	701	O

Treatment	702	711	O
with	712	716	O
D	717	718	O
-	718	719	O
Trp	719	722	O
-	722	723	O
6	723	724	O
-	724	725	O
LH	725	727	O
-	727	728	O
RH	728	730	O
greatly	731	738	O
reduced	739	746	O
serum	747	752	B-Organism_substance
LH	753	755	O
and	756	759	O
testosterone	760	772	O
levels	773	779	O
without	780	787	O
raising	788	795	O
serum	796	801	B-Organism_substance
prolactin	802	811	O
.	811	812	O

After	813	818	O
1	819	820	O
-	820	821	O
2	821	822	O
weeks	823	828	O
of	829	831	O
therapy	832	839	O
,	839	840	O
there	841	846	O
was	847	850	O
relief	851	857	O
of	858	860	O
subjective	861	871	O
symptoms	872	880	O
and	881	884	O
a	885	886	O
reversal	887	895	O
of	896	898	O
the	899	902	O
signs	903	908	O
of	909	911	O
prostatism	912	922	O
as	923	925	O
well	926	930	O
as	931	933	O
a	934	935	O
marked	936	942	O
decrease	943	951	O
in	952	954	O
bone	955	959	B-Organ
pain	960	964	O
.	964	965	O

At	966	968	O
90	969	971	O
days	972	976	O
52	977	979	O
patients	980	988	O
had	989	992	O
complete	993	1001	O
relief	1002	1008	O
of	1009	1011	O
prostatism	1012	1022	O
and	1023	1026	O
21	1027	1029	O
had	1030	1033	O
only	1034	1038	O
mild	1039	1043	O
signs	1044	1049	O
and	1050	1053	O
symptoms	1054	1062	O
.	1062	1063	O

Seventy	1064	1071	O
patients	1072	1080	O
were	1081	1085	O
experiencing	1086	1098	O
no	1099	1101	O
bone	1102	1106	B-Organ
pain	1107	1111	O
and	1112	1115	O
an	1116	1118	O
additional	1119	1129	O
six	1130	1133	O
had	1134	1137	O
only	1138	1142	O
mild	1143	1147	O
pain	1148	1152	O
.	1152	1153	O

Prostatic	1154	1163	B-Organ
size	1164	1168	O
,	1168	1169	O
evaluated	1170	1179	O
by	1180	1182	O
rectal	1183	1189	O
examination	1190	1201	O
and	1202	1205	O
transabdominal	1206	1220	B-Organism_subdivision
ultrasonography	1221	1236	O
,	1236	1237	O
reverted	1238	1246	O
to	1247	1249	O
normal	1250	1256	O
in	1257	1259	O
26	1260	1262	O
.	1262	1263	O
4	1263	1264	O
%	1264	1265	O
of	1266	1268	O
patients	1269	1277	O
(	1278	1279	O
complete	1279	1287	O
remission	1288	1297	O
)	1297	1298	O
and	1299	1302	O
was	1303	1306	O
reduced	1307	1314	O
by	1315	1317	O
more	1318	1322	O
than	1323	1327	O
50	1328	1330	O
%	1330	1331	O
in	1332	1334	O
an	1335	1337	O
additional	1338	1348	O
17	1349	1351	O
.	1351	1352	O
6	1352	1353	O
%	1353	1354	O
(	1355	1356	O
partial	1356	1363	O
remission	1364	1373	O
)	1373	1374	O
,	1374	1375	O
the	1376	1379	O
overall	1380	1387	O
rate	1388	1392	O
of	1393	1395	O
complete	1396	1404	O
plus	1405	1409	O
partial	1410	1417	O
regression	1418	1428	O
of	1429	1431	O
prostatic	1432	1441	B-Organ
enlargement	1442	1453	O
being	1454	1459	O
44	1460	1462	O
%	1462	1463	O
.	1463	1464	O

Scans	1465	1470	O
showed	1471	1477	O
a	1478	1479	O
major	1480	1485	O
improvement	1486	1497	O
of	1498	1500	O
bone	1501	1505	B-Pathological_formation
lesions	1506	1513	I-Pathological_formation
in	1514	1516	O
14	1517	1519	O
.	1519	1520	O
8	1520	1521	O
%	1521	1522	O
of	1523	1525	O
cases	1526	1531	O
.	1531	1532	O

This	1533	1537	O
response	1538	1546	O
increased	1547	1556	O
to	1557	1559	O
37	1560	1562	O
%	1562	1563	O
after	1564	1569	O
more	1570	1574	O
than	1575	1579	O
6	1580	1581	O
months	1582	1588	O
of	1589	1591	O
follow	1592	1598	O
-	1598	1599	O
up	1599	1601	O
.	1601	1602	O

Prostatic	1603	1612	B-Organ
acid	1613	1617	O
phosphatase	1618	1629	O
levels	1630	1636	O
were	1637	1641	O
decreased	1642	1651	O
by	1652	1654	O
more	1655	1659	O
than	1660	1664	O
50	1665	1667	O
%	1667	1668	O
in	1669	1671	O
61	1672	1674	O
%	1674	1675	O
of	1676	1678	O
the	1679	1682	O
patients	1683	1691	O
,	1691	1692	O
but	1693	1696	O
this	1697	1701	O
test	1702	1706	O
appears	1707	1714	O
to	1715	1717	O
be	1718	1720	O
a	1721	1722	O
less	1723	1727	O
valid	1728	1733	O
marker	1734	1740	O
than	1741	1745	O
the	1746	1749	O
lipid	1750	1755	O
-	1755	1756	O
associated	1756	1766	O
sialic	1767	1773	O
acid	1774	1778	O
(	1779	1780	O
LASA	1780	1784	O
)	1784	1785	O
.	1785	1786	O

The	1787	1790	O
increase	1791	1799	O
in	1800	1802	O
LASA	1803	1807	O
before	1808	1814	O
treatment	1815	1824	O
and	1825	1828	O
a	1829	1830	O
reduction	1831	1840	O
after	1841	1846	O
treatment	1847	1856	O
can	1857	1860	O
frequently	1861	1871	O
be	1872	1874	O
correlated	1875	1885	O
with	1886	1890	O
the	1891	1894	O
objective	1895	1904	O
volume	1905	1911	O
of	1912	1914	O
the	1915	1918	O
neoplasms	1919	1928	B-Pathological_formation
.	1928	1929	O

No	1930	1932	O
flare	1933	1938	O
-	1938	1939	O
up	1939	1941	O
of	1942	1944	O
the	1945	1948	O
disease	1949	1956	O
was	1957	1960	O
encountered	1961	1972	O
,	1972	1973	O
and	1974	1977	O
there	1978	1983	O
were	1984	1988	O
no	1989	1991	O
side	1992	1996	O
effects	1997	2004	O
except	2005	2011	O
for	2012	2015	O
impotence	2016	2025	O
.	2025	2026	O

Statistical	2027	2038	O
analyses	2039	2047	O
of	2048	2050	O
results	2051	2058	O
by	2059	2061	O
the	2062	2065	O
method	2066	2072	O
of	2073	2075	O
Lee	2076	2079	O
and	2080	2083	O
Wesley	2084	2090	O
indicated	2091	2100	O
that	2101	2105	O
the	2106	2109	O
incidence	2110	2119	O
of	2120	2122	O
complete	2123	2131	O
and	2132	2135	O
partial	2136	2143	O
regression	2144	2154	O
(	2155	2156	O
CR	2156	2158	O
and	2159	2162	O
PR	2163	2165	O
)	2165	2166	O
observed	2167	2175	O
with	2176	2180	O
D	2181	2182	O
-	2182	2183	O
Trp	2183	2186	O
-	2186	2187	O
6	2187	2188	O
-	2188	2189	O
LH	2189	2191	O
-	2191	2192	O
RH	2192	2194	O
was	2195	2198	O
not	2199	2202	O
significantly	2203	2216	O
different	2217	2226	O
from	2227	2231	O
that	2232	2236	O
recorded	2237	2245	O
in	2246	2248	O
previous	2249	2257	O
studies	2258	2265	O
for	2266	2269	O
another	2270	2277	O
LH	2278	2280	O
-	2280	2281	O
RH	2281	2283	O
analog	2284	2290	O
,	2290	2291	O
Buserelin	2292	2301	O
.	2301	2302	O

However	2303	2310	O
,	2310	2311	O
CR	2312	2314	O
and	2315	2318	O
PR	2319	2321	O
obtained	2322	2330	O
with	2331	2335	O
D	2336	2337	O
-	2337	2338	O
Trp	2338	2341	O
-	2341	2342	O
6	2342	2343	O
-	2343	2344	O
LH	2344	2346	O
-	2346	2347	O
RH	2347	2349	O
(	2350	2351	O
44	2351	2353	O
%	2353	2354	O
)	2354	2355	O
were	2356	2360	O
significantly	2361	2374	O
higher	2375	2381	O
than	2382	2386	O
with	2387	2391	O
subcapsular	2392	2403	O
orchiectomy	2404	2415	O
(	2416	2417	O
22	2417	2419	O
%	2419	2420	O
)	2420	2421	O
.	2421	2422	O

Hormonal	2423	2431	O
effects	2432	2439	O
and	2440	2443	O
some	2444	2448	O
other	2449	2454	O
actions	2455	2462	O
of	2463	2465	O
D	2466	2467	O
-	2467	2468	O
Trp	2468	2471	O
-	2471	2472	O
6	2472	2473	O
-	2473	2474	O
LH	2474	2476	O
-	2476	2477	O
RH	2477	2479	O
were	2480	2484	O
compared	2485	2493	O
and	2494	2497	O
contrasted	2498	2508	O
with	2509	2513	O
those	2514	2519	O
produced	2520	2528	O
by	2529	2531	O
castration	2532	2542	O
,	2542	2543	O
estrogens	2544	2553	O
,	2553	2554	O
antiandrogens	2555	2568	O
,	2568	2569	O
and	2570	2573	O
progestogens	2574	2586	O
.	2586	2587	O
(	2587	2588	O
ABSTRACT	2588	2596	O
TRUNCATED	2597	2606	O
AT	2607	2609	O
400	2610	2613	O
WORDS	2614	2619	O
)	2619	2620	O

[	0	1	O
Histophysiology	1	16	O
and	17	20	O
histopathology	21	35	O
of	36	38	O
the	39	42	O
adrenals	43	51	B-Organ
in	52	54	O
experimental	55	67	O
hypokinesia	68	79	O
]	79	80	O
.	80	81	O

In	82	84	O
experiments	85	96	O
on	97	99	O
male	100	104	O
rats	105	109	O
in	110	112	O
the	113	116	O
course	117	123	O
of	124	126	O
3	127	128	O
-	128	129	O
month	129	134	O
hypokinesia	135	146	O
phasic	147	153	O
changes	154	161	O
were	162	166	O
observed	167	175	O
in	176	178	O
the	179	182	O
relative	183	191	O
adrenal	192	199	B-Organ
gland	200	205	I-Organ
weight	206	212	O
,	212	213	O
in	214	216	O
the	217	220	O
volume	221	227	O
of	228	230	O
the	231	234	O
cell	235	239	B-Cellular_component
nuclei	240	246	I-Cellular_component
of	247	249	O
the	250	253	O
glomerular	254	264	B-Multi-tissue_structure
,	264	265	O
fasicular	266	275	B-Multi-tissue_structure
zones	276	281	I-Multi-tissue_structure
and	282	285	O
the	286	289	O
medulla	290	297	B-Multi-tissue_structure
,	297	298	O
in	299	301	O
the	302	305	O
activity	306	314	O
of	315	317	O
the	318	321	O
succinic	322	330	O
dehydrogenase	331	344	O
,	344	345	O
alkaline	346	354	O
and	355	358	O
acid	359	363	O
phosphatases	364	376	O
,	376	377	O
in	378	380	O
the	381	384	O
RNA	385	388	O
and	389	392	O
catecholamine	393	406	O
content	407	414	O
.	414	415	O

These	416	421	O
changes	422	429	O
are	430	433	O
associated	434	444	O
with	445	449	O
variations	450	460	O
in	461	463	O
the	464	467	O
secretion	468	477	O
and	478	481	O
biosynthesis	482	494	O
of	495	497	O
the	498	501	O
hormones	502	510	O
of	511	513	O
the	514	517	O
cortical	518	526	B-Multi-tissue_structure
and	527	530	O
the	531	534	O
medullary	535	544	B-Multi-tissue_structure
layer	545	550	I-Multi-tissue_structure
of	551	553	O
the	554	557	O
adrenal	558	565	B-Organ
glands	566	572	I-Organ
during	573	579	O
the	580	583	O
hypokinetic	584	595	O
stress	596	602	O
development	603	614	O
.	614	615	O

Dynorphin	0	9	O
is	10	12	O
contained	13	22	O
within	23	29	O
hippocampal	30	41	B-Tissue
mossy	42	47	I-Tissue
fibers	48	54	I-Tissue
:	54	55	O
immunochemical	56	70	O
alterations	71	82	O
after	83	88	O
kainic	89	95	O
acid	96	100	O
administration	101	115	O
and	116	119	O
colchicine	120	130	O
-	130	131	O
induced	131	138	O
neurotoxicity	139	152	O
.	152	153	O

Antisera	154	162	B-Organism_substance
raised	163	169	O
against	170	177	O
synthetic	178	187	O
dynorphin	188	197	O
or	198	200	O
[	201	202	O
Leu5	202	206	O
]	206	207	O
enkephalin	207	217	O
demonstrate	218	229	O
immunostaining	230	244	O
in	245	247	O
hippocampal	248	259	B-Tissue
mossy	260	265	I-Tissue
fibers	266	272	I-Tissue
and	273	276	O
in	277	279	O
dentate	280	287	B-Cell
granule	288	295	I-Cell
cells	296	301	I-Cell
.	301	302	O

However	303	310	O
,	310	311	O
dynorphin	312	321	O
immunoreactivity	322	338	O
(	339	340	O
ir	340	342	O
)	342	343	O
appears	344	351	O
to	352	354	O
be	355	357	O
denser	358	364	O
in	365	367	O
immunocytochemical	368	386	O
preparations	387	399	O
and	400	403	O
is	404	406	O
quantitatively	407	421	O
greater	422	429	O
by	430	432	O
radioimmunoassay	433	449	O
than	450	454	O
enkephalin	455	465	O
-	465	466	O
ir	466	468	O
.	468	469	O

Immunostaining	470	484	O
with	485	489	O
dynorphin	490	499	O
antisera	500	508	O
is	509	511	O
eliminated	512	522	O
by	523	525	O
adsorption	526	536	O
with	537	541	O
1	542	543	O
-	543	544	O
100	544	547	O
microM	548	554	O
dynorphin	555	564	O
-	564	565	O
17	565	567	O
whereas	568	575	O
immunostaining	576	590	O
with	591	595	O
enkephalin	596	606	O
antisera	607	615	O
is	616	618	O
eliminated	619	629	O
by	630	632	O
adsorption	633	643	O
with	644	648	O
1	649	650	O
-	650	651	O
100	651	654	O
microM	655	661	O
[	662	663	O
Leu5	663	667	O
]	667	668	O
enkephalin	668	678	O
,	678	679	O
dynorphin	680	689	O
-	689	690	O
17	690	692	O
,	692	693	O
dynorphin	694	703	O
-	703	704	O
(	704	705	O
1	705	706	O
-	706	707	O
13	707	709	O
)	709	710	O
,	710	711	O
or	712	714	O
alpha	715	720	O
-	720	721	O
neo	721	724	O
-	724	725	O
endorphin	725	734	O
.	734	735	O

Intrahippocampal	736	752	B-Multi-tissue_structure
colchicine	753	763	O
injections	764	774	O
,	774	775	O
which	776	781	O
selectively	782	793	O
destroy	794	801	O
dentate	802	809	O
granule	810	817	O
cells	818	823	O
,	823	824	O
significantly	825	838	O
decrease	839	847	O
the	848	851	O
dynorphin	852	861	O
-	861	862	O
ir	862	864	O
and	865	868	O
enkephalin	869	879	O
-	879	880	O
ir	880	882	O
levels	883	889	O
in	890	892	O
rat	893	896	O
hippocampus	897	908	B-Multi-tissue_structure
.	908	909	O

Intraventricularly	910	928	B-Multi-tissue_structure
administered	929	941	O
kainic	942	948	O
acid	949	953	O
,	953	954	O
which	955	960	O
selectively	961	972	O
destroys	973	981	O
CA3	982	985	B-Cell
-	985	986	I-Cell
4	986	987	I-Cell
pyramidal	988	997	I-Cell
cells	998	1003	I-Cell
,	1003	1004	O
results	1005	1012	O
in	1013	1015	O
an	1016	1018	O
increase	1019	1027	O
of	1028	1030	O
enkephalin	1031	1041	O
immunostaining	1042	1056	O
in	1057	1059	O
mossy	1060	1065	B-Tissue
fibers	1066	1072	I-Tissue
and	1073	1076	O
a	1077	1078	O
significant	1079	1090	O
increase	1091	1099	O
in	1100	1102	O
enkephalin	1103	1113	O
-	1113	1114	O
ir	1114	1116	O
by	1117	1119	O
radioimmunoassay	1120	1136	O
in	1137	1139	O
whole	1140	1145	O
hippocampus	1146	1157	B-Multi-tissue_structure
.	1157	1158	O

The	1159	1162	O
enkephalin	1163	1173	B-Cell
-	1173	1174	I-Cell
ir	1174	1176	I-Cell
cells	1177	1182	I-Cell
and	1183	1186	O
fibers	1187	1193	B-Tissue
in	1194	1196	O
entorhinal	1197	1207	B-Multi-tissue_structure
/	1207	1208	O
perirhinal	1208	1218	B-Multi-tissue_structure
cortex	1219	1225	I-Multi-tissue_structure
,	1225	1226	O
which	1227	1232	O
innervate	1233	1242	O
rat	1243	1246	O
hippocampus	1247	1258	B-Multi-tissue_structure
and	1259	1262	O
dentate	1263	1270	B-Multi-tissue_structure
gyrus	1271	1276	I-Multi-tissue_structure
,	1276	1277	O
do	1278	1280	O
not	1281	1284	O
contain	1285	1292	O
dynorphin	1293	1302	O
-	1302	1303	O
ir	1303	1305	O
.	1305	1306	O

Differential	0	12	O
reactivity	13	23	O
of	24	26	O
the	27	30	O
functional	31	41	O
sulfhydryl	42	52	O
groups	53	59	O
of	60	62	O
cysteine	63	71	O
-	71	72	O
32	72	74	O
and	75	78	O
cysteine	79	87	O
-	87	88	O
35	88	90	O
present	91	98	O
in	99	101	O
the	102	105	O
reduced	106	113	O
form	114	118	O
of	119	121	O
thioredoxin	122	133	O
from	134	138	O
Escherichia	139	150	O
coli	151	155	O
.	155	156	O

Only	157	161	O
one	162	165	O
of	166	168	O
the	169	172	O
sulfhydryl	173	183	O
groups	184	190	O
from	191	195	O
Cys	196	199	O
-	199	200	O
32	200	202	O
and	203	206	O
Cys	207	210	O
-	210	211	O
35	211	213	O
in	214	216	O
the	217	220	O
active	221	227	O
center	228	234	O
of	235	237	O
native	238	244	O
Escherichia	245	256	O
coli	257	261	O
thioredoxin	262	273	O
-	273	274	O
(	274	275	O
SH	275	277	O
)	277	278	O
2	278	279	O
was	280	283	O
alkylated	284	293	O
by	294	296	O
excess	297	303	O
iodoacetic	304	314	O
acid	315	319	O
at	320	322	O
pH	323	325	O
values	326	332	O
below	333	338	O
8	339	340	O
.	340	341	O
0	341	342	O
.	342	343	O

Both	344	348	O
groups	349	355	O
reacted	356	363	O
in	364	366	O
the	367	370	O
protein	371	378	O
denatured	379	388	O
with	389	393	O
4	394	395	O
.	395	396	O
5	396	397	O
M	398	399	O
guanidine	400	409	O
hydrochloride	410	423	O
.	423	424	O

The	425	428	O
second	429	435	O
order	436	441	O
rate	442	446	O
of	447	449	O
alkylation	450	460	O
of	461	463	O
thioredoxin	464	475	O
-	475	476	O
(	476	477	O
SH	477	479	O
)	479	480	O
2	480	481	O
with	482	486	O
1	487	488	O
eq	489	491	O
of	492	494	O
iodoacetic	495	505	O
acid	506	510	O
was	511	514	O
pH	515	517	O
-	517	518	O
dependent	518	527	O
and	528	531	O
showed	532	538	O
independent	539	550	O
initial	551	558	O
reactions	559	568	O
of	569	571	O
one	572	575	O
thiolate	576	584	O
ion	585	588	O
with	589	593	O
a	594	595	O
pK	596	598	O
value	599	604	O
of	605	607	O
6	608	609	O
.	609	610	O
7	610	611	O
and	612	615	O
a	616	617	O
second	618	624	O
with	625	629	O
a	630	631	O
pK	632	634	O
value	635	640	O
close	641	646	O
to	647	649	O
9	650	651	O
.	651	652	O
0	652	653	O
.	653	654	O

The	655	658	O
same	659	663	O
pH	664	666	O
dependence	667	677	O
was	678	681	O
observed	682	690	O
for	691	694	O
alkylation	695	705	O
with	706	710	O
iodoacetamide	711	724	O
but	725	728	O
the	729	732	O
apparent	733	741	O
rate	742	746	O
constant	747	755	O
,	755	756	O
107	757	760	O
M	761	762	O
-	762	763	O
1	763	764	O
S	765	766	O
-	766	767	O
1	767	768	O
at	769	771	O
pH	772	774	O
7	775	776	O
.	776	777	O
2	777	778	O
,	778	779	O
was	780	783	O
about	784	789	O
20	790	792	O
-	792	793	O
fold	793	797	O
higher	798	804	O
than	805	809	O
the	810	813	O
corresponding	814	827	O
rate	828	832	O
with	833	837	O
iodoacetate	838	849	O
.	849	850	O

The	851	854	O
sulfhydryl	855	865	O
group	866	871	O
with	872	876	O
a	877	878	O
pK	879	881	O
value	882	887	O
of	888	890	O
6	891	892	O
.	892	893	O
7	893	894	O
was	895	898	O
shown	899	904	O
to	905	907	O
belong	908	914	O
to	915	917	O
Cys	918	921	O
-	921	922	O
32	922	924	O
by	925	927	O
labeling	928	936	O
thioredoxin	937	948	O
with	949	953	O
[	954	955	O
14C	955	958	O
]	958	959	O
iodoacetic	959	969	O
acid	970	974	O
followed	975	983	O
by	984	986	O
complete	987	995	O
alkylation	996	1006	O
with	1007	1011	O
[	1012	1013	O
3H	1013	1015	O
]	1015	1016	O
iodoacetate	1016	1027	O
and	1028	1031	O
amino	1032	1037	O
acid	1038	1042	O
sequence	1043	1051	O
analysis	1052	1060	O
of	1061	1063	O
peptides	1064	1072	O
from	1073	1077	O
the	1078	1081	O
active	1082	1088	O
center	1089	1095	O
.	1095	1096	O

The	1097	1100	O
abnormally	1101	1111	O
low	1112	1115	O
pK	1116	1118	O
value	1119	1124	O
of	1125	1127	O
Cys	1128	1131	O
-	1131	1132	O
32	1132	1134	O
is	1135	1137	O
suggested	1138	1147	O
to	1148	1150	O
arise	1151	1156	O
by	1157	1159	O
electrostatic	1160	1173	O
influence	1174	1183	O
from	1184	1188	O
a	1189	1190	O
positive	1191	1199	O
charge	1200	1206	O
on	1207	1209	O
the	1210	1213	O
amino	1214	1219	O
group	1220	1225	O
of	1226	1228	O
Lys	1229	1232	O
-	1232	1233	O
36	1233	1235	O
.	1235	1236	O

A	1237	1238	O
mechanism	1239	1248	O
of	1249	1251	O
action	1252	1258	O
for	1259	1262	O
thioredoxin	1263	1274	O
-	1274	1275	O
(	1275	1276	O
SH	1276	1278	O
)	1278	1279	O
2	1279	1280	O
as	1281	1283	O
a	1284	1285	O
protein	1286	1293	O
disulfide	1294	1303	O
reductase	1304	1313	O
has	1314	1317	O
been	1318	1322	O
formulated	1323	1333	O
.	1333	1334	O

This	1335	1339	O
is	1340	1342	O
based	1343	1348	O
on	1349	1351	O
an	1352	1354	O
initial	1355	1362	O
nucleophilic	1363	1375	O
attack	1376	1382	O
by	1383	1385	O
the	1386	1389	O
thiolate	1390	1398	O
of	1399	1401	O
Cys	1402	1405	O
-	1405	1406	O
32	1406	1408	O
with	1409	1413	O
the	1414	1417	O
formation	1418	1427	O
of	1428	1430	O
an	1431	1433	O
unstable	1434	1442	O
transient	1443	1452	O
mixed	1453	1458	O
disulfide	1459	1468	O
involving	1469	1478	O
Cys	1479	1482	O
-	1482	1483	O
32	1483	1485	O
and	1486	1489	O
one	1490	1493	O
of	1494	1496	O
the	1497	1500	O
sulfurs	1501	1508	O
in	1509	1511	O
the	1512	1515	O
substrate	1516	1525	O
.	1525	1526	O

This	1527	1531	O
is	1532	1534	O
followed	1535	1543	O
by	1544	1546	O
a	1547	1548	O
conformational	1549	1563	O
change	1564	1570	O
and	1571	1574	O
a	1575	1576	O
nucleophilic	1577	1589	O
attack	1590	1596	O
of	1597	1599	O
Cys	1600	1603	O
-	1603	1604	O
35	1604	1606	O
to	1607	1609	O
give	1610	1614	O
the	1615	1618	O
14	1619	1621	O
-	1621	1622	O
membered	1622	1630	O
disulfide	1631	1640	O
ring	1641	1645	O
in	1646	1648	O
thioredoxin	1649	1660	O
-	1660	1661	O
S2	1661	1663	O
and	1664	1667	O
the	1668	1671	O
dithiol	1672	1679	O
of	1680	1682	O
the	1683	1686	O
substrate	1687	1696	O
.	1696	1697	O

Identification	0	14	O
of	15	17	O
NAB1	18	22	O
,	22	23	O
a	24	25	O
repressor	26	35	O
of	36	38	O
NGFI	39	43	O
-	43	44	O
A	44	45	O
-	45	46	O
and	47	50	O
Krox20	51	57	O
-	57	58	O
mediated	58	66	O
transcription	67	80	O
.	80	81	O

NGFI	82	86	O
-	86	87	O
A	87	88	O
(	89	90	O
also	90	94	O
called	95	101	O
Egr1	102	106	O
,	106	107	O
Zif268	108	114	O
,	114	115	O
or	116	118	O
Krox24	119	125	O
)	125	126	O
and	127	130	O
the	131	134	O
closely	135	142	O
related	143	150	O
proteins	151	159	O
Krox20	160	166	O
,	166	167	O
NGFI	168	172	O
-	172	173	O
C	173	174	O
,	174	175	O
and	176	179	O
Egr3	180	184	O
are	185	188	O
zinc	189	193	O
-	193	194	O
finger	194	200	O
transcription	201	214	O
factors	215	222	O
encoded	223	230	O
by	231	233	O
immediate	234	243	O
-	243	244	O
early	244	249	O
genes	250	255	O
which	256	261	O
are	262	265	O
induced	266	273	O
by	274	276	O
a	277	278	O
wide	279	283	O
variety	284	291	O
of	292	294	O
extracellular	295	308	B-Immaterial_anatomical_entity
stimuli	309	316	O
.	316	317	O

NGFI	318	322	O
-	322	323	O
A	323	324	O
has	325	328	O
been	329	333	O
implicated	334	344	O
in	345	347	O
cell	348	352	B-Cell
proliferation	353	366	O
,	366	367	O
macrophage	368	378	B-Cell
differentiation	379	394	O
,	394	395	O
synaptic	396	404	B-Cellular_component
activation	405	415	O
,	415	416	O
and	417	420	O
long	421	425	O
-	425	426	O
term	426	430	O
potentiation	431	443	O
,	443	444	O
whereas	445	452	O
Krox20	453	459	O
is	460	462	O
critical	463	471	O
for	472	475	O
proper	476	482	O
hindbrain	483	492	O
segmentation	493	505	O
and	506	509	O
peripheral	510	520	B-Multi-tissue_structure
nerve	521	526	I-Multi-tissue_structure
myelination	527	538	O
.	538	539	O

In	540	542	O
previous	543	551	O
work	552	556	O
,	556	557	O
a	558	559	O
structure	560	569	O
/	569	570	O
function	570	578	O
analysis	579	587	O
of	588	590	O
NGFI	591	595	O
-	595	596	O
A	596	597	O
revealed	598	606	O
a	607	608	O
34	609	611	O
-	611	612	O
aa	612	614	O
inhibitory	615	625	O
domain	626	632	O
that	633	637	O
was	638	641	O
hypothesized	642	654	O
to	655	657	O
be	658	660	O
the	661	664	O
target	665	671	O
of	672	674	O
a	675	676	O
cellular	677	685	B-Cell
factor	686	692	O
that	693	697	O
represses	698	707	O
NGFI	708	712	O
-	712	713	O
A	713	714	O
transcriptional	715	730	O
activity	731	739	O
.	739	740	O

Using	741	746	O
the	747	750	O
yeast	751	756	O
two	757	760	O
-	760	761	O
hybrid	761	767	O
system	768	774	O
,	774	775	O
we	776	778	O
have	779	783	O
isolated	784	792	O
a	793	794	O
cDNA	795	799	O
clone	800	805	O
which	806	811	O
encodes	812	819	O
a	820	821	O
protein	822	829	O
that	830	834	O
interacts	835	844	O
with	845	849	O
this	850	854	O
inhibitory	855	865	O
domain	866	872	O
and	873	876	O
inhibits	877	885	O
the	886	889	O
ability	890	897	O
of	898	900	O
NGFI	901	905	O
-	905	906	O
A	906	907	O
to	908	910	O
activate	911	919	O
transcription	920	933	O
.	933	934	O

This	935	939	O
NGFI	940	944	O
-	944	945	O
A	945	946	O
-	946	947	O
binding	947	954	O
protein	955	962	O
,	962	963	O
NAB1	964	968	O
,	968	969	O
is	970	972	O
a	973	974	O
570	975	978	O
-	978	979	O
aa	979	981	O
nuclear	982	989	B-Cellular_component
protein	990	997	O
that	998	1002	O
bears	1003	1008	O
no	1009	1011	O
obvious	1012	1019	O
sequence	1020	1028	O
homology	1029	1037	O
to	1038	1040	O
known	1041	1046	O
proteins	1047	1055	O
.	1055	1056	O

NAB1	1057	1061	O
also	1062	1066	O
represses	1067	1076	O
Krox20	1077	1083	O
activity	1084	1092	O
,	1092	1093	O
but	1094	1097	O
it	1098	1100	O
does	1101	1105	O
not	1106	1109	O
influence	1110	1119	O
Egr3	1120	1124	O
or	1125	1127	O
NGFI	1128	1132	O
-	1132	1133	O
G	1133	1134	O
,	1134	1135	O
thus	1136	1140	O
providing	1141	1150	O
a	1151	1152	O
mechanism	1153	1162	O
for	1163	1166	O
the	1167	1170	O
differential	1171	1183	O
regulation	1184	1194	O
of	1195	1197	O
this	1198	1202	O
family	1203	1209	O
of	1210	1212	O
immediate	1213	1222	O
-	1222	1223	O
early	1223	1228	O
transcription	1229	1242	O
factors	1243	1250	O
.	1250	1251	O

Comparison	0	10	O
of	11	13	O
image	14	19	O
(	20	21	O
CAS	21	24	O
200	25	28	O
)	28	29	O
and	30	33	O
flow	34	38	O
cytometry	39	48	O
determined	49	59	O
DNA	60	63	O
content	64	71	O
of	72	74	O
paraffin	75	83	O
-	83	84	O
embedded	84	92	O
Hodgkin	93	100	B-Tissue
'	100	101	I-Tissue
s	101	102	I-Tissue
disease	103	110	I-Tissue
tissue	111	117	I-Tissue
.	117	118	O

To	119	121	O
assess	122	128	O
the	129	132	O
reliability	133	144	O
of	145	147	O
DNA	148	151	O
estimation	152	162	O
using	163	168	O
image	169	174	O
cytometry	175	184	O
,	184	185	O
deparaffinized	186	200	O
lymph	201	206	B-Multi-tissue_structure
nodes	207	212	I-Multi-tissue_structure
from	213	217	O
70	218	220	O
patients	221	229	O
with	230	234	O
Hodgkin	235	242	O
'	242	243	O
s	243	244	O
disease	245	252	O
were	253	257	O
examined	258	266	O
and	267	270	O
the	271	274	O
results	275	282	O
obtained	283	291	O
were	292	296	O
compared	297	305	O
with	306	310	O
those	311	316	O
from	317	321	O
flow	322	326	O
cytometry	327	336	O
.	336	337	O

Image	338	343	O
analysis	344	352	O
without	353	360	O
discriminating	361	375	O
between	376	383	O
the	384	387	O
various	388	395	O
cell	396	400	B-Cell
types	401	406	O
,	406	407	O
as	408	410	O
found	411	416	O
in	417	419	O
Hodgkin	420	427	O
'	427	428	O
s	428	429	O
disease	430	437	O
,	437	438	O
revealed	439	447	O
no	448	450	O
separate	451	459	O
aneuploid	460	469	O
peak	470	474	O
.	474	475	O

Selecting	476	485	O
on	486	488	O
morphologically	489	504	O
defined	505	512	O
nuclear	513	520	B-Cellular_component
types	521	526	O
DNA	527	530	O
aneuploidy	531	541	O
was	542	545	O
detected	546	554	O
in	555	557	O
20	558	560	O
%	560	561	O
of	562	564	O
the	565	568	O
cases	569	574	O
(	575	576	O
14	576	578	O
/	578	579	O
70	579	581	O
)	581	582	O
.	582	583	O

The	584	587	O
aneuploid	588	597	O
populations	598	609	O
were	610	614	O
limited	615	622	O
to	623	625	O
the	626	629	O
population	630	640	O
of	641	643	O
nuclei	644	650	B-Cellular_component
defined	651	658	O
as	659	661	O
Reed	662	666	O
-	666	667	O
Sternberg	667	676	O
(	677	678	O
RS	678	680	O
)	680	681	O
-	681	682	O
like	682	686	O
or	687	689	O
medium	690	696	O
-	696	697	O
sized	697	702	O
lymphocytes	703	714	B-Cell
.	714	715	O

Benign	716	722	B-Pathological_formation
lymph	723	728	I-Pathological_formation
nodes	729	734	I-Pathological_formation
DNA	735	738	O
aneuploidy	739	749	O
was	750	753	O
not	754	757	O
found	758	763	O
in	764	766	O
any	767	770	O
of	771	773	O
the	774	777	O
controls	778	786	O
.	786	787	O

Comparison	788	798	O
of	799	801	O
DNA	802	805	O
histograms	806	816	O
obtained	817	825	O
by	826	828	O
image	829	834	O
and	835	838	O
flow	839	843	O
cytometry	844	853	O
showed	854	860	O
aneuploid	861	870	O
peaks	871	876	O
using	877	882	O
image	883	888	O
cytometry	889	898	O
in	899	901	O
4	902	903	O
of	904	906	O
30	907	909	O
diploid	910	917	O
and	918	921	O
10	922	924	O
of	925	927	O
40	928	930	O
aneuploid	931	940	O
flow	941	945	O
histograms	946	956	O
.	956	957	O

In	958	960	O
conclusion	961	971	O
,	971	972	O
image	973	978	O
analysis	979	987	O
using	988	993	O
the	994	997	O
CAS	998	1001	O
200	1002	1005	O
system	1006	1012	O
as	1013	1015	O
compared	1016	1024	O
to	1025	1027	O
flow	1028	1032	O
cytometry	1033	1042	O
is	1043	1045	O
more	1046	1050	O
time	1051	1055	O
-	1055	1056	O
consuming	1056	1065	O
and	1066	1069	O
less	1070	1074	O
sensitive	1075	1084	O
to	1085	1087	O
assess	1088	1094	O
ploidy	1095	1101	O
status	1102	1108	O
,	1108	1109	O
although	1110	1118	O
it	1119	1121	O
may	1122	1125	O
provide	1126	1133	O
extra	1134	1139	O
information	1140	1151	O
in	1152	1154	O
some	1155	1159	O
selected	1160	1168	O
cases	1169	1174	O
.	1174	1175	O

Evidence	1176	1184	O
is	1185	1187	O
obtained	1188	1196	O
that	1197	1201	O
DNA	1202	1205	O
aneuploidy	1206	1216	O
in	1217	1219	O
Hodgkin	1220	1227	O
'	1227	1228	O
s	1228	1229	O
disease	1230	1237	O
is	1238	1240	O
preferentially	1241	1255	O
expressed	1256	1265	O
by	1266	1268	O
cells	1269	1274	B-Cell
with	1275	1279	O
the	1280	1283	O
RS	1284	1286	O
/	1286	1287	O
H	1287	1288	O
-	1288	1289	O
like	1289	1293	O
and	1294	1297	O
medium	1298	1304	O
-	1304	1305	O
sized	1305	1310	O
lymphocyte	1311	1321	B-Cell
morphology	1322	1332	O
.	1332	1333	O

Imaging	0	7	O
techniques	8	18	O
for	19	22	O
the	23	26	O
assessment	27	37	O
of	38	40	O
body	41	45	B-Organism_subdivision
composition	46	57	O
.	57	58	O

Three	59	64	O
imaging	65	72	O
methods	73	80	O
,	80	81	O
ultrasound	82	92	O
imaging	93	100	O
(	101	102	O
UI	102	104	O
)	104	105	O
,	105	106	O
computer	107	115	O
-	115	116	O
assisted	116	124	O
axial	125	130	O
tomography	131	141	O
(	142	143	O
CAT	143	146	O
)	146	147	O
and	148	151	O
magnetic	152	160	O
resonance	161	170	O
imaging	171	178	O
(	179	180	O
MRI	180	183	O
)	183	184	O
,	184	185	O
are	186	189	O
widely	190	196	O
used	197	201	O
in	202	204	O
medicine	205	213	O
.	213	214	O

Their	215	220	O
application	221	232	O
to	233	235	O
the	236	239	O
assessment	240	250	O
of	251	253	O
body	254	258	B-Organism_subdivision
composition	259	270	O
in	271	273	O
nutrition	274	283	O
research	284	292	O
is	293	295	O
still	296	301	O
being	302	307	O
explored	308	316	O
and	317	320	O
developed	321	330	O
.	330	331	O

Ultrasound	332	342	O
imaging	343	350	O
yields	351	357	O
poor	358	362	O
image	363	368	O
quality	369	376	O
but	377	380	O
,	380	381	O
because	382	389	O
it	390	392	O
is	393	395	O
cheap	396	401	O
and	402	405	O
safe	406	410	O
,	410	411	O
deserves	412	420	O
further	421	428	O
exploration	429	440	O
.	440	441	O

Both	442	446	O
CAT	447	450	O
and	451	454	O
MRI	455	458	O
can	459	462	O
produce	463	470	O
images	471	477	O
with	478	482	O
good	483	487	O
discrimination	488	502	O
among	503	508	O
bone	509	513	B-Organ
,	513	514	O
muscle	515	521	B-Organ
and	522	525	O
adipose	526	533	B-Tissue
tissue	534	540	I-Tissue
.	540	541	O

Movement	542	550	O
artifacts	551	560	O
tend	561	565	O
to	566	568	O
be	569	571	O
more	572	576	O
serious	577	584	O
in	585	587	O
MRI	588	591	O
than	592	596	O
in	597	599	O
CAT	600	603	O
due	604	607	O
to	608	610	O
the	611	614	O
longer	615	621	O
imaging	622	629	O
time	630	634	O
.	634	635	O

On	636	638	O
the	639	642	O
other	643	648	O
hand	649	653	O
,	653	654	O
the	655	658	O
X	659	660	O
-	660	661	O
ray	661	664	O
exposure	665	673	O
in	674	676	O
CAT	677	680	O
is	681	683	O
likely	684	690	O
to	691	693	O
limit	694	699	O
its	700	703	O
use	704	707	O
in	708	710	O
human	711	716	O
nutrition	717	726	O
research	727	735	O
.	735	736	O

Repeated	737	745	O
measurements	746	758	O
of	759	761	O
tissue	762	768	B-Tissue
volumes	769	776	O
by	777	779	O
CAT	780	783	O
and	784	787	O
MRI	788	791	O
give	792	796	O
similar	797	804	O
CV	805	807	O
.	807	808	O

In	809	811	O
both	812	816	O
CAT	817	820	O
and	821	824	O
MRI	825	828	O
,	828	829	O
intra	830	835	O
-	835	836	O
abdominal	836	845	B-Tissue
adipose	846	853	I-Tissue
tissue	854	860	I-Tissue
presents	861	869	O
greater	870	877	O
problems	878	886	O
of	887	889	O
measurement	890	901	O
than	902	906	O
subcutaneous	907	919	B-Tissue
adipose	920	927	I-Tissue
tissue	928	934	I-Tissue
.	934	935	O

Validation	936	946	O
studies	947	954	O
with	955	959	O
77	960	962	O
-	962	963	O
kg	963	965	O
pigs	966	970	O
of	971	973	O
MRI	974	977	O
,	977	978	O
using	979	984	O
13	985	987	O
slices	988	994	O
,	994	995	O
predicted	996	1005	O
total	1006	1011	O
body	1012	1016	B-Organism_subdivision
lipid	1017	1022	O
with	1023	1027	O
residual	1028	1036	O
standard	1037	1045	O
deviation	1046	1055	O
of	1056	1058	O
1	1059	1060	O
.	1060	1061	O
9	1061	1062	O
%	1062	1063	O
.	1063	1064	O

In	1065	1067	O
validating	1068	1078	O
any	1079	1082	O
of	1083	1085	O
these	1086	1091	O
methods	1092	1099	O
,	1099	1100	O
account	1101	1108	O
should	1109	1115	O
be	1116	1118	O
take	1119	1123	O
of	1124	1126	O
the	1127	1130	O
extent	1131	1137	O
to	1138	1140	O
which	1141	1146	O
the	1147	1150	O
information	1151	1162	O
they	1163	1167	O
give	1168	1172	O
can	1173	1176	O
augment	1177	1184	O
that	1185	1189	O
given	1190	1195	O
by	1196	1198	O
more	1199	1203	O
simple	1204	1210	O
measures	1211	1219	O
like	1220	1224	O
age	1225	1228	O
and	1229	1232	O
weight	1233	1239	O
.	1239	1240	O

Defective	0	9	O
biliary	10	17	O
copper	18	24	O
excretion	25	34	O
in	35	37	O
Wilson	38	44	O
'	44	45	O
s	45	46	O
disease	47	54	O
:	54	55	O
the	56	59	O
role	60	64	O
of	65	67	O
caeruloplasmin	68	82	O
.	82	83	O

Previous	84	92	O
studies	93	100	O
have	101	105	O
failed	106	112	O
to	113	115	O
explain	116	123	O
the	124	127	O
link	128	132	O
between	133	140	O
copper	141	147	O
accumulation	148	160	O
and	161	164	O
abnormal	165	173	O
caeruloplasmin	174	188	O
expression	189	199	O
in	200	202	O
Wilson	203	209	O
'	209	210	O
s	210	211	O
disease	212	219	O
.	219	220	O

Furthermore	221	232	O
,	232	233	O
despite	234	241	O
the	242	245	O
isolation	246	255	O
of	256	258	O
a	259	260	O
candidate	261	270	O
gene	271	275	O
for	276	279	O
Wilson	280	286	O
'	286	287	O
s	287	288	O
disease	289	296	O
,	296	297	O
which	298	303	O
predicts	304	312	O
a	313	314	O
defective	315	324	O
copper	325	331	O
transport	332	341	O
protein	342	349	O
,	349	350	O
the	351	354	O
localization	355	367	O
of	368	370	O
this	371	375	O
putative	376	384	O
protein	385	392	O
and	393	396	O
its	397	400	O
relationship	401	413	O
to	414	416	O
the	417	420	O
pathway	421	428	O
involved	429	437	O
in	438	440	O
copper	441	447	O
excretion	448	457	O
and	458	461	O
to	462	464	O
caeruloplasmin	465	479	O
remain	480	486	O
unknown	487	494	O
.	494	495	O

We	496	498	O
now	499	502	O
present	503	510	O
evidence	511	519	O
that	520	524	O
caeruloplasmin	525	539	O
,	539	540	O
the	541	544	O
major	545	550	O
plasma	551	557	B-Organism_substance
copper	558	564	O
-	564	565	O
carrying	565	573	O
protein	574	581	O
,	581	582	O
is	583	585	O
present	586	593	O
in	594	596	O
the	597	600	O
liver	601	606	B-Organ
in	607	609	O
Wilson	610	616	O
'	616	617	O
s	617	618	O
disease	619	626	O
,	626	627	O
and	628	631	O
thus	632	636	O
that	637	641	O
reduced	642	649	O
circulating	650	661	O
levels	662	668	O
of	669	671	O
the	672	675	O
protein	676	683	O
result	684	690	O
from	691	695	O
a	696	697	O
post	698	702	O
-	702	703	O
translational	703	716	O
defect	717	723	O
in	724	726	O
the	727	730	O
secretory	731	740	O
pathway	741	748	O
.	748	749	O

We	750	752	O
have	753	757	O
also	758	762	O
identified	763	773	O
a	774	775	O
novel	776	781	O
form	782	786	O
of	787	789	O
caeruloplasmin	790	804	O
,	804	805	O
molecular	806	815	O
weight	816	822	O
125	823	826	O
kD	827	829	O
,	829	830	O
which	831	836	O
we	837	839	O
propose	840	847	O
may	848	851	O
act	852	855	O
as	856	858	O
the	859	862	O
carrier	863	870	O
for	871	874	O
excretory	875	884	O
copper	885	891	O
into	892	896	O
bile	897	901	B-Organism_substance
,	901	902	O
since	903	908	O
it	909	911	O
is	912	914	O
normally	915	923	O
present	924	931	O
in	932	934	O
both	935	939	O
liver	940	945	B-Organ
and	946	949	O
bile	950	954	B-Organism_substance
,	954	955	O
although	956	964	O
largely	965	972	O
absent	973	979	O
from	980	984	O
serum	985	990	B-Organism_substance
,	990	991	O
and	992	995	O
undetectable	996	1008	O
in	1009	1011	O
bile	1012	1016	B-Organism_substance
from	1017	1021	O
Wilson	1022	1028	O
'	1028	1029	O
s	1029	1030	O
disease	1031	1038	O
patients	1039	1047	O
.	1047	1048	O

The	1049	1052	O
presence	1053	1061	O
of	1062	1064	O
this	1065	1069	O
form	1070	1074	O
of	1075	1077	O
caeruloplasmin	1078	1092	O
in	1093	1095	O
Wilson	1096	1102	O
'	1102	1103	O
s	1103	1104	O
disease	1105	1112	O
liver	1113	1118	B-Organ
suggests	1119	1127	O
that	1128	1132	O
a	1133	1134	O
related	1135	1142	O
post	1143	1147	O
-	1147	1148	O
translational	1148	1161	O
defect	1162	1168	O
may	1169	1172	O
also	1173	1177	O
be	1178	1180	O
responsible	1181	1192	O
for	1193	1196	O
its	1197	1200	O
absence	1201	1208	O
from	1209	1213	O
bile	1214	1218	B-Organism_substance
in	1219	1221	O
Wilson	1222	1228	O
'	1228	1229	O
s	1229	1230	O
disease	1231	1238	O
.	1238	1239	O

This	1240	1244	O
study	1245	1250	O
thus	1251	1255	O
provides	1256	1264	O
the	1265	1268	O
first	1269	1274	O
plausible	1275	1284	O
explanation	1285	1296	O
of	1297	1299	O
a	1300	1301	O
link	1302	1306	O
between	1307	1314	O
the	1315	1318	O
defective	1319	1328	O
copper	1329	1335	O
excretion	1336	1345	O
and	1346	1349	O
the	1350	1353	O
reduced	1354	1361	O
plasma	1362	1368	B-Organism_substance
caeruloplasmin	1369	1383	O
,	1383	1384	O
which	1385	1390	O
characterize	1391	1403	O
Wilson	1404	1410	O
'	1410	1411	O
s	1411	1412	O
disease	1413	1420	O
.	1420	1421	O

Conservative	0	12	O
treatment	13	22	O
of	23	25	O
endometriosis	26	39	O
:	39	40	O
the	41	44	O
effects	45	52	O
of	53	55	O
limited	56	63	O
surgery	64	71	O
and	72	75	O
hormonal	76	84	O
pseudopregnancy	85	100	O
.	100	101	O

This	102	106	O
study	107	112	O
compares	113	121	O
the	122	125	O
effects	126	133	O
of	134	136	O
limited	137	144	O
surgery	145	152	O
or	153	155	O
hormonal	156	164	O
pseudopregnancy	165	180	O
,	180	181	O
or	182	184	O
a	185	186	O
combination	187	198	O
of	199	201	O
these	202	207	O
two	208	211	O
,	211	212	O
upon	213	217	O
fertility	218	227	O
and	228	231	O
the	232	235	O
need	236	240	O
for	241	244	O
subsequent	245	255	O
surgery	256	263	O
with	264	268	O
respect	269	276	O
to	277	279	O
the	280	283	O
extent	284	290	O
of	291	293	O
the	294	297	O
disease	298	305	O
at	306	308	O
the	309	312	O
time	313	317	O
of	318	320	O
initial	321	328	O
diagnosis	329	338	O
in	339	341	O
patients	342	350	O
with	351	355	O
endometriosis	356	369	O
externa	370	377	O
.	377	378	O

Of	379	381	O
the	382	385	O
61	386	388	O
patients	389	397	O
who	398	401	O
desired	402	409	O
to	410	412	O
enhance	413	420	O
or	421	423	O
preserve	424	432	O
reproductive	433	445	O
capacity	446	454	O
,	454	455	O
20	456	458	O
patients	459	467	O
became	468	474	O
pregnant	475	483	O
,	483	484	O
for	485	488	O
a	489	490	O
pregnancy	491	500	O
rate	501	505	O
of	506	508	O
33	509	511	O
%	511	512	O
.	512	513	O

The	514	517	O
pregnancy	518	527	O
rate	528	532	O
in	533	535	O
all	536	539	O
categories	540	550	O
,	550	551	O
that	552	556	O
is	557	559	O
,	559	560	O
those	561	566	O
patients	567	575	O
treated	576	583	O
with	584	588	O
pseudopregnancy	589	604	O
,	604	605	O
conservative	606	618	O
surgery	619	626	O
,	626	627	O
and	628	631	O
combined	632	640	O
pseudopregnancy	641	656	O
and	657	660	O
surgery	661	668	O
,	668	669	O
was	670	673	O
found	674	679	O
to	680	682	O
be	683	685	O
in	686	688	O
direct	689	695	O
relationship	696	708	O
to	709	711	O
the	712	715	O
initial	716	723	O
extent	724	730	O
of	731	733	O
disease	734	741	O
.	741	742	O

In	743	745	O
such	746	750	O
patients	751	759	O
,	759	760	O
conservative	761	773	O
surgery	774	781	O
alone	782	787	O
seemed	788	794	O
to	795	797	O
give	798	802	O
the	803	806	O
best	807	811	O
results	812	819	O
in	820	822	O
the	823	826	O
achievement	827	838	O
of	839	841	O
pregnancy	842	851	O
.	851	852	O

There	853	858	O
seemed	859	865	O
to	866	868	O
be	869	871	O
little	872	878	O
difference	879	889	O
between	890	897	O
pseudopregnancy	898	913	O
alone	914	919	O
and	920	923	O
conservative	924	936	O
surgery	937	944	O
in	945	947	O
regard	948	954	O
to	955	957	O
the	958	961	O
need	962	966	O
for	967	970	O
subsequent	971	981	O
surgery	982	989	O
after	990	995	O
initial	996	1003	O
therapy	1004	1011	O
,	1011	1012	O
although	1013	1021	O
there	1022	1027	O
seemed	1028	1034	O
to	1035	1037	O
be	1038	1040	O
a	1041	1042	O
significantly	1043	1056	O
greater	1057	1064	O
chance	1065	1071	O
for	1072	1075	O
the	1076	1079	O
need	1080	1084	O
for	1085	1088	O
subsequent	1089	1099	O
surgery	1100	1107	O
in	1108	1110	O
patients	1111	1119	O
receiving	1120	1129	O
a	1130	1131	O
combination	1132	1143	O
of	1144	1146	O
the	1147	1150	O
two	1151	1154	O
forms	1155	1160	O
of	1161	1163	O
therapy	1164	1171	O
.	1171	1172	O

The	1173	1176	O
need	1177	1181	O
for	1182	1185	O
subsequent	1186	1196	O
surgery	1197	1204	O
after	1205	1210	O
initial	1211	1218	O
therapy	1219	1226	O
in	1227	1229	O
80	1230	1232	O
patients	1233	1241	O
increased	1242	1251	O
in	1252	1254	O
direct	1255	1261	O
relationship	1262	1274	O
to	1275	1277	O
the	1278	1281	O
initial	1282	1289	O
extent	1290	1296	O
of	1297	1299	O
disease	1300	1307	O
present	1308	1315	O
,	1315	1316	O
despite	1317	1324	O
the	1325	1328	O
form	1329	1333	O
of	1334	1336	O
therapy	1337	1344	O
used	1345	1349	O
.	1349	1350	O

Fifty	1351	1356	O
-	1356	1357	O
nine	1357	1361	O
other	1362	1367	O
patients	1368	1376	O
with	1377	1381	O
endometriosis	1382	1395	O
,	1395	1396	O
who	1397	1400	O
did	1401	1404	O
not	1405	1408	O
desire	1409	1415	O
to	1416	1418	O
preserve	1419	1427	O
fertility	1428	1437	O
and	1438	1441	O
presented	1442	1451	O
for	1452	1455	O
relief	1456	1462	O
of	1463	1465	O
other	1466	1471	O
symptoms	1472	1480	O
,	1480	1481	O
underwent	1482	1491	O
initial	1492	1499	O
"	1500	1501	O
radical	1501	1508	O
"	1508	1509	O
therapy	1510	1517	O
.	1517	1518	O

Forty	1519	1524	O
-	1524	1525	O
six	1525	1528	O
patients	1529	1537	O
underwent	1538	1547	O
complete	1548	1556	O
operation	1557	1566	O
,	1566	1567	O
including	1568	1577	O
removal	1578	1585	O
of	1586	1588	O
uterus	1589	1595	B-Organ
,	1595	1596	O
tubes	1597	1602	B-Multi-tissue_structure
and	1603	1606	O
ovaries	1607	1614	B-Organ
,	1614	1615	O
and	1616	1619	O
none	1620	1624	O
required	1625	1633	O
subsequent	1634	1644	O
reoperation	1645	1656	O
.	1656	1657	O

Of	1658	1660	O
the	1661	1664	O
13	1665	1667	O
remaining	1668	1677	O
patients	1678	1686	O
,	1686	1687	O
who	1688	1691	O
underwent	1692	1701	O
incomplete	1702	1712	O
surgical	1713	1721	O
removal	1722	1729	O
,	1729	1730	O
leaving	1731	1738	O
one	1739	1742	O
or	1743	1745	O
both	1746	1750	O
ovaries	1751	1758	B-Organ
in	1759	1761	O
situ	1762	1766	O
,	1766	1767	O
11	1768	1770	O
required	1771	1779	O
subsequent	1780	1790	O
reoperation	1791	1802	O
for	1803	1806	O
recurrent	1807	1816	O
pelvic	1817	1823	O
endometriosis	1824	1837	O
.	1837	1838	O

Lack	0	4	O
of	5	7	O
developmental	8	21	O
and	22	25	O
reproductive	26	38	O
toxicity	39	47	O
of	48	50	O
2	51	52	O
,	52	53	O
3	53	54	O
,	54	55	O
3	55	56	O
'	56	57	O
,	57	58	O
4	58	59	O
,	59	60	O
4	61	62	O
'	62	63	O
-	63	64	O
pentachlorobiphenyl	64	83	O
(	84	85	O
PCB	85	88	O
105	89	92	O
)	92	93	O
in	94	96	O
ring	97	101	O
-	101	102	O
necked	102	108	O
pheasants	109	118	O
.	118	119	O

Mono	120	124	O
-	124	125	O
ortho	125	130	O
PCBs	131	135	O
are	136	139	O
global	140	146	O
contaminants	147	159	O
of	160	162	O
wildlife	163	171	O
with	172	176	O
the	177	180	O
potential	181	190	O
to	191	193	O
produce	194	201	O
toxicity	202	210	O
by	211	213	O
an	214	216	O
aryl	217	221	O
hydrocarbon	222	233	O
receptor	234	242	O
(	243	244	O
AhR	244	247	O
)	247	248	O
-	248	249	O
mediated	249	257	O
mechanism	258	267	O
.	267	268	O

To	269	271	O
determine	272	281	O
the	282	285	O
potency	286	293	O
of	294	296	O
2	297	298	O
,	298	299	O
3	299	300	O
,	300	301	O
3	301	302	O
'	302	303	O
,	303	304	O
4	304	305	O
,	305	306	O
4	307	308	O
'	308	309	O
-	309	310	O
pentachlorobiphenyl	310	329	O
(	330	331	O
PCB	331	334	O
105	335	338	O
)	338	339	O
for	340	343	O
producing	344	353	O
reproductive	354	366	O
and	367	370	O
developmental	371	384	O
toxicity	385	393	O
,	393	394	O
adult	395	400	O
ring	401	405	O
-	405	406	O
necked	406	412	O
pheasant	413	421	O
hens	422	426	O
(	427	428	O
Phasianus	428	437	O
colchicus	438	447	O
)	447	448	O
were	449	453	O
orally	454	460	O
dosed	461	466	O
with	467	471	O
0	472	473	O
,	473	474	O
0	475	476	O
.	476	477	O
06	477	479	O
,	479	480	O
0	481	482	O
.	482	483	O
6	483	484	O
,	484	485	O
or	486	488	O
6	489	490	O
mg	491	493	O
PCB	494	497	O
105	498	501	O
/	501	502	O
kg	502	504	O
hen	505	508	O
/	508	509	O
week	509	513	O
for	514	517	O
10	518	520	O
weeks	521	526	O
to	527	529	O
achieve	530	537	O
cumulative	538	548	O
doses	549	554	O
of	555	557	O
0	558	559	O
,	559	560	O
0	561	562	O
.	562	563	O
6	563	564	O
,	564	565	O
6	566	567	O
,	567	568	O
or	569	571	O
60	572	574	O
mg	575	577	O
PCB	578	581	O
105	582	585	O
/	585	586	O
kg	586	588	O
hen	589	592	O
after	593	598	O
which	599	604	O
hens	605	609	O
were	610	614	O
bred	615	619	O
with	620	624	O
untreated	625	634	O
roosters	635	643	O
once	644	648	O
per	649	652	O
week	653	657	O
for	658	661	O
8	662	663	O
weeks	664	669	O
.	669	670	O

Except	671	677	O
at	678	680	O
week	681	685	O
6	686	687	O
of	688	690	O
the	691	694	O
egg	695	698	B-Developing_anatomical_structure
-	698	699	O
laying	699	705	O
period	706	712	O
when	713	717	O
cumulative	718	728	O
egg	729	732	B-Developing_anatomical_structure
production	733	743	O
in	744	746	O
the	747	750	O
6	751	752	O
mg	753	755	O
PCB	756	759	O
105	760	763	O
/	763	764	O
kg	764	766	O
hen	767	770	O
group	771	776	O
was	777	780	O
greater	781	788	O
than	789	793	O
controls	794	802	O
,	802	803	O
fertilized	804	814	O
egg	815	818	B-Developing_anatomical_structure
production	819	829	O
was	830	833	O
not	834	837	O
significantly	838	851	O
different	852	861	O
between	862	869	O
treatment	870	879	O
groups	880	886	O
.	886	887	O

Embryo	888	894	B-Developing_anatomical_structure
mortality	895	904	O
and	905	908	O
chick	909	914	O
mortality	915	924	O
were	925	929	O
not	930	933	O
significantly	934	947	O
different	948	957	O
between	958	965	O
treatment	966	975	O
groups	976	982	O
.	982	983	O

Total	984	989	O
body	990	994	B-Organism_subdivision
and	995	998	O
heart	999	1004	B-Organ
weights	1005	1012	O
of	1013	1015	O
all	1016	1019	O
chicks	1020	1026	O
1	1027	1028	O
day	1029	1032	O
posthatch	1033	1042	O
(	1043	1044	O
dph	1044	1047	O
)	1047	1048	O
were	1049	1053	O
not	1054	1057	O
different	1058	1067	O
between	1068	1075	O
groups	1076	1082	O
,	1082	1083	O
however	1084	1091	O
,	1091	1092	O
liver	1093	1098	B-Organ
weights	1099	1106	O
of	1107	1109	O
chicks	1110	1116	O
from	1117	1121	O
the	1122	1125	O
60	1126	1128	O
mg	1129	1131	O
/	1131	1132	O
kg	1132	1134	O
treatment	1135	1144	O
group	1145	1150	O
were	1151	1155	O
greater	1156	1163	O
than	1164	1168	O
controls	1169	1177	O
at	1178	1180	O
1	1181	1182	O
dph	1183	1186	O
.	1186	1187	O

The	1188	1191	O
first	1192	1197	O
chick	1198	1203	O
to	1204	1206	O
hatch	1207	1212	O
from	1213	1217	O
each	1218	1222	O
hen	1223	1226	O
was	1227	1230	O
reared	1231	1237	O
to	1238	1240	O
21	1241	1243	O
dph	1244	1247	O
and	1248	1251	O
among	1252	1257	O
these	1258	1263	O
birds	1264	1269	O
,	1269	1270	O
the	1271	1274	O
total	1275	1280	O
body	1281	1285	B-Organism_subdivision
,	1285	1286	O
liver	1287	1292	B-Organ
,	1292	1293	O
and	1294	1297	O
heart	1298	1303	B-Organ
weights	1304	1311	O
were	1312	1316	O
not	1317	1320	O
different	1321	1330	O
between	1331	1338	O
groups	1339	1345	O
.	1345	1346	O

There	1347	1352	O
were	1353	1357	O
no	1358	1360	O
dose	1361	1365	O
-	1365	1366	O
related	1366	1373	O
malformations	1374	1387	O
of	1388	1390	O
the	1391	1394	O
beak	1395	1399	B-Organism_subdivision
or	1400	1402	O
limbs	1403	1408	B-Organism_subdivision
,	1408	1409	O
and	1410	1413	O
no	1414	1416	O
signs	1417	1422	O
of	1423	1425	O
subcutaneous	1426	1438	B-Pathological_formation
edema	1439	1444	I-Pathological_formation
,	1444	1445	O
ascites	1446	1453	B-Organism_substance
,	1453	1454	O
or	1455	1457	O
pericardial	1458	1469	B-Pathological_formation
edema	1470	1475	I-Pathological_formation
in	1476	1478	O
chicks	1479	1485	O
at	1486	1488	O
1	1489	1490	O
or	1491	1493	O
21	1494	1496	O
dph	1497	1500	O
.	1500	1501	O

Hepatic	1502	1509	O
microsomal	1510	1520	O
monooxygenase	1521	1534	O
activities	1535	1545	O
[	1546	1547	O
ethoxyresorufin	1547	1562	O
-	1562	1563	O
O	1563	1564	O
-	1564	1565	O
dealkylase	1565	1575	O
(	1576	1577	O
EROD	1577	1581	O
)	1581	1582	O
,	1582	1583	O
benzyloxyresorufin	1584	1602	O
-	1602	1603	O
O	1603	1604	O
-	1604	1605	O
dealkylase	1605	1615	O
(	1616	1617	O
BROD	1617	1621	O
)	1621	1622	O
,	1622	1623	O
and	1624	1627	O
methyloxyresorufin	1628	1646	O
-	1646	1647	O
O	1647	1648	O
-	1648	1649	O
dealkylase	1649	1659	O
(	1660	1661	O
MROD	1661	1665	O
)	1665	1666	O
]	1666	1667	O
were	1668	1672	O
significantly	1673	1686	O
elevated	1687	1695	O
in	1696	1698	O
chicks	1699	1705	O
at	1706	1708	O
1	1709	1710	O
dph	1711	1714	O
from	1715	1719	O
hens	1720	1724	O
given	1725	1730	O
a	1731	1732	O
cumulative	1733	1743	O
PCB	1744	1747	O
105	1748	1751	O
dose	1752	1756	O
of	1757	1759	O
6	1760	1761	O
mg	1762	1764	O
/	1764	1765	O
kg	1765	1767	O
and	1768	1771	O
in	1772	1774	O
chicks	1775	1781	O
at	1782	1784	O
21	1785	1787	O
dph	1788	1791	O
from	1792	1796	O
hens	1797	1801	O
given	1802	1807	O
a	1808	1809	O
cumulative	1810	1820	O
PCB	1821	1824	O
dose	1825	1829	O
of	1830	1832	O
60	1833	1835	O
mg	1836	1838	O
/	1838	1839	O
kg	1839	1841	O
.	1841	1842	O

These	1843	1848	O
results	1849	1856	O
indicate	1857	1865	O
that	1866	1870	O
a	1871	1872	O
cumulative	1873	1883	O
PCB	1884	1887	O
105	1888	1891	O
dose	1892	1896	O
up	1897	1899	O
to	1900	1902	O
60	1903	1905	O
mg	1906	1908	O
/	1908	1909	O
kg	1909	1911	O
hen	1912	1915	O
does	1916	1920	O
not	1921	1924	O
decrease	1925	1933	O
the	1934	1937	O
production	1938	1948	O
of	1949	1951	O
fertilized	1952	1962	O
eggs	1963	1967	B-Developing_anatomical_structure
or	1968	1970	O
increase	1971	1979	O
embryo	1980	1986	B-Developing_anatomical_structure
or	1987	1989	O
chick	1990	1995	O
mortality	1996	2005	O
in	2006	2008	O
ring	2009	2013	O
-	2013	2014	O
necked	2014	2020	O
pheasants	2021	2030	O
,	2030	2031	O
but	2032	2035	O
does	2036	2040	O
increase	2041	2049	O
chick	2050	2055	O
hepatic	2056	2063	B-Organ
monooxygenase	2064	2077	O
activity	2078	2086	O
.	2086	2087	O

Detection	0	9	O
of	10	12	O
total	13	18	O
assist	19	25	O
and	26	29	O
sucking	30	37	O
points	38	44	O
based	45	50	O
on	51	53	O
the	54	57	O
pulsatility	58	69	O
of	70	72	O
a	73	74	O
continuous	75	85	O
flow	86	90	O
artificial	91	101	O
heart	102	107	O
:	107	108	O
in	109	111	O
vivo	112	116	O
evaluation	117	127	O
.	127	128	O

Our	129	132	O
novel	133	138	O
control	139	146	O
strategy	147	155	O
for	156	159	O
a	160	161	O
continuous	162	172	O
flow	173	177	O
artificial	178	188	O
heart	189	194	O
by	195	197	O
detecting	198	207	O
the	208	211	O
total	212	217	O
assist	218	224	O
and	225	228	O
sucking	229	236	O
points	237	243	O
based	244	249	O
on	250	252	O
pump	253	257	O
pulsatility	258	269	O
was	270	273	O
evaluated	274	283	O
in	284	286	O
acute	287	292	O
animal	293	299	O
experiments	300	311	O
using	312	317	O
beagle	318	324	O
dogs	325	329	O
and	330	333	O
our	334	337	O
mixed	338	343	O
flow	344	348	O
pump	349	353	O
.	353	354	O

The	355	358	O
pump	359	363	O
was	364	367	O
installed	368	377	O
as	378	380	O
a	381	382	O
left	383	387	B-Multi-tissue_structure
ventricular	388	399	I-Multi-tissue_structure
(	400	401	O
LV	401	403	B-Multi-tissue_structure
)	403	404	O
bypass	405	411	O
through	412	419	O
a	420	421	O
left	422	426	O
thoracotomy	427	438	O
.	438	439	O

To	440	442	O
change	443	449	O
LV	450	452	B-Multi-tissue_structure
contractility	453	466	O
,	466	467	O
the	468	471	O
left	472	476	O
coronary	477	485	B-Multi-tissue_structure
arteries	486	494	I-Multi-tissue_structure
were	495	499	O
occluded	500	508	O
for	509	512	O
30	513	515	O
min	516	519	O
,	519	520	O
followed	521	529	O
by	530	532	O
a	533	534	O
120	535	538	O
min	539	542	O
reperfusion	543	554	O
.	554	555	O

To	556	558	O
change	559	565	O
LV	566	568	B-Multi-tissue_structure
end	569	572	O
diastolic	573	582	O
pressure	583	591	O
(	592	593	O
LVEDP	593	598	O
)	598	599	O
,	599	600	O
dextran	601	608	O
solution	609	617	O
was	618	621	O
rapidly	622	629	O
infused	630	637	O
.	637	638	O

To	639	641	O
estimate	642	650	O
the	651	654	O
pump	655	659	O
pulsatility	660	671	O
without	672	679	O
any	680	683	O
specific	684	692	O
sensor	693	699	O
,	699	700	O
we	701	703	O
calculated	704	714	O
the	715	718	O
index	719	724	O
of	725	727	O
current	728	735	O
amplitude	736	745	O
(	746	747	O
ICA	747	750	O
)	750	751	O
,	751	752	O
which	753	758	O
was	759	762	O
obtained	763	771	O
from	772	776	O
the	777	780	O
amplitude	781	790	O
of	791	793	O
the	794	797	O
motor	798	803	O
current	804	811	O
waveform	812	820	O
divided	821	828	O
by	829	831	O
the	832	835	O
simultaneous	836	848	O
mean	849	853	O
value	854	859	O
.	859	860	O

To	861	863	O
investigate	864	875	O
the	876	879	O
basic	880	885	O
characteristics	886	901	O
of	902	904	O
the	905	908	O
ICA	909	912	O
,	912	913	O
the	914	917	O
pump	918	922	O
speed	923	928	O
was	929	932	O
changed	933	940	O
temporarily	941	952	O
from	953	957	O
2	958	959	O
,	959	960	O
300	960	963	O
rpm	964	967	O
to	968	970	O
5	971	972	O
,	972	973	O
000	973	976	O
rpm	977	980	O
.	980	981	O

In	982	984	O
92	985	987	O
%	987	988	O
of	989	991	O
all	992	995	O
measurements	996	1008	O
,	1008	1009	O
the	1010	1013	O
ICA	1014	1017	O
plotted	1018	1025	O
against	1026	1033	O
the	1034	1037	O
pump	1038	1042	O
speed	1043	1048	O
had	1049	1052	O
a	1053	1054	O
peak	1055	1059	O
point	1060	1065	O
(	1066	1067	O
t	1067	1068	O
-	1068	1069	O
point	1069	1074	O
)	1074	1075	O
that	1076	1080	O
corresponded	1081	1093	O
highly	1094	1100	O
with	1101	1105	O
the	1106	1109	O
turning	1110	1117	O
point	1118	1123	O
from	1124	1128	O
partial	1129	1136	O
to	1137	1139	O
total	1140	1145	O
assistance	1146	1156	O
.	1156	1157	O

The	1158	1161	O
ICA	1162	1165	O
also	1166	1170	O
had	1171	1174	O
a	1175	1176	O
trough	1177	1183	O
(	1184	1185	O
s	1185	1186	O
-	1186	1187	O
point	1187	1192	O
)	1192	1193	O
that	1194	1198	O
corresponded	1199	1211	O
with	1212	1216	O
the	1217	1220	O
beginning	1221	1230	O
of	1231	1233	O
severe	1234	1240	O
sucking	1241	1248	O
in	1249	1251	O
most	1252	1256	O
cases	1257	1262	O
.	1262	1263	O

Only	1264	1268	O
preload	1269	1276	O
significantly	1277	1290	O
influenced	1291	1301	O
pump	1302	1306	O
flow	1307	1311	O
rate	1312	1316	O
at	1317	1319	O
the	1320	1323	O
t	1324	1325	O
-	1325	1326	O
point	1326	1331	O
from	1332	1336	O
among	1337	1342	O
preload	1343	1350	O
(	1351	1352	O
LVEDP	1352	1357	O
)	1357	1358	O
,	1358	1359	O
afterload	1360	1369	O
(	1370	1371	O
SAoP	1371	1375	O
)	1375	1376	O
,	1376	1377	O
and	1378	1381	O
contractility	1382	1395	O
(	1396	1397	O
max	1397	1400	O
LV	1401	1403	B-Multi-tissue_structure
dP	1404	1406	O
/	1406	1407	O
dt	1407	1409	O
)	1409	1410	O
,	1410	1411	O
by	1412	1414	O
which	1415	1420	O
we	1421	1423	O
can	1424	1427	O
simulate	1428	1436	O
Starling	1437	1445	O
'	1445	1446	O
s	1446	1447	O
law	1448	1451	O
of	1452	1454	O
the	1455	1458	O
natural	1459	1466	O
heart	1467	1472	B-Organ
.	1472	1473	O

We	1474	1476	O
concluded	1477	1486	O
that	1487	1491	O
a	1492	1493	O
continuous	1494	1504	O
flow	1505	1509	O
artificial	1510	1520	O
heart	1521	1526	O
could	1527	1532	O
be	1533	1535	O
well	1536	1540	O
controlled	1541	1551	O
by	1552	1554	O
detecting	1555	1564	O
the	1565	1568	O
t	1569	1570	O
-	1570	1571	O
point	1571	1576	O
and	1577	1580	O
s	1581	1582	O
-	1582	1583	O
point	1583	1588	O
.	1588	1589	O

Images	0	6	O

Figure	7	13	O
1	14	15	O

Figure	16	22	O
2	23	24	O

Figure	25	31	O
3	32	33	O

Figure	34	40	O
4	41	42	O

Results	0	7	O

Images	0	6	O

FIGURE	7	13	O
2	14	15	O
.	15	16	O

Nf	0	2	O
and	3	6	O
GA	7	9	O
-	9	10	O
1	10	11	O
DNA	12	15	O
polymerases	16	27	O
couple	28	34	O
polymerization	35	49	O
to	50	52	O
strand	53	59	O
displacement	60	72	O
processively	73	85	O

The	86	89	O
results	90	97	O
presented	98	107	O
in	108	110	O
this	111	115	O
paper	116	121	O
clearly	122	129	O
indicate	130	138	O
that	139	143	O
Nf	144	146	O
and	147	150	O
GA	151	153	O
-	153	154	O
1	154	155	O
DNA	156	159	O
polymerases	160	171	O
can	172	175	O
account	176	183	O
for	184	187	O
their	188	193	O
genome	194	200	O
replication	201	212	O
without	213	220	O
the	221	224	O
assistance	225	235	O
of	236	238	O
unwinding	239	248	O
and	249	252	O
processivity	253	265	O
factors	266	273	O
,	273	274	O
in	275	277	O
contrast	278	286	O
to	287	289	O
most	290	294	O
replicative	295	306	O
DNA	307	310	O
polymerases	311	322	O
which	323	328	O
require	329	336	O
their	337	342	O
physical	343	351	O
association	352	363	O
to	364	366	O
processivity	367	379	O
factors	380	387	O
and	388	391	O
DNA	392	395	O
unwinding	396	405	O
proteins	406	414	O
(	415	416	O
1	416	417	O
,	417	418	O
70	418	420	O
)	420	421	O
.	421	422	O

Strand	423	429	O
displacement	430	442	O
capacity	443	451	O
has	452	455	O
also	456	460	O
been	461	465	O
shown	466	471	O
for	472	475	O
other	476	481	O
protein	482	489	O
-	489	490	O
primed	490	496	O
DNA	497	500	O
polymerases	501	512	O
as	513	515	O
those	516	521	O
of	522	524	O
bacteriophages	525	539	O
phi29	540	545	O
(	546	547	O
10	547	549	O
)	549	550	O
,	550	551	O
Cp	552	554	O
-	554	555	O
1	555	556	O
(	557	558	O
71	558	560	O
)	560	561	O
and	562	565	O
PRD1	566	570	O
(	571	572	O
72	572	574	O
,	574	575	O
73	575	577	O
)	577	578	O
.	578	579	O

On	580	582	O
the	583	586	O
contrary	587	595	O
,	595	596	O
adenovirus	597	607	O
DNA	608	611	O
polymerase	612	622	O
,	622	623	O
although	624	632	O
processive	633	643	O
,	643	644	O
cannot	645	651	O
couple	652	658	O
polymerization	659	673	O
to	674	676	O
strand	677	683	O
displacement	684	696	O
,	696	697	O
requiring	698	707	O
the	708	711	O
DNA	712	715	O
unwinding	716	725	O
activity	726	734	O
of	735	737	O
the	738	741	O
adenovirus	742	752	O
DBP	753	756	O
to	757	759	O
perform	760	767	O
strand	768	774	O
displacement	775	787	O
(	788	789	O
74	789	791	O
,	791	792	O
75	792	794	O
)	794	795	O
.	795	796	O

Whereas	797	804	O
it	805	807	O
was	808	811	O
possible	812	820	O
to	821	823	O
obtain	824	830	O
GA	831	833	O
-	833	834	O
1	834	835	O
DNA	836	839	O
replication	840	851	O
by	852	854	O
using	855	860	O
exclusively	861	872	O
the	873	876	O
GA	877	879	O
-	879	880	O
1	880	881	O
TP	882	884	O
and	885	888	O
DNA	889	892	O
polymerase	893	903	O
,	903	904	O
Nf	905	907	O
DNA	908	911	O
polymerase	912	922	O
,	922	923	O
although	924	932	O
provided	933	941	O
with	942	946	O
competent	947	956	O
strand	957	963	O
displacement	964	976	O
and	977	980	O
processivity	981	993	O
features	994	1002	O
,	1002	1003	O
required	1004	1012	O
the	1013	1016	O
presence	1017	1025	O
of	1026	1028	O
Nf	1029	1031	O
DBP	1032	1035	O
for	1036	1039	O
an	1040	1042	O
effective	1043	1052	O
in	1053	1055	O
vitro	1056	1061	O
replication	1062	1073	O
of	1074	1076	O
Nf	1077	1079	O
TP	1080	1082	O
-	1082	1083	O
DNA	1083	1086	O
.	1086	1087	O

Results	1088	1095	O
presented	1096	1105	O
here	1106	1110	O
show	1111	1115	O
that	1116	1120	O
Nf	1121	1123	O
DBP	1124	1127	O
strongly	1128	1136	O
stimulates	1137	1147	O
the	1148	1151	O
formation	1152	1161	O
of	1162	1164	O
the	1165	1168	O
TP	1169	1171	O
-	1171	1172	O
dAMP	1172	1176	O
initiation	1177	1187	O
complex	1188	1195	O
by	1196	1198	O
decreasing	1199	1209	O
the	1210	1213	O
Km	1214	1216	O
for	1217	1220	O
dATP	1221	1225	O
and	1226	1229	O
facilitates	1230	1241	O
the	1242	1245	O
transition	1246	1256	O
from	1257	1261	O
initiation	1262	1272	O
to	1273	1275	O
elongation	1276	1286	O
,	1286	1287	O
as	1288	1290	O
it	1291	1293	O
occurs	1294	1300	O
in	1301	1303	O
phi29	1304	1309	O
(	1310	1311	O
76	1311	1313	O
)	1313	1314	O
.	1314	1315	O

These	1316	1321	O
results	1322	1329	O
point	1330	1335	O
to	1336	1338	O
either	1339	1345	O
a	1346	1347	O
specific	1348	1356	O
and	1357	1360	O
direct	1361	1367	O
contact	1368	1375	O
between	1376	1383	O
DBP	1384	1387	O
and	1388	1391	O
DNA	1392	1395	O
polymerase	1396	1406	O
that	1407	1411	O
promotes	1412	1420	O
conformational	1421	1435	O
changes	1436	1443	O
at	1444	1446	O
the	1447	1450	O
polymerization	1451	1465	O
active	1466	1472	O
site	1473	1477	O
or	1478	1480	O
to	1481	1483	O
an	1484	1486	O
effect	1487	1493	O
of	1494	1496	O
DBP	1497	1500	O
in	1501	1503	O
conferring	1504	1514	O
the	1515	1518	O
optimal	1519	1526	O
template	1527	1535	O
structure	1536	1545	O
to	1546	1548	O
direct	1549	1555	O
initiating	1556	1566	O
nucleotide	1567	1577	O
insertion	1578	1587	O
.	1587	1588	O

A	1589	1590	O
similar	1591	1598	O
role	1599	1603	O
has	1604	1607	O
been	1608	1612	O
proposed	1613	1621	O
for	1622	1625	O
adenovirus	1626	1636	O
DBP	1637	1640	O
,	1640	1641	O
a	1642	1643	O
DNA	1644	1647	O
unwinding	1648	1657	O
protein	1658	1665	O
(	1666	1667	O
77	1667	1669	O
)	1669	1670	O
.	1670	1671	O

As	1672	1674	O
in	1675	1677	O
the	1678	1681	O
case	1682	1686	O
of	1687	1689	O
phi29	1690	1695	O
and	1696	1699	O
Nf	1700	1702	O
DBP	1703	1706	O
,	1706	1707	O
this	1708	1712	O
protein	1713	1720	O
stimulates	1721	1731	O
the	1732	1735	O
rate	1736	1740	O
of	1741	1743	O
initiation	1744	1754	O
also	1755	1759	O
by	1760	1762	O
decreasing	1763	1773	O
the	1774	1777	O
Km	1778	1780	O
for	1781	1784	O
the	1785	1788	O
initiating	1789	1799	O
nucleotide	1800	1810	O
(	1811	1812	O
74	1812	1814	O
)	1814	1815	O
.	1815	1816	O

The	1817	1820	O
fact	1821	1825	O
that	1826	1830	O
an	1831	1833	O
adenovirus	1834	1844	O
DBP	1845	1848	O
mutant	1849	1855	O
defective	1856	1865	O
in	1866	1868	O
unwinding	1869	1878	O
can	1879	1882	O
still	1883	1888	O
stimulate	1889	1898	O
initiation	1899	1909	O
precludes	1910	1919	O
the	1920	1923	O
unwinding	1924	1933	O
role	1934	1938	O
as	1939	1941	O
the	1942	1945	O
one	1946	1949	O
responsible	1950	1961	O
for	1962	1965	O
such	1966	1970	O
an	1971	1973	O
activation	1974	1984	O
(	1985	1986	O
77	1986	1988	O
,	1988	1989	O
78	1989	1991	O
)	1991	1992	O
.	1992	1993	O

In	1994	1996	O
this	1997	2001	O
case	2002	2006	O
,	2006	2007	O
contacts	2008	2016	O
between	2017	2024	O
DBP	2025	2028	O
and	2029	2032	O
pTP	2033	2036	O
/	2036	2037	O
DNA	2037	2040	O
polymerase	2041	2051	O
complex	2052	2059	O
have	2060	2064	O
been	2065	2069	O
reported	2070	2078	O
(	2079	2080	O
77	2080	2082	O
)	2082	2083	O
.	2083	2084	O

The	2085	2088	O
effect	2089	2095	O
of	2096	2098	O
Nf	2099	2101	O
DBP	2102	2105	O
in	2106	2108	O
promoting	2109	2118	O
elongation	2119	2129	O
of	2130	2132	O
the	2133	2136	O
initiation	2137	2147	O
products	2148	2156	O
could	2157	2162	O
be	2163	2165	O
due	2166	2169	O
to	2170	2172	O
a	2173	2174	O
decrease	2175	2183	O
of	2184	2186	O
the	2187	2190	O
Km	2191	2193	O
also	2194	2198	O
for	2199	2202	O
the	2203	2206	O
incorporation	2207	2220	O
of	2221	2223	O
the	2224	2227	O
dNMPs	2228	2233	O
during	2234	2240	O
the	2241	2244	O
transition	2245	2255	O
stage	2256	2261	O
from	2262	2266	O
initiation	2267	2277	O
to	2278	2280	O
elongation	2281	2291	O
,	2291	2292	O
to	2293	2295	O
a	2296	2297	O
different	2298	2307	O
type	2308	2312	O
of	2313	2315	O
contact	2316	2323	O
with	2324	2328	O
the	2329	2332	O
DNA	2333	2336	O
polymerase	2337	2347	O
that	2348	2352	O
helps	2353	2358	O
transition	2359	2369	O
to	2370	2372	O
elongation	2373	2383	O
,	2383	2384	O
or	2385	2387	O
both	2388	2392	O
.	2392	2393	O

The	2394	2397	O
similarity	2398	2408	O
in	2409	2411	O
replication	2412	2423	O
rates	2424	2429	O
when	2430	2434	O
comparing	2435	2444	O
M13	2445	2448	O
DNA	2449	2452	O
replication	2453	2464	O
,	2464	2465	O
performed	2466	2475	O
in	2476	2478	O
the	2479	2482	O
absence	2483	2490	O
of	2491	2493	O
DBP	2494	2497	O
(	2498	2499	O
2400	2499	2503	O
nt	2504	2506	O
/	2506	2507	O
min	2507	2510	O
)	2510	2511	O
,	2511	2512	O
with	2513	2517	O
Nf	2518	2520	O
TP	2521	2523	O
-	2523	2524	O
DNA	2524	2527	O
replication	2528	2539	O
in	2540	2542	O
the	2543	2546	O
presence	2547	2555	O
of	2556	2558	O
DBP	2559	2562	O
(	2563	2564	O
2260	2564	2568	O
nt	2569	2571	O
/	2571	2572	O
min	2572	2575	O
)	2575	2576	O
,	2576	2577	O
suggests	2578	2586	O
that	2587	2591	O
the	2592	2595	O
DBP	2596	2599	O
stimulatory	2600	2611	O
role	2612	2616	O
is	2617	2619	O
restricted	2620	2630	O
to	2631	2633	O
the	2634	2637	O
first	2638	2643	O
phases	2644	2650	O
of	2651	2653	O
Nf	2654	2656	O
TP	2657	2659	O
-	2659	2660	O
DNA	2660	2663	O
replication	2664	2675	O
.	2675	2676	O

2	0	1	O
-	1	2	O
Theory	3	9	O

Scanning	10	18	O
holography	19	29	O
is	30	32	O
a	33	34	O
two	35	38	O
-	38	39	O
pupil	39	44	O
interaction	45	56	O
method	57	63	O
[	64	65	O
8	65	66	O
]	66	67	O
by	68	70	O
which	71	76	O
incoherent	77	87	O
imaging	88	95	O
with	96	100	O
complex	101	108	O
point	109	114	O
-	114	115	O
spread	115	121	O
-	121	122	O
functions	122	131	O
(	132	133	O
PSF	133	136	O
)	136	137	O
is	138	140	O
possible	141	149	O
.	149	150	O

The	151	154	O
method	155	161	O
has	162	165	O
recently	166	174	O
been	175	179	O
applied	180	187	O
to	188	190	O
the	191	194	O
recording	195	204	O
of	205	207	O
high	208	212	O
resolution	213	223	O
holographic	224	235	O
images	236	242	O
of	243	245	O
incoherent	246	256	O
objects	257	264	O
and	265	268	O
fluorescent	269	280	O
biological	281	291	O
specimens	292	301	O
[	302	303	O
6	303	304	O
,	304	305	O
7	305	306	O
]	306	307	O
.	307	308	O

A	309	310	O
single	311	317	O
-	317	318	O
sideband	318	326	O
in	327	329	O
-	329	330	O
line	330	334	O
Fresnel	335	342	O
hologram	343	351	O
is	352	354	O
obtained	355	363	O
by	364	366	O
a	367	368	O
2D	369	371	O
raster	372	378	O
scan	379	383	O
of	384	386	O
the	387	390	O
object	391	397	O
with	398	402	O
the	403	406	O
superposed	407	417	O
3D	418	420	O
diffraction	421	432	O
distributions	433	446	O
of	447	449	O
two	450	453	O
pupils	454	460	O
,	460	461	O
as	462	464	O
sketched	465	473	O
in	474	476	O
fig	477	480	O
.	480	481	O

1	482	483	O
.	483	484	O

The	485	488	O
two	489	492	O
pupil	493	498	O
distributions	499	512	O
P	513	514	O
~	514	515	O
1	515	516	O
(	516	517	O
rho	517	520	O
-	520	521	O
-	521	522	O
>	522	523	O
)	523	524	O
MathType	525	533	O
@	533	534	O
MTEF	534	538	O
@	538	539	O
5	539	540	O
@	540	541	O
5	541	542	O
@	542	543	O
+	543	544	O
=	544	545	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	545	630	O
=	630	631	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	631	662	O
=	662	663	O
OqFfea0dXdd9vqai	663	679	O
=	679	680	O
hGuQ8kuc9pgc9s8qqaq	680	699	O
=	699	700	O
dirpe0xb9q8qiLsFr0	700	718	O
=	718	719	O
vr0	719	722	O
=	722	723	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa	723	840	O
@	840	841	O
3295	841	845	O
@	845	846	O
and	847	850	O
P	851	852	O
~	852	853	O
2	853	854	O
(	854	855	O
rho	855	858	O
-	858	859	O
-	859	860	O
>	860	861	O
)	861	862	O
MathType	863	871	O
@	871	872	O
MTEF	872	876	O
@	876	877	O
5	877	878	O
@	878	879	O
5	879	880	O
@	880	881	O
+	881	882	O
=	882	883	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	883	968	O
=	968	969	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	969	1000	O
=	1000	1001	O
OqFfea0dXdd9vqai	1001	1017	O
=	1017	1018	O
hGuQ8kuc9pgc9s8qqaq	1018	1037	O
=	1037	1038	O
dirpe0xb9q8qiLsFr0	1038	1056	O
=	1056	1057	O
vr0	1057	1060	O
=	1060	1061	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa	1061	1178	O
@	1178	1179	O
3297	1179	1183	O
@	1183	1184	O
from	1185	1189	O
the	1190	1193	O
same	1194	1198	O
source	1199	1205	O
(	1206	1207	O
for	1207	1210	O
example	1211	1218	O
,	1218	1219	O
but	1220	1223	O
not	1224	1227	O
necessarily	1228	1239	O
,	1239	1240	O
a	1241	1242	O
laser	1243	1248	O
)	1248	1249	O
are	1250	1253	O
combined	1254	1262	O
by	1263	1265	O
a	1266	1267	O
beam	1268	1272	O
splitter	1273	1281	O
in	1282	1284	O
the	1285	1288	O
pupil	1289	1294	O
plane	1295	1300	O
of	1301	1303	O
the	1304	1307	O
objective	1308	1317	O
where	1318	1323	O
they	1324	1328	O
interfere	1329	1338	O
,	1338	1339	O
forming	1340	1347	O
a	1348	1349	O
Fresnel	1350	1357	O
pattern	1358	1365	O
with	1366	1370	O
a	1371	1372	O
depth	1373	1378	O
-	1378	1379	O
dependent	1379	1388	O
Fresnel	1389	1396	O
number	1397	1403	O
.	1403	1404	O

To	1405	1407	O
obtain	1408	1414	O
the	1415	1418	O
conventional	1419	1431	O
point	1432	1437	O
-	1437	1438	O
spread	1438	1444	O
function	1445	1453	O
of	1454	1456	O
wide	1457	1461	O
field	1462	1467	O
imaging	1468	1475	O
,	1475	1476	O
P1	1477	1479	O
is	1480	1482	O
chosen	1483	1489	O
as	1490	1492	O
a	1493	1494	O
point	1495	1500	O
source	1501	1507	O
,	1507	1508	O
and	1509	1512	O
P2	1513	1515	O
as	1516	1518	O
a	1519	1520	O
spherical	1521	1530	O
wave	1531	1535	O
with	1536	1540	O
appropriate	1541	1552	O
curvature	1553	1562	O
.	1562	1563	O

The	1564	1567	O
3D	1568	1570	O
specimen	1571	1579	O
is	1580	1582	O
placed	1583	1589	O
in	1590	1592	O
the	1593	1596	O
focal	1597	1602	O
region	1603	1609	O
of	1610	1612	O
the	1613	1616	O
objective	1617	1626	O
,	1626	1627	O
and	1628	1631	O
scattered	1632	1641	O
lights	1642	1648	O
(	1649	1650	O
transmitted	1650	1661	O
,	1661	1662	O
reflected	1663	1672	O
,	1672	1673	O
and	1674	1677	O
fluorescent	1678	1689	O
)	1689	1690	O
are	1691	1694	O
collected	1695	1704	O
by	1705	1707	O
non	1708	1711	O
-	1711	1712	O
imaging	1712	1719	O
detectors	1720	1729	O
.	1729	1730	O

The	1731	1734	O
hologram	1735	1743	O
data	1744	1748	O
can	1749	1752	O
be	1753	1755	O
obtained	1756	1764	O
by	1765	1767	O
heterodyne	1768	1778	O
detection	1779	1788	O
with	1789	1793	O
one	1794	1797	O
of	1798	1800	O
the	1801	1804	O
pupils	1805	1811	O
shifted	1812	1819	O
in	1820	1822	O
frequency	1823	1832	O
(	1833	1834	O
as	1834	1836	O
done	1837	1841	O
in	1842	1844	O
this	1845	1849	O
work	1850	1854	O
)	1854	1855	O
,	1855	1856	O
or	1857	1859	O
by	1860	1862	O
a	1863	1864	O
homodyne	1865	1873	O
method	1874	1880	O
requiring	1881	1890	O
the	1891	1894	O
capture	1895	1902	O
of	1903	1905	O
at	1906	1908	O
least	1909	1914	O
three	1915	1920	O
frames	1921	1927	O
with	1928	1932	O
different	1933	1942	O
relative	1943	1951	O
phases	1952	1958	O
between	1959	1966	O
the	1967	1970	O
two	1971	1974	O
pupils	1975	1981	O
[	1982	1983	O
9	1983	1984	O
]	1984	1985	O
.	1985	1986	O

The	1987	1990	O
amplitude	1991	2000	O
distribution	2001	2013	O
of	2014	2016	O
the	2017	2020	O
illuminating	2021	2033	O
beam	2034	2038	O
,	2038	2039	O
in	2040	2042	O
a	2043	2044	O
transverse	2045	2055	O
plane	2056	2061	O
at	2062	2064	O
an	2065	2067	O
axial	2068	2073	O
distance	2074	2082	O
z	2083	2084	O
from	2085	2089	O
the	2090	2093	O
focal	2094	2099	O
plane	2100	2105	O
of	2106	2108	O
the	2109	2112	O
objective	2113	2122	O
,	2122	2123	O
is	2124	2126	O
the	2127	2130	O
Fourier	2131	2138	O
transform	2139	2148	O
of	2149	2151	O
the	2152	2155	O
combined	2156	2164	O
pupil	2165	2170	O
distributions	2171	2184	O
[	2185	2186	O
10	2186	2188	O
]	2188	2189	O
.	2189	2190	O

Namely	2191	2197	O
:	2197	2198	O

Figure	2199	2205	O
1	2206	2207	O

Experimental	2208	2220	O
set	2221	2224	O
up	2225	2227	O
of	2228	2230	O
a	2231	2232	O
scanning	2233	2241	O
holographic	2242	2253	O
microscope	2254	2264	O
.	2264	2265	O

Sketch	2266	2272	O
of	2273	2275	O
the	2276	2279	O
experimental	2280	2292	O
setup	2293	2298	O
.	2298	2299	O

M	2300	2301	O
'	2301	2302	O
s	2302	2303	O
are	2304	2307	O
mirrors	2308	2315	O
,	2315	2316	O
BS	2317	2319	O
'	2319	2320	O
s	2320	2321	O
are	2322	2325	O
beam	2326	2330	O
splitters	2331	2340	O
,	2340	2341	O
EO	2342	2344	O
is	2345	2347	O
an	2348	2350	O
electro	2351	2358	O
-	2358	2359	O
optic	2359	2364	O
phase	2365	2370	O
modulator	2371	2380	O
.	2380	2381	O

Lens	2382	2386	O
L1	2387	2389	O
(	2390	2391	O
achromat	2391	2399	O
doublet	2400	2407	O
16	2408	2410	O
cm	2411	2413	O
focal	2414	2419	O
length	2420	2426	O
)	2426	2427	O
produces	2428	2436	O
the	2437	2440	O
desired	2441	2448	O
Fresnel	2449	2456	O
pattern	2457	2464	O
in	2465	2467	O
the	2468	2471	O
focal	2472	2477	O
plane	2478	2483	O
of	2484	2486	O
L2	2487	2489	O
(	2490	2491	O
achromat	2491	2499	O
doublet	2500	2507	O
16	2508	2510	O
cm	2511	2513	O
focal	2514	2519	O
length	2520	2526	O
)	2526	2527	O
.	2527	2528	O

L2	2529	2531	O
and	2532	2535	O
the	2536	2539	O
objective	2540	2549	O
form	2550	2554	O
a	2555	2556	O
4	2557	2558	O
-	2558	2559	O
f	2559	2560	O
system	2561	2567	O
projecting	2568	2578	O
a	2579	2580	O
reduced	2581	2588	O
image	2589	2594	O
of	2595	2597	O
the	2598	2601	O
Fresnel	2602	2609	O
pattern	2610	2617	O
onto	2618	2622	O
the	2623	2626	O
specimen	2627	2635	O
.	2635	2636	O

L3	2637	2639	O
(	2640	2641	O
achromat	2641	2649	O
doublet	2650	2657	O
12	2658	2660	O
cm	2661	2663	O
focal	2664	2669	O
length	2670	2676	O
)	2676	2677	O
projects	2678	2686	O
the	2687	2690	O
images	2691	2697	O
of	2698	2700	O
the	2701	2704	O
pupils	2705	2711	O
on	2712	2714	O
the	2715	2718	O
pinhole	2719	2726	O
detector	2727	2735	O
.	2735	2736	O

(	2737	2738	O
Not	2738	2741	O
shown	2742	2747	O
are	2748	2751	O
the	2752	2755	O
beam	2756	2760	O
expanders	2761	2770	O
used	2771	2775	O
to	2776	2778	O
illuminate	2779	2789	O
the	2790	2793	O
pupils	2794	2800	O
)	2800	2801	O
.	2801	2802	O

S	2803	2804	O
(	2804	2805	O
r	2805	2806	O
-	2806	2807	O
-	2807	2808	O
>	2808	2809	O
,	2809	2810	O
z	2810	2811	O
)	2811	2812	O
=	2812	2813	O
F	2813	2814	O
-	2814	2815	O
1	2815	2816	O
{	2816	2817	O
[	2817	2818	O
P	2818	2819	O
~	2819	2820	O
1	2820	2821	O
(	2821	2822	O
rho	2822	2825	O
-	2825	2826	O
-	2826	2827	O
>	2827	2828	O
;	2828	2829	O
z	2829	2830	O
)	2830	2831	O
+	2831	2832	O
P	2832	2833	O
~	2833	2834	O
2	2834	2835	O
(	2835	2836	O
rho	2836	2839	O
-	2839	2840	O
-	2840	2841	O
>	2841	2842	O
;	2842	2843	O
z	2843	2844	O
)	2844	2845	O
exp	2845	2848	O
(	2849	2850	O
-	2850	2851	O
iOmegat	2851	2858	O
]	2858	2859	O
}	2859	2860	O
,	2860	2861	O
(	2862	2863	O
1a	2863	2865	O
)	2865	2866	O
MathType	2867	2875	O
@	2875	2876	O
MTEF	2876	2880	O
@	2880	2881	O
5	2881	2882	O
@	2882	2883	O
5	2883	2884	O
@	2884	2885	O
+	2885	2886	O
=	2886	2887	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	2887	2972	O
=	2972	2973	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	2973	3004	O
=	3004	3005	O
OqFfea0dXdd9vqai	3005	3021	O
=	3021	3022	O
hGuQ8kuc9pgc9s8qqaq	3022	3041	O
=	3041	3042	O
dirpe0xb9q8qiLsFr0	3042	3060	O
=	3060	3061	O
vr0	3061	3064	O
=	3064	3065	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGtbWucqGGOaakcuWGYbGCgaWcaiabcYcaSiabdQha6jabcMcaPiabg2da9iabdAeagnaaCaaaleqabaGaeyOeI0IaeGymaedaaOWaaiWabeaadaWadaqaaiqbdcfaqzaaiaWaaSbaaSqaaiabigdaXaqabaGccqGGOaakiiGacuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiabgUcaRiqbdcfaqzaaiaWaaSbaaSqaaiabikdaYaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiGbcwgaLjabcIha4jabcchaWjabcIcaOiabgkHiTiabdMgaPjabfM6axjabdsha0bGaay5waiaaw2faaaGaay5Eaiaaw2haaiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaIXaqmcqqGHbqyaiaawIcacaGLPaaaaaa	3065	3570	O
@	3570	3571	O
5D95	3571	3575	O
@	3575	3576	O

where	3577	3582	O

P	3583	3584	O
~	3584	3585	O
1	3585	3586	O
,	3586	3587	O
2	3587	3588	O
(	3588	3589	O
rho	3589	3592	O
-	3592	3593	O
-	3593	3594	O
>	3594	3595	O
;	3595	3596	O
z	3596	3597	O
)	3597	3598	O
=	3598	3599	O
P	3599	3600	O
~	3600	3601	O
1	3601	3602	O
,	3602	3603	O
2	3603	3604	O
(	3604	3605	O
rho	3605	3608	O
-	3608	3609	O
-	3609	3610	O
>	3610	3611	O
)	3611	3612	O
exp	3612	3615	O
(	3616	3617	O
ipilambdazrho2	3617	3631	O
)	3631	3632	O
(	3633	3634	O
1b	3634	3636	O
)	3636	3637	O
MathType	3638	3646	O
@	3646	3647	O
MTEF	3647	3651	O
@	3651	3652	O
5	3652	3653	O
@	3653	3654	O
5	3654	3655	O
@	3655	3656	O
+	3656	3657	O
=	3657	3658	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	3658	3743	O
=	3743	3744	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	3744	3775	O
=	3775	3776	O
OqFfea0dXdd9vqai	3776	3792	O
=	3792	3793	O
hGuQ8kuc9pgc9s8qqaq	3793	3812	O
=	3812	3813	O
dirpe0xb9q8qiLsFr0	3813	3831	O
=	3831	3832	O
vr0	3832	3835	O
=	3835	3836	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmcqGGSaalcqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcqGH9aqpcuWGqbaugaacamaaBaaaleaacqaIXaqmcqGGSaalcqaIYaGmaeqaaOGaeiikaGIaf8xWdiNbaSaacqGGPaqkcyGGLbqzcqGG4baEcqGGWbaCcqGGOaakcqWGPbqAcqWFapaCcqWF7oaBcqWG6bGEcqWFbpGCdaahaaWcbeqaaiabikdaYaaakiabcMcaPiaaxMaacaWLjaWaaeWaaeaacqaIXaqmcqqGIbGyaiaawIcacaGLPaaaaaa	3836	4237	O
@	4237	4238	O
53A8	4238	4242	O
@	4242	4243	O

are	4244	4247	O
the	4248	4251	O
generalized	4252	4263	O
defocused	4264	4273	O
pupils	4274	4280	O
[	4281	4282	O
11	4282	4284	O
]	4284	4285	O
.	4285	4286	O

F	4287	4288	O
-	4288	4289	O
1	4289	4290	O
stands	4291	4297	O
for	4298	4301	O
inverse	4302	4309	O
Fourier	4310	4317	O
transform	4318	4327	O
,	4327	4328	O
and	4329	4332	O
Omega	4333	4338	O
is	4339	4341	O
the	4342	4345	O
frequency	4346	4355	O
shift	4356	4361	O
of	4362	4364	O
one	4365	4368	O
of	4369	4371	O
the	4372	4375	O
pupils	4376	4382	O
.	4382	4383	O

The	4384	4387	O
transverse	4388	4398	O
spatial	4399	4406	O
frequency	4407	4416	O
vector	4417	4423	O
rho	4424	4427	O
-	4427	4428	O
-	4428	4429	O
>	4429	4430	O
MathType	4431	4439	O
@	4439	4440	O
MTEF	4440	4444	O
@	4444	4445	O
5	4445	4446	O
@	4446	4447	O
5	4447	4448	O
@	4448	4449	O
+	4449	4450	O
=	4450	4451	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	4451	4536	O
=	4536	4537	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	4537	4568	O
=	4568	4569	O
OqFfea0dXdd9vqai	4569	4585	O
=	4585	4586	O
hGuQ8kuc9pgc9s8qqaq	4586	4605	O
=	4605	4606	O
dirpe0xb9q8qiLsFr0	4606	4624	O
=	4624	4625	O
vr0	4625	4628	O
=	4628	4629	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacuWFbpGCgaWcaaaa	4629	4691	O
@	4691	4692	O
2E85	4692	4696	O
@	4696	4697	O
=	4698	4699	O
r	4700	4701	O
-	4701	4702	O
-	4702	4703	O
>	4703	4704	O
MathType	4705	4713	O
@	4713	4714	O
MTEF	4714	4718	O
@	4718	4719	O
5	4719	4720	O
@	4720	4721	O
5	4721	4722	O
@	4722	4723	O
+	4723	4724	O
=	4724	4725	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	4725	4810	O
=	4810	4811	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	4811	4842	O
=	4842	4843	O
OqFfea0dXdd9vqai	4843	4859	O
=	4859	4860	O
hGuQ8kuc9pgc9s8qqaq	4860	4879	O
=	4879	4880	O
dirpe0xb9q8qiLsFr0	4880	4898	O
=	4898	4899	O
vr0	4899	4902	O
=	4902	4903	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	4903	4961	O
@	4961	4962	O
2E2B	4962	4966	O
@	4966	4967	O
P	4967	4968	O
/	4968	4969	O
lambdaf0	4969	4977	O
is	4978	4980	O
proportional	4981	4993	O
to	4994	4996	O
the	4997	5000	O
real	5001	5005	O
space	5006	5011	O
coordinate	5012	5022	O
r	5023	5024	O
-	5024	5025	O
-	5025	5026	O
>	5026	5027	O
MathType	5028	5036	O
@	5036	5037	O
MTEF	5037	5041	O
@	5041	5042	O
5	5042	5043	O
@	5043	5044	O
5	5044	5045	O
@	5045	5046	O
+	5046	5047	O
=	5047	5048	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	5048	5133	O
=	5133	5134	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	5134	5165	O
=	5165	5166	O
OqFfea0dXdd9vqai	5166	5182	O
=	5182	5183	O
hGuQ8kuc9pgc9s8qqaq	5183	5202	O
=	5202	5203	O
dirpe0xb9q8qiLsFr0	5203	5221	O
=	5221	5222	O
vr0	5222	5225	O
=	5225	5226	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	5226	5284	O
@	5284	5285	O
2E2B	5285	5289	O
@	5289	5290	O
P	5290	5291	O
in	5292	5294	O
the	5295	5298	O
pupil	5299	5304	O
plane	5305	5310	O
[	5311	5312	O
10	5312	5314	O
]	5314	5315	O
.	5315	5316	O
lambda	5317	5323	O
is	5324	5326	O
the	5327	5330	O
wavelength	5331	5341	O
of	5342	5344	O
the	5345	5348	O
illumination	5349	5361	O
,	5361	5362	O
and	5363	5366	O
f0	5367	5369	O
is	5370	5372	O
the	5373	5376	O
focal	5377	5382	O
length	5383	5389	O
of	5390	5392	O
the	5393	5396	O
objective	5397	5406	O
.	5406	5407	O

The	5408	5411	O
two	5412	5415	O
pupils	5416	5422	O
used	5423	5427	O
to	5428	5430	O
obtain	5431	5437	O
an	5438	5440	O
in	5441	5443	O
-	5443	5444	O
line	5444	5448	O
Fresnel	5449	5456	O
hologram	5457	5465	O
are	5466	5469	O
,	5469	5470	O
respectively	5471	5483	O
,	5483	5484	O
a	5485	5486	O
spherical	5487	5496	O
wave	5497	5501	O
filling	5502	5509	O
the	5510	5513	O
pupil	5514	5519	O
of	5520	5522	O
the	5523	5526	O
objective	5527	5536	O
,	5536	5537	O
and	5538	5541	O
a	5542	5543	O
point	5544	5549	O
at	5550	5552	O
the	5553	5556	O
center	5557	5563	O
of	5564	5566	O
that	5567	5571	O
pupil	5572	5577	O
:	5577	5578	O

P	5579	5580	O
~	5580	5581	O
1	5581	5582	O
(	5582	5583	O
rho	5583	5586	O
-	5586	5587	O
-	5587	5588	O
>	5588	5589	O
)	5589	5590	O
MathType	5591	5599	O
@	5599	5600	O
MTEF	5600	5604	O
@	5604	5605	O
5	5605	5606	O
@	5606	5607	O
5	5607	5608	O
@	5608	5609	O
+	5609	5610	O
=	5610	5611	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	5611	5696	O
=	5696	5697	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	5697	5728	O
=	5728	5729	O
OqFfea0dXdd9vqai	5729	5745	O
=	5745	5746	O
hGuQ8kuc9pgc9s8qqaq	5746	5765	O
=	5765	5766	O
dirpe0xb9q8qiLsFr0	5766	5784	O
=	5784	5785	O
vr0	5785	5788	O
=	5788	5789	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa	5789	5906	O
@	5906	5907	O
3295	5907	5911	O
@	5911	5912	O
=	5913	5914	O
exp	5915	5918	O
(	5918	5919	O
ipilambdaz0rho2	5919	5934	O
)	5934	5935	O
circ	5935	5939	O
(	5939	5940	O
rho	5940	5943	O
/	5943	5944	O
rhoMAX	5944	5950	O
)	5950	5951	O

P	5952	5953	O
~	5953	5954	O
2	5954	5955	O
(	5955	5956	O
rho	5956	5959	O
-	5959	5960	O
-	5960	5961	O
>	5961	5962	O
)	5962	5963	O
=	5963	5964	O
delta	5964	5969	O
(	5969	5970	O
rho	5970	5973	O
-	5973	5974	O
-	5974	5975	O
>	5975	5976	O
)	5976	5977	O
.	5977	5978	O

(	5979	5980	O
2	5980	5981	O
)	5981	5982	O
MathType	5983	5991	O
@	5991	5992	O
MTEF	5992	5996	O
@	5996	5997	O
5	5997	5998	O
@	5998	5999	O
5	5999	6000	O
@	6000	6001	O
+	6001	6002	O
=	6002	6003	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	6003	6088	O
=	6088	6089	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	6089	6120	O
=	6120	6121	O
OqFfea0dXdd9vqai	6121	6137	O
=	6137	6138	O
hGuQ8kuc9pgc9s8qqaq	6138	6157	O
=	6157	6158	O
dirpe0xb9q8qiLsFr0	6158	6176	O
=	6176	6177	O
vr0	6177	6180	O
=	6180	6181	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpcqWF0oazcqGGOaakcuWFbpGCgaWcaiabcMcaPiabc6caUiaaxMaacaWLjaWaaeWaaeaacqaIYaGmaiaawIcacaGLPaaaaaa	6181	6398	O
@	6398	6399	O
3D5F	6399	6403	O
@	6403	6404	O

circ	6405	6409	O
(	6409	6410	O
x	6410	6411	O
)	6411	6412	O
is	6413	6415	O
a	6416	6417	O
disc	6418	6422	O
function	6423	6431	O
of	6432	6434	O
unit	6435	6439	O
radius	6440	6446	O
.	6446	6447	O

rhoMAX	6448	6454	O
=	6455	6456	O
sinalpha	6457	6465	O
/	6465	6466	O
lambda	6466	6472	O
is	6473	6475	O
the	6476	6479	O
cutoff	6480	6486	O
frequency	6487	6496	O
of	6497	6499	O
the	6500	6503	O
objective	6504	6513	O
,	6513	6514	O
where	6515	6520	O
sinalpha	6521	6529	O
=	6530	6531	O
NA	6532	6534	O
is	6535	6537	O
its	6538	6541	O
numerical	6542	6551	O
aperture	6552	6560	O
.	6560	6561	O

The	6562	6565	O
Fresnel	6566	6573	O
pattern	6574	6581	O
projected	6582	6591	O
on	6592	6594	O
the	6595	6598	O
object	6599	6605	O
is	6606	6608	O
the	6609	6612	O
interference	6613	6625	O
of	6626	6628	O
the	6629	6632	O
Fourier	6633	6640	O
transforms	6641	6651	O
of	6652	6654	O
the	6655	6658	O
two	6659	6662	O
pupils	6663	6669	O
,	6669	6670	O
namely	6671	6677	O
a	6678	6679	O
spherical	6680	6689	O
wave	6690	6694	O
and	6695	6698	O
a	6699	6700	O
plane	6701	6706	O
wave	6707	6711	O
in	6712	6714	O
the	6715	6718	O
paraxial	6719	6727	O
approximation	6728	6741	O
.	6741	6742	O

The	6743	6746	O
Fresnel	6747	6754	O
number	6755	6761	O
of	6762	6764	O
this	6765	6769	O
pattern	6770	6777	O
is	6778	6780	O
determined	6781	6791	O
by	6792	6794	O
the	6795	6798	O
free	6799	6803	O
parameter	6804	6813	O
z0	6814	6816	O
,	6816	6817	O
which	6818	6823	O
is	6824	6826	O
the	6827	6830	O
distance	6831	6839	O
from	6840	6844	O
the	6845	6848	O
objective	6849	6858	O
'	6858	6859	O
s	6859	6860	O
focal	6861	6866	O
plane	6867	6872	O
to	6873	6875	O
the	6876	6879	O
point	6880	6885	O
where	6886	6891	O
the	6892	6895	O
spherical	6896	6905	O
wave	6906	6910	O
comes	6911	6916	O
to	6917	6919	O
a	6920	6921	O
focus	6922	6927	O
.	6927	6928	O

There	6929	6934	O
are	6935	6938	O
two	6939	6942	O
possible	6943	6951	O
modes	6952	6957	O
of	6958	6960	O
operation	6961	6970	O
,	6970	6971	O
depending	6972	6981	O
on	6982	6984	O
the	6985	6988	O
detector	6989	6997	O
geometry	6998	7006	O
[	7007	7008	O
5	7008	7009	O
]	7009	7010	O
.	7010	7011	O

With	7012	7016	O
a	7017	7018	O
spatially	7019	7028	O
integrating	7029	7040	O
detector	7041	7049	O
,	7049	7050	O
the	7051	7054	O
resulting	7055	7064	O
data	7065	7069	O
is	7070	7072	O
a	7073	7074	O
convolution	7075	7086	O
of	7087	7089	O
the	7090	7093	O
object	7094	7100	O
'	7100	7101	O
s	7101	7102	O
intensity	7103	7112	O
distribution	7113	7125	O
with	7126	7130	O
the	7131	7134	O
desired	7135	7142	O
complex	7143	7150	O
PSF	7151	7154	O
(	7155	7156	O
namely	7156	7162	O
,	7162	7163	O
a	7164	7165	O
spherical	7166	7175	O
wave	7176	7180	O
with	7181	7185	O
a	7186	7187	O
radius	7188	7194	O
of	7195	7197	O
curvature	7198	7207	O
z0	7208	7210	O
+	7211	7212	O
z	7213	7214	O
,	7214	7215	O
and	7216	7219	O
a	7220	7221	O
radius	7222	7228	O
a	7229	7230	O
=	7231	7232	O
z0sinalpha	7233	7243	O
,	7243	7244	O
in	7245	7247	O
this	7248	7252	O
case	7253	7257	O
)	7257	7258	O
.	7258	7259	O

This	7260	7264	O
detection	7265	7274	O
mode	7275	7279	O
leads	7280	7285	O
to	7286	7288	O
a	7289	7290	O
hologram	7291	7299	O
from	7300	7304	O
which	7305	7310	O
the	7311	7314	O
three	7315	7320	O
-	7320	7321	O
dimensional	7321	7332	O
distribution	7333	7345	O
of	7346	7348	O
scattering	7349	7359	O
intensity	7360	7369	O
,	7369	7370	O
absorption	7371	7381	O
,	7381	7382	O
and	7383	7386	O
fluorescence	7387	7399	O
intensity	7400	7409	O
can	7410	7413	O
be	7414	7416	O
reconstructed	7417	7430	O
.	7430	7431	O

With	7432	7436	O
a	7437	7438	O
point	7439	7444	O
detector	7445	7453	O
at	7454	7456	O
the	7457	7460	O
center	7461	7467	O
of	7468	7470	O
a	7471	7472	O
conjugate	7473	7482	O
pupil	7483	7488	O
plane	7489	7494	O
,	7494	7495	O
the	7496	7499	O
resulting	7500	7509	O
data	7510	7514	O
is	7515	7517	O
a	7518	7519	O
convolution	7520	7531	O
of	7532	7534	O
the	7535	7538	O
object	7539	7545	O
'	7545	7546	O
s	7546	7547	O
complex	7548	7555	O
amplitude	7556	7565	O
distribution	7566	7578	O
with	7579	7583	O
the	7584	7587	O
same	7588	7592	O
complex	7593	7600	O
PSF	7601	7604	O
.	7604	7605	O

The	7606	7609	O
reconstruction	7610	7624	O
of	7625	7627	O
this	7628	7632	O
hologram	7633	7641	O
gives	7642	7647	O
the	7648	7651	O
three	7652	7657	O
-	7657	7658	O
dimensional	7658	7669	O
distribution	7670	7682	O
of	7683	7685	O
the	7686	7689	O
specimen	7690	7698	O
'	7698	7699	O
s	7699	7700	O
complex	7701	7708	O
amplitude	7709	7718	O
transmittance	7719	7732	O
.	7732	7733	O

In	7734	7736	O
particular	7737	7747	O
,	7747	7748	O
assuming	7749	7757	O
that	7758	7762	O
multiple	7763	7771	O
scattering	7772	7782	O
can	7783	7786	O
be	7787	7789	O
ignored	7790	7797	O
,	7797	7798	O
the	7799	7802	O
phase	7803	7808	O
of	7809	7811	O
the	7812	7815	O
reconstruction	7816	7830	O
is	7831	7833	O
a	7834	7835	O
quantitative	7836	7848	O
measure	7849	7856	O
of	7857	7859	O
the	7860	7863	O
integrated	7864	7874	O
optical	7875	7882	O
path	7883	7887	O
length	7888	7894	O
through	7895	7902	O
the	7903	7906	O
specimen	7907	7915	O
.	7915	7916	O

These	7917	7922	O
two	7923	7926	O
modes	7927	7932	O
of	7933	7935	O
operation	7936	7945	O
are	7946	7949	O
similar	7950	7957	O
to	7958	7960	O
the	7961	7964	O
usual	7965	7970	O
coherent	7971	7979	O
/	7979	7980	O
incoherent	7980	7990	O
imaging	7991	7998	O
modes	7999	8004	O
of	8005	8007	O
a	8008	8009	O
conventional	8010	8022	O
system	8023	8029	O
,	8029	8030	O
which	8031	8036	O
are	8037	8040	O
obtained	8041	8049	O
by	8050	8052	O
using	8053	8058	O
,	8058	8059	O
respectively	8060	8072	O
,	8072	8073	O
a	8074	8075	O
point	8076	8081	O
source	8082	8088	O
,	8088	8089	O
or	8090	8092	O
a	8093	8094	O
large	8095	8100	O
spatially	8101	8110	O
incoherent	8111	8121	O
source	8122	8128	O
.	8128	8129	O

In	8130	8132	O
scanning	8133	8141	O
holography	8142	8152	O
,	8152	8153	O
the	8154	8157	O
detector	8158	8166	O
size	8167	8171	O
plays	8172	8177	O
a	8178	8179	O
similar	8180	8187	O
role	8188	8192	O
to	8193	8195	O
that	8196	8200	O
of	8201	8203	O
the	8204	8207	O
source	8208	8214	O
size	8215	8219	O
in	8220	8222	O
conventional	8223	8235	O
imaging	8236	8243	O
.	8243	8244	O

For	8245	8248	O
simplicity	8249	8259	O
,	8259	8260	O
let	8261	8264	O
'	8264	8265	O
s	8265	8266	O
assume	8267	8273	O
an	8274	8276	O
object	8277	8283	O
with	8284	8288	O
an	8289	8291	O
amplitude	8292	8301	O
transmittance	8302	8315	O
T	8316	8317	O
(	8317	8318	O
r	8318	8319	O
-	8319	8320	O
-	8320	8321	O
>	8321	8322	O
MathType	8323	8331	O
@	8331	8332	O
MTEF	8332	8336	O
@	8336	8337	O
5	8337	8338	O
@	8338	8339	O
5	8339	8340	O
@	8340	8341	O
+	8341	8342	O
=	8342	8343	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	8343	8428	O
=	8428	8429	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	8429	8460	O
=	8460	8461	O
OqFfea0dXdd9vqai	8461	8477	O
=	8477	8478	O
hGuQ8kuc9pgc9s8qqaq	8478	8497	O
=	8497	8498	O
dirpe0xb9q8qiLsFr0	8498	8516	O
=	8516	8517	O
vr0	8517	8520	O
=	8520	8521	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	8521	8579	O
@	8579	8580	O
2E2B	8580	8584	O
@	8584	8585	O
,	8585	8586	O
z	8587	8588	O
)	8588	8589	O
.	8589	8590	O

Note	8591	8595	O
that	8596	8600	O
for	8601	8604	O
an	8605	8607	O
incoherent	8608	8618	O
or	8619	8621	O
fluorescent	8622	8633	O
object	8634	8640	O
,	8640	8641	O
the	8642	8645	O
phase	8646	8651	O
of	8652	8654	O
the	8655	8658	O
transmitted	8659	8670	O
field	8671	8676	O
is	8677	8679	O
a	8680	8681	O
random	8682	8688	O
variable	8689	8697	O
,	8697	8698	O
and	8699	8702	O
only	8703	8707	O
the	8708	8711	O
intensity	8712	8721	O
I	8722	8723	O
(	8723	8724	O
r	8724	8725	O
-	8725	8726	O
-	8726	8727	O
>	8727	8728	O
MathType	8729	8737	O
@	8737	8738	O
MTEF	8738	8742	O
@	8742	8743	O
5	8743	8744	O
@	8744	8745	O
5	8745	8746	O
@	8746	8747	O
+	8747	8748	O
=	8748	8749	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	8749	8834	O
=	8834	8835	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	8835	8866	O
=	8866	8867	O
OqFfea0dXdd9vqai	8867	8883	O
=	8883	8884	O
hGuQ8kuc9pgc9s8qqaq	8884	8903	O
=	8903	8904	O
dirpe0xb9q8qiLsFr0	8904	8922	O
=	8922	8923	O
vr0	8923	8926	O
=	8926	8927	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	8927	8985	O
@	8985	8986	O
2E2B	8986	8990	O
@	8990	8991	O
,	8991	8992	O
z	8993	8994	O
)	8994	8995	O
=	8996	8997	O
|	8998	8999	O
T	8999	9000	O
(	9000	9001	O
r	9001	9002	O
-	9002	9003	O
-	9003	9004	O
>	9004	9005	O
MathType	9006	9014	O
@	9014	9015	O
MTEF	9015	9019	O
@	9019	9020	O
5	9020	9021	O
@	9021	9022	O
5	9022	9023	O
@	9023	9024	O
+	9024	9025	O
=	9025	9026	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	9026	9111	O
=	9111	9112	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	9112	9143	O
=	9143	9144	O
OqFfea0dXdd9vqai	9144	9160	O
=	9160	9161	O
hGuQ8kuc9pgc9s8qqaq	9161	9180	O
=	9180	9181	O
dirpe0xb9q8qiLsFr0	9181	9199	O
=	9199	9200	O
vr0	9200	9203	O
=	9203	9204	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	9204	9262	O
@	9262	9263	O
2E2B	9263	9267	O
@	9267	9268	O
,	9268	9269	O
z	9270	9271	O
)	9271	9272	O
|	9272	9273	O
2	9273	9274	O
is	9275	9277	O
measurable	9278	9288	O
.	9288	9289	O

For	9290	9293	O
a	9294	9295	O
quasi	9296	9301	O
transparent	9302	9313	O
object	9314	9320	O
,	9320	9321	O
the	9322	9325	O
phase	9326	9331	O
is	9332	9334	O
equal	9335	9340	O
to	9341	9343	O
the	9344	9347	O
integrated	9348	9358	O
optical	9359	9366	O
thickness	9367	9376	O
of	9377	9379	O
the	9380	9383	O
object	9384	9390	O
:	9390	9391	O
Phi	9392	9395	O
(	9395	9396	O
r	9396	9397	O
-	9397	9398	O
-	9398	9399	O
>	9399	9400	O
MathType	9401	9409	O
@	9409	9410	O
MTEF	9410	9414	O
@	9414	9415	O
5	9415	9416	O
@	9416	9417	O
5	9417	9418	O
@	9418	9419	O
+	9419	9420	O
=	9420	9421	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	9421	9506	O
=	9506	9507	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	9507	9538	O
=	9538	9539	O
OqFfea0dXdd9vqai	9539	9555	O
=	9555	9556	O
hGuQ8kuc9pgc9s8qqaq	9556	9575	O
=	9575	9576	O
dirpe0xb9q8qiLsFr0	9576	9594	O
=	9594	9595	O
vr0	9595	9598	O
=	9598	9599	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	9599	9657	O
@	9657	9658	O
2E2B	9658	9662	O
@	9662	9663	O
)	9663	9664	O
=	9665	9666	O
(	9667	9668	O
2pi	9668	9671	O
/	9671	9672	O
lambda	9672	9678	O
)	9678	9679	O
integraldzn	9679	9690	O
(	9690	9691	O
r	9691	9692	O
-	9692	9693	O
-	9693	9694	O
>	9694	9695	O
MathType	9696	9704	O
@	9704	9705	O
MTEF	9705	9709	O
@	9709	9710	O
5	9710	9711	O
@	9711	9712	O
5	9712	9713	O
@	9713	9714	O
+	9714	9715	O
=	9715	9716	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	9716	9801	O
=	9801	9802	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	9802	9833	O
=	9833	9834	O
OqFfea0dXdd9vqai	9834	9850	O
=	9850	9851	O
hGuQ8kuc9pgc9s8qqaq	9851	9870	O
=	9870	9871	O
dirpe0xb9q8qiLsFr0	9871	9889	O
=	9889	9890	O
vr0	9890	9893	O
=	9893	9894	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	9894	9952	O
@	9952	9953	O
2E2B	9953	9957	O
@	9957	9958	O
,	9958	9959	O
z	9960	9961	O
)	9961	9962	O
,	9962	9963	O
where	9964	9969	O
n	9970	9971	O
(	9971	9972	O
r	9972	9973	O
-	9973	9974	O
-	9974	9975	O
>	9975	9976	O
MathType	9977	9985	O
@	9985	9986	O
MTEF	9986	9990	O
@	9990	9991	O
5	9991	9992	O
@	9992	9993	O
5	9993	9994	O
@	9994	9995	O
+	9995	9996	O
=	9996	9997	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	9997	10082	O
=	10082	10083	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	10083	10114	O
=	10114	10115	O
OqFfea0dXdd9vqai	10115	10131	O
=	10131	10132	O
hGuQ8kuc9pgc9s8qqaq	10132	10151	O
=	10151	10152	O
dirpe0xb9q8qiLsFr0	10152	10170	O
=	10170	10171	O
vr0	10171	10174	O
=	10174	10175	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	10175	10233	O
@	10233	10234	O
2E2B	10234	10238	O
@	10238	10239	O
,	10239	10240	O
z	10241	10242	O
)	10242	10243	O
is	10244	10246	O
the	10247	10250	O
3D	10251	10253	O
distribution	10254	10266	O
of	10267	10269	O
refractive	10270	10280	O
index	10281	10286	O
.	10286	10287	O

The	10288	10291	O
amplitude	10292	10301	O
distribution	10302	10314	O
after	10315	10320	O
the	10321	10324	O
object	10325	10331	O
is	10332	10334	O
written	10335	10342	O
as	10343	10345	O

A	10346	10347	O
(	10347	10348	O
r	10348	10349	O
-	10349	10350	O
-	10350	10351	O
>	10351	10352	O
MathType	10353	10361	O
@	10361	10362	O
MTEF	10362	10366	O
@	10366	10367	O
5	10367	10368	O
@	10368	10369	O
5	10369	10370	O
@	10370	10371	O
+	10371	10372	O
=	10372	10373	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	10373	10458	O
=	10458	10459	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	10459	10490	O
=	10490	10491	O
OqFfea0dXdd9vqai	10491	10507	O
=	10507	10508	O
hGuQ8kuc9pgc9s8qqaq	10508	10527	O
=	10527	10528	O
dirpe0xb9q8qiLsFr0	10528	10546	O
=	10546	10547	O
vr0	10547	10550	O
=	10550	10551	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	10551	10609	O
@	10609	10610	O
2E2B	10610	10614	O
@	10614	10615	O
,	10615	10616	O
t	10617	10618	O
)	10618	10619	O
=	10620	10621	O
integraldzS	10622	10633	O
(	10633	10634	O
r	10634	10635	O
-	10635	10636	O
-	10636	10637	O
>	10637	10638	O
MathType	10639	10647	O
@	10647	10648	O
MTEF	10648	10652	O
@	10652	10653	O
5	10653	10654	O
@	10654	10655	O
5	10655	10656	O
@	10656	10657	O
+	10657	10658	O
=	10658	10659	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	10659	10744	O
=	10744	10745	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	10745	10776	O
=	10776	10777	O
OqFfea0dXdd9vqai	10777	10793	O
=	10793	10794	O
hGuQ8kuc9pgc9s8qqaq	10794	10813	O
=	10813	10814	O
dirpe0xb9q8qiLsFr0	10814	10832	O
=	10832	10833	O
vr0	10833	10836	O
=	10836	10837	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	10837	10895	O
@	10895	10896	O
2E2B	10896	10900	O
@	10900	10901	O
,	10901	10902	O
z	10903	10904	O
)	10904	10905	O
T	10905	10906	O
[	10906	10907	O
r	10907	10908	O
-	10908	10909	O
-	10909	10910	O
>	10910	10911	O
MathType	10912	10920	O
@	10920	10921	O
MTEF	10921	10925	O
@	10925	10926	O
5	10926	10927	O
@	10927	10928	O
5	10928	10929	O
@	10929	10930	O
+	10930	10931	O
=	10931	10932	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	10932	11017	O
=	11017	11018	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	11018	11049	O
=	11049	11050	O
OqFfea0dXdd9vqai	11050	11066	O
=	11066	11067	O
hGuQ8kuc9pgc9s8qqaq	11067	11086	O
=	11086	11087	O
dirpe0xb9q8qiLsFr0	11087	11105	O
=	11105	11106	O
vr0	11106	11109	O
=	11109	11110	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	11110	11168	O
@	11168	11169	O
2E2B	11169	11173	O
@	11173	11174	O
-	11174	11175	O
r	11175	11176	O
-	11176	11177	O
-	11177	11178	O
>	11178	11179	O
MathType	11180	11188	O
@	11188	11189	O
MTEF	11189	11193	O
@	11193	11194	O
5	11194	11195	O
@	11195	11196	O
5	11196	11197	O
@	11197	11198	O
+	11198	11199	O
=	11199	11200	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	11200	11285	O
=	11285	11286	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	11286	11317	O
=	11317	11318	O
OqFfea0dXdd9vqai	11318	11334	O
=	11334	11335	O
hGuQ8kuc9pgc9s8qqaq	11335	11354	O
=	11354	11355	O
dirpe0xb9q8qiLsFr0	11355	11373	O
=	11373	11374	O
vr0	11374	11377	O
=	11377	11378	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	11378	11436	O
@	11436	11437	O
2E2B	11437	11441	O
@	11441	11442	O
S	11442	11443	O
(	11443	11444	O
t	11444	11445	O
)	11445	11446	O
,	11446	11447	O
z	11448	11449	O
]	11449	11450	O
,	11450	11451	O
(	11452	11453	O
3	11453	11454	O
)	11454	11455	O

where	11456	11461	O
r	11462	11463	O
-	11463	11464	O
-	11464	11465	O
>	11465	11466	O
MathType	11467	11475	O
@	11475	11476	O
MTEF	11476	11480	O
@	11480	11481	O
5	11481	11482	O
@	11482	11483	O
5	11483	11484	O
@	11484	11485	O
+	11485	11486	O
=	11486	11487	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	11487	11572	O
=	11572	11573	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	11573	11604	O
=	11604	11605	O
OqFfea0dXdd9vqai	11605	11621	O
=	11621	11622	O
hGuQ8kuc9pgc9s8qqaq	11622	11641	O
=	11641	11642	O
dirpe0xb9q8qiLsFr0	11642	11660	O
=	11660	11661	O
vr0	11661	11664	O
=	11664	11665	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	11665	11723	O
@	11723	11724	O
2E2B	11724	11728	O
@	11728	11729	O
S	11729	11730	O
(	11730	11731	O
t	11731	11732	O
)	11732	11733	O
is	11734	11736	O
the	11737	11740	O
instantaneous	11741	11754	O
position	11755	11763	O
of	11764	11766	O
the	11767	11770	O
2D	11771	11773	O
raster	11774	11780	O
scan	11781	11785	O
.	11785	11786	O

The	11787	11790	O
incoherent	11791	11801	O
imaging	11802	11809	O
mode	11810	11814	O
is	11815	11817	O
obtained	11818	11826	O
with	11827	11831	O
a	11832	11833	O
spatially	11834	11843	O
integrating	11844	11855	O
detector	11856	11864	O
,	11864	11865	O
leading	11866	11873	O
to	11874	11876	O
a	11877	11878	O
temporal	11879	11887	O
signal	11888	11894	O
proportional	11895	11907	O
to	11908	11910	O
the	11911	11914	O
integrated	11915	11925	O
intensity	11926	11935	O
,	11935	11936	O
integrald2r	11937	11948	O
|	11948	11949	O
A	11949	11950	O
(	11950	11951	O
r	11951	11952	O
-	11952	11953	O
-	11953	11954	O
>	11954	11955	O
MathType	11956	11964	O
@	11964	11965	O
MTEF	11965	11969	O
@	11969	11970	O
5	11970	11971	O
@	11971	11972	O
5	11972	11973	O
@	11973	11974	O
+	11974	11975	O
=	11975	11976	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	11976	12061	O
=	12061	12062	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	12062	12093	O
=	12093	12094	O
OqFfea0dXdd9vqai	12094	12110	O
=	12110	12111	O
hGuQ8kuc9pgc9s8qqaq	12111	12130	O
=	12130	12131	O
dirpe0xb9q8qiLsFr0	12131	12149	O
=	12149	12150	O
vr0	12150	12153	O
=	12153	12154	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	12154	12212	O
@	12212	12213	O
2E2B	12213	12217	O
@	12217	12218	O
,	12218	12219	O
t	12220	12221	O
)	12221	12222	O
|	12222	12223	O
2	12223	12224	O
,	12224	12225	O
which	12226	12231	O
is	12232	12234	O
stored	12235	12241	O
in	12242	12244	O
the	12245	12248	O
computer	12249	12257	O
.	12257	12258	O

The	12259	12262	O
data	12263	12267	O
corresponding	12268	12281	O
to	12282	12284	O
each	12285	12289	O
hologram	12290	12298	O
line	12299	12303	O
is	12304	12306	O
cut	12307	12310	O
from	12311	12315	O
the	12316	12319	O
signal	12320	12326	O
,	12326	12327	O
and	12328	12331	O
band	12332	12336	O
pass	12337	12341	O
filtered	12342	12350	O
to	12351	12353	O
extract	12354	12361	O
the	12362	12365	O
term	12366	12370	O
oscillating	12371	12382	O
at	12383	12385	O
Omega	12386	12391	O
.	12391	12392	O

The	12393	12396	O
lines	12397	12402	O
are	12403	12406	O
then	12407	12411	O
rearranged	12412	12422	O
in	12423	12425	O
a	12426	12427	O
2D	12428	12430	O
format	12431	12437	O
.	12437	12438	O

The	12439	12442	O
resulting	12443	12452	O
hologram	12453	12461	O
amplitude	12462	12471	O
is	12472	12474	O
found	12475	12480	O
to	12481	12483	O
be	12484	12486	O

HI	12487	12489	O
(	12489	12490	O
r	12490	12491	O
-	12491	12492	O
-	12492	12493	O
>	12493	12494	O
MathType	12495	12503	O
@	12503	12504	O
MTEF	12504	12508	O
@	12508	12509	O
5	12509	12510	O
@	12510	12511	O
5	12511	12512	O
@	12512	12513	O
+	12513	12514	O
=	12514	12515	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	12515	12600	O
=	12600	12601	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	12601	12632	O
=	12632	12633	O
OqFfea0dXdd9vqai	12633	12649	O
=	12649	12650	O
hGuQ8kuc9pgc9s8qqaq	12650	12669	O
=	12669	12670	O
dirpe0xb9q8qiLsFr0	12670	12688	O
=	12688	12689	O
vr0	12689	12692	O
=	12692	12693	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	12693	12751	O
@	12751	12752	O
2E2B	12752	12756	O
@	12756	12757	O
)	12757	12758	O
=	12759	12760	O
integraldzI	12761	12772	O
(	12772	12773	O
r	12773	12774	O
-	12774	12775	O
-	12775	12776	O
>	12776	12777	O
MathType	12778	12786	O
@	12786	12787	O
MTEF	12787	12791	O
@	12791	12792	O
5	12792	12793	O
@	12793	12794	O
5	12794	12795	O
@	12795	12796	O
+	12796	12797	O
=	12797	12798	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	12798	12883	O
=	12883	12884	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	12884	12915	O
=	12915	12916	O
OqFfea0dXdd9vqai	12916	12932	O
=	12932	12933	O
hGuQ8kuc9pgc9s8qqaq	12933	12952	O
=	12952	12953	O
dirpe0xb9q8qiLsFr0	12953	12971	O
=	12971	12972	O
vr0	12972	12975	O
=	12975	12976	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	12976	13034	O
@	13034	13035	O
2E2B	13035	13039	O
@	13039	13040	O
,	13040	13041	O
z	13042	13043	O
)	13043	13044	O
(	13045	13046	O
+	13046	13047	O
)	13047	13048	O
[	13049	13050	O
p1	13050	13052	O
(	13052	13053	O
r	13053	13054	O
-	13054	13055	O
-	13055	13056	O
>	13056	13057	O
MathType	13058	13066	O
@	13066	13067	O
MTEF	13067	13071	O
@	13071	13072	O
5	13072	13073	O
@	13073	13074	O
5	13074	13075	O
@	13075	13076	O
+	13076	13077	O
=	13077	13078	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	13078	13163	O
=	13163	13164	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	13164	13195	O
=	13195	13196	O
OqFfea0dXdd9vqai	13196	13212	O
=	13212	13213	O
hGuQ8kuc9pgc9s8qqaq	13213	13232	O
=	13232	13233	O
dirpe0xb9q8qiLsFr0	13233	13251	O
=	13251	13252	O
vr0	13252	13255	O
=	13255	13256	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	13256	13314	O
@	13314	13315	O
2E2B	13315	13319	O
@	13319	13320	O
,	13320	13321	O
z	13322	13323	O
)	13323	13324	O
p	13324	13325	O
*	13325	13326	O
2	13326	13327	O
(	13327	13328	O
r	13328	13329	O
-	13329	13330	O
-	13330	13331	O
>	13331	13332	O
MathType	13333	13341	O
@	13341	13342	O
MTEF	13342	13346	O
@	13346	13347	O
5	13347	13348	O
@	13348	13349	O
5	13349	13350	O
@	13350	13351	O
+	13351	13352	O
=	13352	13353	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	13353	13438	O
=	13438	13439	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	13439	13470	O
=	13470	13471	O
OqFfea0dXdd9vqai	13471	13487	O
=	13487	13488	O
hGuQ8kuc9pgc9s8qqaq	13488	13507	O
=	13507	13508	O
dirpe0xb9q8qiLsFr0	13508	13526	O
=	13526	13527	O
vr0	13527	13530	O
=	13530	13531	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	13531	13589	O
@	13589	13590	O
2E2B	13590	13594	O
@	13594	13595	O
,	13595	13596	O
z	13597	13598	O
)	13598	13599	O
]	13599	13600	O
,	13600	13601	O
(	13602	13603	O
4	13603	13604	O
)	13604	13605	O

where	13606	13611	O
(	13612	13613	O
+	13613	13614	O
)	13614	13615	O
symbolizes	13616	13626	O
a	13627	13628	O
convolution	13629	13640	O
integral	13641	13649	O
,	13649	13650	O
I	13651	13652	O
(	13652	13653	O
r	13653	13654	O
-	13654	13655	O
-	13655	13656	O
>	13656	13657	O
MathType	13658	13666	O
@	13666	13667	O
MTEF	13667	13671	O
@	13671	13672	O
5	13672	13673	O
@	13673	13674	O
5	13674	13675	O
@	13675	13676	O
+	13676	13677	O
=	13677	13678	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	13678	13763	O
=	13763	13764	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	13764	13795	O
=	13795	13796	O
OqFfea0dXdd9vqai	13796	13812	O
=	13812	13813	O
hGuQ8kuc9pgc9s8qqaq	13813	13832	O
=	13832	13833	O
dirpe0xb9q8qiLsFr0	13833	13851	O
=	13851	13852	O
vr0	13852	13855	O
=	13855	13856	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	13856	13914	O
@	13914	13915	O
2E2B	13915	13919	O
@	13919	13920	O
,	13920	13921	O
z	13922	13923	O
)	13923	13924	O
=	13925	13926	O
|	13927	13928	O
T	13928	13929	O
(	13929	13930	O
r	13930	13931	O
-	13931	13932	O
-	13932	13933	O
>	13933	13934	O
MathType	13935	13943	O
@	13943	13944	O
MTEF	13944	13948	O
@	13948	13949	O
5	13949	13950	O
@	13950	13951	O
5	13951	13952	O
@	13952	13953	O
+	13953	13954	O
=	13954	13955	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	13955	14040	O
=	14040	14041	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	14041	14072	O
=	14072	14073	O
OqFfea0dXdd9vqai	14073	14089	O
=	14089	14090	O
hGuQ8kuc9pgc9s8qqaq	14090	14109	O
=	14109	14110	O
dirpe0xb9q8qiLsFr0	14110	14128	O
=	14128	14129	O
vr0	14129	14132	O
=	14132	14133	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	14133	14191	O
@	14191	14192	O
2E2B	14192	14196	O
@	14196	14197	O
,	14197	14198	O
z	14199	14200	O
)	14200	14201	O
|	14201	14202	O
2	14202	14203	O
,	14203	14204	O
and	14205	14208	O
p1	14209	14211	O
,	14211	14212	O
2	14212	14213	O
(	14213	14214	O
r	14214	14215	O
-	14215	14216	O
-	14216	14217	O
>	14217	14218	O
MathType	14219	14227	O
@	14227	14228	O
MTEF	14228	14232	O
@	14232	14233	O
5	14233	14234	O
@	14234	14235	O
5	14235	14236	O
@	14236	14237	O
+	14237	14238	O
=	14238	14239	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	14239	14324	O
=	14324	14325	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	14325	14356	O
=	14356	14357	O
OqFfea0dXdd9vqai	14357	14373	O
=	14373	14374	O
hGuQ8kuc9pgc9s8qqaq	14374	14393	O
=	14393	14394	O
dirpe0xb9q8qiLsFr0	14394	14412	O
=	14412	14413	O
vr0	14413	14416	O
=	14416	14417	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	14417	14475	O
@	14475	14476	O
2E2B	14476	14480	O
@	14480	14481	O
,	14481	14482	O
z	14483	14484	O
)	14484	14485	O
are	14486	14489	O
the	14490	14493	O
inverse	14494	14501	O
Fourier	14502	14509	O
transforms	14510	14520	O
of	14521	14523	O
the	14524	14527	O
defocused	14528	14537	O
pupil	14538	14543	O
distributions	14544	14557	O
(	14558	14559	O
eq	14559	14561	O
.	14561	14562	O
1b	14562	14564	O
)	14564	14565	O
.	14565	14566	O

The	14567	14570	O
superscript	14571	14582	O
*	14583	14584	O
stands	14585	14591	O
for	14592	14595	O
complex	14596	14603	O
conjugate	14604	14613	O
.	14613	14614	O

The	14615	14618	O
hologram	14619	14627	O
is	14628	14630	O
thus	14631	14635	O
the	14636	14639	O
convolution	14640	14651	O
of	14652	14654	O
the	14655	14658	O
object	14659	14665	O
intensity	14666	14675	O
with	14676	14680	O
a	14681	14682	O
spherical	14683	14692	O
wave	14693	14697	O
,	14697	14698	O
i	14699	14700	O
.	14700	14701	O
e	14701	14702	O
.	14702	14703	O
an	14704	14706	O
in	14707	14709	O
-	14709	14710	O
line	14710	14714	O
single	14715	14721	O
-	14721	14722	O
sideband	14722	14730	O
Gabor	14731	14736	O
hologram	14737	14745	O
.	14745	14746	O

In	14747	14749	O
Fourier	14750	14757	O
space	14758	14763	O
,	14763	14764	O
the	14765	14768	O
hologram	14769	14777	O
can	14778	14781	O
be	14782	14784	O
written	14785	14792	O
as	14793	14795	O

H	14796	14797	O
~	14797	14798	O
I	14798	14799	O
(	14799	14800	O
rho	14800	14803	O
-	14803	14804	O
-	14804	14805	O
>	14805	14806	O
)	14806	14807	O
=	14807	14808	O
integraldzI	14808	14819	O
~	14819	14820	O
(	14820	14821	O
rho	14821	14824	O
-	14824	14825	O
-	14825	14826	O
>	14826	14827	O
;	14827	14828	O
z	14828	14829	O
)	14829	14830	O
[	14830	14831	O
P	14831	14832	O
~	14832	14833	O
1	14833	14834	O
(	14834	14835	O
rho	14835	14838	O
-	14838	14839	O
-	14839	14840	O
>	14840	14841	O
;	14841	14842	O
z	14842	14843	O
)	14843	14844	O
(	14844	14845	O
*	14845	14846	O
)	14846	14847	O
P	14847	14848	O
~	14848	14849	O
2	14849	14850	O
(	14850	14851	O
rho	14851	14854	O
-	14854	14855	O
-	14855	14856	O
>	14856	14857	O
;	14857	14858	O
z	14858	14859	O
)	14859	14860	O
]	14860	14861	O
,	14861	14862	O
(	14863	14864	O
5	14864	14865	O
)	14865	14866	O
MathType	14867	14875	O
@	14875	14876	O
MTEF	14876	14880	O
@	14880	14881	O
5	14881	14882	O
@	14882	14883	O
5	14883	14884	O
@	14884	14885	O
+	14885	14886	O
=	14886	14887	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	14887	14972	O
=	14972	14973	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	14973	15004	O
=	15004	15005	O
OqFfea0dXdd9vqai	15005	15021	O
=	15021	15022	O
hGuQ8kuc9pgc9s8qqaq	15022	15041	O
=	15041	15042	O
dirpe0xb9q8qiLsFr0	15042	15060	O
=	15060	15061	O
vr0	15061	15064	O
=	15064	15065	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGjbqsaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdMeajzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkdaWadaqaaiqbdcfaqzaaiaWaaSbaaSqaaiabigdaXaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiabgEPielqbdcfaqzaaiaWaaSbaaSqaaiabikdaYaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPaGaay5waiaaw2faaiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaI1aqnaiaawIcacaGLPaaaaaa	15065	15550	O
@	15550	15551	O
58FF	15551	15555	O
@	15555	15556	O

where	15557	15562	O
(	15563	15564	O
+	15564	15565	O
)	15565	15566	O
symbolizes	15567	15577	O
a	15578	15579	O
correlation	15580	15591	O
integral	15592	15600	O
.	15600	15601	O

With	15602	15606	O
the	15607	15610	O
pupils	15611	15617	O
of	15618	15620	O
eq	15621	15623	O
.	15623	15624	O
2	15624	15625	O
,	15625	15626	O
we	15627	15629	O
find	15630	15634	O
,	15634	15635	O
in	15636	15638	O
the	15639	15642	O
paraxial	15643	15651	O
approximation	15652	15665	O
,	15665	15666	O

H	15667	15668	O
~	15668	15669	O
I	15669	15670	O
(	15670	15671	O
rho	15671	15674	O
-	15674	15675	O
-	15675	15676	O
>	15676	15677	O
)	15677	15678	O
=	15678	15679	O
integraldzI	15679	15690	O
~	15690	15691	O
(	15691	15692	O
rho	15692	15695	O
-	15695	15696	O
-	15696	15697	O
>	15697	15698	O
;	15698	15699	O
z	15699	15700	O
)	15700	15701	O
exp	15701	15704	O
[	15705	15706	O
ipilambda	15706	15715	O
(	15715	15716	O
z0	15716	15718	O
+	15718	15719	O
z	15719	15720	O
)	15720	15721	O
rho2	15721	15725	O
]	15725	15726	O
circ	15726	15730	O
(	15730	15731	O
rho	15731	15734	O
/	15734	15735	O
rhoMAX	15735	15741	O
)	15741	15742	O
,	15742	15743	O
(	15744	15745	O
6	15745	15746	O
)	15746	15747	O
MathType	15748	15756	O
@	15756	15757	O
MTEF	15757	15761	O
@	15761	15762	O
5	15762	15763	O
@	15763	15764	O
5	15764	15765	O
@	15765	15766	O
+	15766	15767	O
=	15767	15768	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	15768	15853	O
=	15853	15854	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	15854	15885	O
=	15885	15886	O
OqFfea0dXdd9vqai	15886	15902	O
=	15902	15903	O
hGuQ8kuc9pgc9s8qqaq	15903	15922	O
=	15922	15923	O
dirpe0xb9q8qiLsFr0	15923	15941	O
=	15941	15942	O
vr0	15942	15945	O
=	15945	15946	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGjbqsaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdMeajzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcyGGLbqzcqGG4baEcqGGWbaCdaWadaqaaiabdMgaPjab	15946	16216	O
=	16216	16217	O
b8aWjab	16217	16224	O
=	16224	16225	O
T7aSjabcIcaOiabdQha6naaBaaaleaacqaIWaamaeqaaOGaey4kaSIaemOEaONaeiykaKIae8xWdi3aaWbaaSqabeaacqaIYaGmaaaakiaawUfacaGLDbaacqWGJbWycqWGPbqAcqWGYbGCcqWGJbWycqGGOaakcqWFbpGCcqGGVaWlcqWFbpGCdaWgaaWcbaGaemyta0KaemyqaeKaemiwaGfabeaakiabcMcaPiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaI2aGnaiaawIcacaGLPaaaaaa	16225	16515	O
@	16515	16516	O
67E3	16516	16520	O
@	16520	16521	O

which	16522	16527	O
is	16528	16530	O
the	16531	16534	O
Fourier	16535	16542	O
transform	16543	16552	O
of	16553	16555	O
the	16556	16559	O
Fresnel	16560	16567	O
hologram	16568	16576	O
of	16577	16579	O
the	16580	16583	O
object	16584	16590	O
'	16590	16591	O
s	16591	16592	O
intensity	16593	16602	O
distribution	16603	16615	O
.	16615	16616	O

The	16617	16620	O
coherent	16621	16629	O
imaging	16630	16637	O
mode	16638	16642	O
is	16643	16645	O
obtained	16646	16654	O
by	16655	16657	O
using	16658	16663	O
a	16664	16665	O
pinhole	16666	16673	O
or	16674	16676	O
a	16677	16678	O
point	16679	16684	O
detector	16685	16693	O
at	16694	16696	O
the	16697	16700	O
center	16701	16707	O
of	16708	16710	O
a	16711	16712	O
conjugate	16713	16722	O
plane	16723	16728	O
of	16729	16731	O
the	16732	16735	O
pupil	16736	16741	O
of	16742	16744	O
the	16745	16748	O
objective	16749	16758	O
.	16758	16759	O

This	16760	16764	O
leads	16765	16770	O
to	16771	16773	O
the	16774	16777	O
hologram	16778	16786	O
amplitude	16787	16796	O

HC	16797	16799	O
(	16799	16800	O
r	16800	16801	O
-	16801	16802	O
-	16802	16803	O
>	16803	16804	O
MathType	16805	16813	O
@	16813	16814	O
MTEF	16814	16818	O
@	16818	16819	O
5	16819	16820	O
@	16820	16821	O
5	16821	16822	O
@	16822	16823	O
+	16823	16824	O
=	16824	16825	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	16825	16910	O
=	16910	16911	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	16911	16942	O
=	16942	16943	O
OqFfea0dXdd9vqai	16943	16959	O
=	16959	16960	O
hGuQ8kuc9pgc9s8qqaq	16960	16979	O
=	16979	16980	O
dirpe0xb9q8qiLsFr0	16980	16998	O
=	16998	16999	O
vr0	16999	17002	O
=	17002	17003	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	17003	17061	O
@	17061	17062	O
2E2B	17062	17066	O
@	17066	17067	O
)	17067	17068	O
=	17069	17070	O
integraldz	17071	17081	O
[	17081	17082	O
T	17082	17083	O
(	17083	17084	O
r	17084	17085	O
-	17085	17086	O
-	17086	17087	O
>	17087	17088	O
MathType	17089	17097	O
@	17097	17098	O
MTEF	17098	17102	O
@	17102	17103	O
5	17103	17104	O
@	17104	17105	O
5	17105	17106	O
@	17106	17107	O
+	17107	17108	O
=	17108	17109	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	17109	17194	O
=	17194	17195	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	17195	17226	O
=	17226	17227	O
OqFfea0dXdd9vqai	17227	17243	O
=	17243	17244	O
hGuQ8kuc9pgc9s8qqaq	17244	17263	O
=	17263	17264	O
dirpe0xb9q8qiLsFr0	17264	17282	O
=	17282	17283	O
vr0	17283	17286	O
=	17286	17287	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	17287	17345	O
@	17345	17346	O
2E2B	17346	17350	O
@	17350	17351	O
,	17351	17352	O
z	17353	17354	O
)	17354	17355	O
(	17356	17357	O
+	17357	17358	O
)	17358	17359	O
p1	17360	17362	O
(	17362	17363	O
r	17363	17364	O
-	17364	17365	O
-	17365	17366	O
>	17366	17367	O
MathType	17368	17376	O
@	17376	17377	O
MTEF	17377	17381	O
@	17381	17382	O
5	17382	17383	O
@	17383	17384	O
5	17384	17385	O
@	17385	17386	O
+	17386	17387	O
=	17387	17388	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	17388	17473	O
=	17473	17474	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	17474	17505	O
=	17505	17506	O
OqFfea0dXdd9vqai	17506	17522	O
=	17522	17523	O
hGuQ8kuc9pgc9s8qqaq	17523	17542	O
=	17542	17543	O
dirpe0xb9q8qiLsFr0	17543	17561	O
=	17561	17562	O
vr0	17562	17565	O
=	17565	17566	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	17566	17624	O
@	17624	17625	O
2E2B	17625	17629	O
@	17629	17630	O
,	17630	17631	O
z	17632	17633	O
)	17633	17634	O
]	17634	17635	O
[	17635	17636	O
T	17636	17637	O
(	17637	17638	O
r	17638	17639	O
-	17639	17640	O
-	17640	17641	O
>	17641	17642	O
MathType	17643	17651	O
@	17651	17652	O
MTEF	17652	17656	O
@	17656	17657	O
5	17657	17658	O
@	17658	17659	O
5	17659	17660	O
@	17660	17661	O
+	17661	17662	O
=	17662	17663	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	17663	17748	O
=	17748	17749	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	17749	17780	O
=	17780	17781	O
OqFfea0dXdd9vqai	17781	17797	O
=	17797	17798	O
hGuQ8kuc9pgc9s8qqaq	17798	17817	O
=	17817	17818	O
dirpe0xb9q8qiLsFr0	17818	17836	O
=	17836	17837	O
vr0	17837	17840	O
=	17840	17841	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	17841	17899	O
@	17899	17900	O
2E2B	17900	17904	O
@	17904	17905	O
,	17905	17906	O
z	17907	17908	O
)	17908	17909	O
(	17910	17911	O
+	17911	17912	O
)	17912	17913	O
p2	17914	17916	O
(	17916	17917	O
r	17917	17918	O
-	17918	17919	O
-	17919	17920	O
>	17920	17921	O
MathType	17922	17930	O
@	17930	17931	O
MTEF	17931	17935	O
@	17935	17936	O
5	17936	17937	O
@	17937	17938	O
5	17938	17939	O
@	17939	17940	O
+	17940	17941	O
=	17941	17942	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	17942	18027	O
=	18027	18028	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	18028	18059	O
=	18059	18060	O
OqFfea0dXdd9vqai	18060	18076	O
=	18076	18077	O
hGuQ8kuc9pgc9s8qqaq	18077	18096	O
=	18096	18097	O
dirpe0xb9q8qiLsFr0	18097	18115	O
=	18115	18116	O
vr0	18116	18119	O
=	18119	18120	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa	18120	18178	O
@	18178	18179	O
2E2B	18179	18183	O
@	18183	18184	O
,	18184	18185	O
z	18186	18187	O
)	18187	18188	O
]	18188	18189	O
*	18189	18190	O
.	18190	18191	O

(	18192	18193	O
7	18193	18194	O
)	18194	18195	O

Where	18196	18201	O
again	18202	18207	O
,	18207	18208	O
(	18209	18210	O
+	18210	18211	O
)	18211	18212	O
symbolizes	18213	18223	O
a	18224	18225	O
convolution	18226	18237	O
product	18238	18245	O
,	18245	18246	O
and	18247	18250	O
the	18251	18254	O
superscript	18255	18266	O
*	18267	18268	O
stands	18269	18275	O
for	18276	18279	O
complex	18280	18287	O
conjugate	18288	18297	O
.	18297	18298	O

In	18299	18301	O
Fourier	18302	18309	O
space	18310	18315	O
,	18315	18316	O

H	18317	18318	O
~	18318	18319	O
C	18319	18320	O
(	18320	18321	O
rho	18321	18324	O
-	18324	18325	O
-	18325	18326	O
>	18326	18327	O
)	18327	18328	O
=	18328	18329	O
integraldzT	18329	18340	O
~	18340	18341	O
(	18341	18342	O
rho	18342	18345	O
-	18345	18346	O
-	18346	18347	O
>	18347	18348	O
;	18348	18349	O
z	18349	18350	O
)	18350	18351	O
P	18351	18352	O
~	18352	18353	O
1	18353	18354	O
(	18354	18355	O
rho	18355	18358	O
-	18358	18359	O
-	18359	18360	O
>	18360	18361	O
;	18361	18362	O
z	18362	18363	O
)	18363	18364	O
(	18364	18365	O
*	18365	18366	O
)	18366	18367	O
T	18367	18368	O
~	18368	18369	O
(	18369	18370	O
rho	18370	18373	O
-	18373	18374	O
-	18374	18375	O
>	18375	18376	O
;	18376	18377	O
z	18377	18378	O
)	18378	18379	O
P	18379	18380	O
~	18380	18381	O
2	18381	18382	O
(	18382	18383	O
rho	18383	18386	O
-	18386	18387	O
-	18387	18388	O
>	18388	18389	O
;	18389	18390	O
z	18390	18391	O
)	18391	18392	O
.	18392	18393	O

(	18394	18395	O
8	18395	18396	O
)	18396	18397	O
MathType	18398	18406	O
@	18406	18407	O
MTEF	18407	18411	O
@	18411	18412	O
5	18412	18413	O
@	18413	18414	O
5	18414	18415	O
@	18415	18416	O
+	18416	18417	O
=	18417	18418	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	18418	18503	O
=	18503	18504	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	18504	18535	O
=	18535	18536	O
OqFfea0dXdd9vqai	18536	18552	O
=	18552	18553	O
hGuQ8kuc9pgc9s8qqaq	18553	18572	O
=	18572	18573	O
dirpe0xb9q8qiLsFr0	18573	18591	O
=	18591	18592	O
vr0	18592	18595	O
=	18595	18596	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGdbWqaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdsfauzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcqGHxkcXcuWGubavgaacaiabcIcaOiqb	18596	18938	O
=	18938	18939	O
f8aYzaalaGaei4oaSJaemOEaONaeiykaKIafmiuaaLbaGaadaWgaaWcbaGaeGOmaidabeaakiabcIcaOiqb	18939	19022	O
=	19022	19023	O
f8aYzaalaGaei4oaSJaemOEaONaeiykaKIaeiOla4IaaCzcaiaaxMaadaqadaqaaiabiIda4aGaayjkaiaawMcaaaaa	19023	19114	O
@	19114	19115	O
5E5B	19115	19119	O
@	19119	19120	O

With	19121	19125	O
the	19126	19129	O
pupils	19130	19136	O
of	19137	19139	O
eq	19140	19142	O
.	19142	19143	O
2	19143	19144	O
,	19144	19145	O
we	19146	19148	O
find	19149	19153	O

H	19154	19155	O
~	19155	19156	O
C	19156	19157	O
(	19157	19158	O
rho	19158	19161	O
-	19161	19162	O
-	19162	19163	O
>	19163	19164	O
)	19164	19165	O
=	19165	19166	O
integraldzT	19166	19177	O
~	19177	19178	O
*	19178	19179	O
(	19179	19180	O
0	19180	19181	O
;	19181	19182	O
z	19182	19183	O
)	19183	19184	O
T	19184	19185	O
~	19185	19186	O
(	19186	19187	O
rho	19187	19190	O
-	19190	19191	O
-	19191	19192	O
>	19192	19193	O
;	19193	19194	O
z	19194	19195	O
)	19195	19196	O
exp	19196	19199	O
[	19200	19201	O
ipilambda	19201	19210	O
(	19210	19211	O
z0	19211	19213	O
+	19213	19214	O
z	19214	19215	O
)	19215	19216	O
rho2	19216	19220	O
]	19220	19221	O
circ	19221	19225	O
(	19225	19226	O
rho	19226	19229	O
/	19229	19230	O
rhoMAX	19230	19236	O
)	19236	19237	O
.	19237	19238	O

(	19239	19240	O
9	19240	19241	O
)	19241	19242	O
MathType	19243	19251	O
@	19251	19252	O
MTEF	19252	19256	O
@	19256	19257	O
5	19257	19258	O
@	19258	19259	O
5	19259	19260	O
@	19260	19261	O
+	19261	19262	O
=	19262	19263	O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY	19263	19348	O
=	19348	19349	O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0	19349	19380	O
=	19380	19381	O
OqFfea0dXdd9vqai	19381	19397	O
=	19397	19398	O
hGuQ8kuc9pgc9s8qqaq	19398	19417	O
=	19417	19418	O
dirpe0xb9q8qiLsFr0	19418	19436	O
=	19436	19437	O
vr0	19437	19440	O
=	19440	19441	O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGdbWqaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdsfauzaaiaGaey4fIOIaeiikaGIaeGimaaJaei4oaSJaemOEaONaeiykaKIafmivaqLbaGaaaSqabeqaniabgUIiYdGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiGbcwgaLjabcIha4jabcchaWnaadmaabaGaemyAaKMae8hWdaNae83UdWMaeiikaGIaemOEaO3aaSbaaSqaaiabicdaWaqabaGccqGHRaWkcqWG6bGEcqGGPaqkcqWFbpGCdaahaaWcbeqaaiabikdaYaaaaOGaay5waiaaw2faaiabdogaJjabdMgaPjabdkhaYjabdogaJjabcIcaOiab	19441	19943	O
=	19943	19944	O
f8aYjabc	19944	19952	O
+	19952	19953	O
caViab	19953	19959	O
=	19959	19960	O
f8aYnaaBaaaleaacqWGnbqtcqWGbbqqcqWGybawaeqaaOGaeiykaKIaeiOla4IaaCzcaiaaxMaadaqadaqaaiabiMda5aGaayjkaiaawMcaaaaa	19960	20071	O
@	20071	20072	O
6F41	20072	20076	O
@	20076	20077	O

Aside	20078	20083	O
from	20084	20088	O
an	20089	20091	O
inconsequential	20092	20107	O
complex	20108	20115	O
constant	20116	20124	O
(	20125	20126	O
the	20126	20129	O
first	20130	20135	O
term	20136	20140	O
under	20141	20146	O
the	20147	20150	O
integral	20151	20159	O
)	20159	20160	O
,	20160	20161	O
eq	20162	20164	O
.	20164	20165	O
9	20165	20166	O
is	20167	20169	O
the	20170	20173	O
Fourier	20174	20181	O
transform	20182	20191	O
of	20192	20194	O
the	20195	20198	O
Fresnel	20199	20206	O
hologram	20207	20215	O
of	20216	20218	O
the	20219	20222	O
object	20223	20229	O
'	20229	20230	O
s	20230	20231	O
complex	20232	20239	O
amplitude	20240	20249	O
distribution	20250	20262	O
.	20262	20263	O

Thus	20264	20268	O
,	20268	20269	O
the	20270	20273	O
reconstruction	20274	20288	O
of	20289	20291	O
the	20292	20295	O
hologram	20296	20304	O
recorded	20305	20313	O
in	20314	20316	O
the	20317	20320	O
coherent	20321	20329	O
mode	20330	20334	O
carries	20335	20342	O
a	20343	20344	O
quantitative	20345	20357	O
measure	20358	20365	O
of	20366	20368	O
the	20369	20372	O
object	20373	20379	O
'	20379	20380	O
s	20380	20381	O
phase	20382	20387	O
distribution	20388	20400	O
.	20400	20401	O

Results	0	7	O

Here	8	12	O
we	13	15	O
include	16	23	O
data	24	28	O
obtained	29	37	O
from	38	42	O
active	43	49	O
,	49	50	O
oscillatory	51	62	O
brain	63	68	B-Multi-tissue_structure
slices	69	75	I-Multi-tissue_structure
as	76	78	O
well	79	83	O
as	84	86	O
from	87	91	O
recordings	92	102	O
during	103	109	O
cortical	110	118	B-Multi-tissue_structure
slow	119	123	O
oscillations	124	136	O
in	137	139	O
anesthetized	140	152	O
animals	153	160	O
.	160	161	O

All	162	165	O
recordings	166	176	O
included	177	185	O
in	186	188	O
this	189	193	O
study	194	199	O
were	200	204	O
obtained	205	213	O
from	214	218	O
the	219	222	O
visual	223	229	B-Multi-tissue_structure
cortex	230	236	I-Multi-tissue_structure
of	237	239	O
the	240	243	O
ferret	244	250	O
(	251	252	O
in	252	254	O
vitro	255	260	O
)	260	261	O
,	261	262	O
cat	263	266	O
(	267	268	O
in	268	270	O
vivo	271	275	O
)	275	276	O
and	277	280	O
from	281	285	O
barrel	286	292	B-Multi-tissue_structure
cortex	293	299	I-Multi-tissue_structure
of	300	302	O
the	303	306	O
rat	307	310	O
(	311	312	O
in	312	314	O
vivo	315	319	O
)	319	320	O
.	320	321	O

Twenty	322	328	O
-	328	329	O
nine	329	333	O
neurons	334	341	B-Cell
recorded	342	350	O
from	351	355	O
ferret	356	362	O
cortical	363	371	B-Multi-tissue_structure
slices	372	378	I-Multi-tissue_structure
are	379	382	O
included	383	391	O
in	392	394	O
this	395	399	O
study	400	405	O
(	406	407	O
22	407	409	O
regular	410	417	O
spiking	418	425	O
(	426	427	O
RS	427	429	O
)	429	430	O
;	430	431	O
5	432	433	O
chattering	434	444	O
(	445	446	O
CH	446	448	O
)	448	449	O
and	450	453	O
2	454	455	O
intrinsic	456	465	O
bursting	466	474	O
(	475	476	O
IB	476	478	O
)	478	479	O
)	479	480	O
,	480	481	O
27	482	484	O
neurons	485	492	B-Cell
from	493	497	O
cat	498	501	O
visual	502	508	B-Multi-tissue_structure
cortex	509	515	I-Multi-tissue_structure
in	516	518	O
vivo	519	523	O
(	524	525	O
14	525	527	O
RS	528	530	O
;	530	531	O
5	532	533	O
CH	534	536	O
;	536	537	O
2	538	539	O
IB	540	542	O
;	542	543	O
3	544	545	O
fast	546	550	O
spiking	551	558	O
(	559	560	O
FS	560	562	O
)	562	563	O
;	563	564	O
plus	565	569	O
3	570	571	O
non	572	575	O
classified	576	586	O
)	586	587	O
and	588	591	O
14	592	594	O
neurons	595	602	B-Cell
from	603	607	O
rat	608	611	O
barrel	612	618	B-Multi-tissue_structure
cortex	619	625	I-Multi-tissue_structure
in	626	628	O
vivo	629	633	O
(	634	635	O
12	635	637	O
RS	638	640	O
;	640	641	O
1	642	643	O
CH	644	646	O
;	646	647	O
1	648	649	O
IB	650	652	O
)	652	653	O
.	653	654	O

Synaptic	655	663	B-Cellular_component
potentials	664	674	O
were	675	679	O
evoked	680	686	O
by	687	689	O
electric	690	698	O
shocks	699	705	O
(	706	707	O
intracortical	707	720	O
or	721	723	O
thalamocortical	724	739	O
connections	740	751	O
)	751	752	O
or	753	755	O
by	756	758	O
means	759	764	O
of	765	767	O
sensory	768	775	O
(	776	777	O
visual	777	783	O
or	784	786	O
whisker	787	794	O
)	794	795	O
stimulation	796	807	O
.	807	808	O

The	809	812	O
main	813	817	O
results	818	825	O
are	826	829	O
:	829	830	O
1	831	832	O
)	832	833	O
Synaptic	834	842	B-Cellular_component
potentials	843	853	O
show	854	858	O
more	859	863	O
paired	864	870	O
pulsed	871	877	O
facilitation	878	890	O
and	891	894	O
synaptic	895	903	B-Cellular_component
augmentation	904	916	O
in	917	919	O
active	920	926	O
than	927	931	O
in	932	934	O
silent	935	941	O
cortical	942	950	B-Multi-tissue_structure
networks	951	959	O
and	960	963	O
2	964	965	O
)	965	966	O
Synaptic	967	975	B-Cellular_component
potentials	976	986	O
occurring	987	996	O
during	997	1003	O
up	1004	1006	O
or	1007	1009	O
activated	1010	1019	O
states	1020	1026	O
of	1027	1029	O
the	1030	1033	O
cortex	1034	1040	B-Multi-tissue_structure
increased	1041	1050	O
their	1051	1056	O
amplitude	1057	1066	O
with	1067	1071	O
respect	1072	1079	O
to	1080	1082	O
those	1083	1088	O
occurring	1089	1098	O
during	1099	1105	O
down	1106	1110	O
states	1111	1117	O
.	1117	1118	O

Ca2	0	3	O
+	3	4	O
Dependence	5	15	O
of	16	18	O
Slob57	19	25	O
Modulation	26	36	O
of	37	39	O
the	40	43	O
Voltage	44	51	O
Dependence	52	62	O
of	63	65	O
Activation	66	76	O
of	77	79	O
dSlo	80	84	O

Ca2	85	88	O
+	88	89	O
plays	90	95	O
a	96	97	O
fundamental	98	109	O
role	110	114	O
in	115	117	O
regulating	118	128	O
the	129	132	O
dSlo	133	137	O
response	138	146	O
to	147	149	O
membrane	150	158	B-Cellular_component
depolarization	159	173	O
.	173	174	O

One	175	178	O
of	179	181	O
the	182	185	O
three	186	191	O
known	192	197	O
Ca2	198	201	O
+	201	202	O
binding	203	210	O
sites	211	216	O
(	217	218	O
Xia	218	221	O
et	222	224	O
al	225	227	O
.	227	228	O
,	228	229	O
2002	230	234	O
;	234	235	O
Bao	236	239	O
et	240	242	O
al	243	245	O
.	245	246	O
,	246	247	O
2002	248	252	O
;	252	253	O
Zeng	254	258	O
et	259	261	O
al	262	264	O
.	264	265	O
,	265	266	O
2005b	267	272	O
)	272	273	O
,	273	274	O
known	275	280	O
as	281	283	O
the	284	287	O
calcium	288	295	O
bowl	296	300	O
(	301	302	O
Schreiber	302	311	O
and	312	315	O
Salkoff	316	323	O
,	323	324	O
1997	325	329	O
)	329	330	O
,	330	331	O
contributes	332	343	O
to	344	346	O
the	347	350	O
high	351	355	O
-	355	356	O
affinity	356	364	O
Ca2	365	368	O
+	368	369	O
sensitivity	370	381	O
of	382	384	O
the	385	388	O
channel	389	396	O
(	397	398	O
Schreiber	398	407	O
and	408	411	O
Salkoff	412	419	O
,	419	420	O
1997	421	425	O
;	425	426	O
Schreiber	427	436	O
et	437	439	O
al	440	442	O
.	442	443	O
,	443	444	O
1999	445	449	O
;	449	450	O
Braun	451	456	O
and	457	460	O
Sy	461	463	O
,	463	464	O
2001	465	469	O
;	469	470	O
Bao	471	474	O
et	475	477	O
al	478	480	O
.	480	481	O
,	481	482	O
2002	483	487	O
;	487	488	O
Niu	489	492	O
and	493	496	O
Magleby	497	504	O
,	504	505	O
2002	506	510	O
;	510	511	O
Xia	512	515	O
et	516	518	O
al	519	521	O
.	521	522	O
,	522	523	O
2002	524	528	O
;	528	529	O
Bao	530	533	O
et	534	536	O
al	537	539	O
.	539	540	O
,	540	541	O
2004	542	546	O
;	546	547	O
Zeng	548	552	O
et	553	555	O
al	556	558	O
.	558	559	O
,	559	560	O
2005b	561	566	O
)	566	567	O
.	567	568	O

We	569	571	O
used	572	576	O
a	577	578	O
mutated	579	586	O
dSlo	587	591	O
channel	592	599	O
with	600	604	O
substitution	605	617	O
of	618	620	O
Asp966	621	627	O
-	627	628	O
Asp970	628	634	O
by	635	637	O
Asn966	638	644	O
-	644	645	O
Asn970	645	651	O
within	652	658	O
its	659	662	O
calcium	663	670	O
bowl	671	675	O
,	675	676	O
which	677	682	O
greatly	683	690	O
reduces	691	698	O
the	699	702	O
channel	703	710	O
'	710	711	O
s	711	712	O
calcium	713	720	O
sensitivity	721	732	O
(	733	734	O
Bian	734	738	O
et	739	741	O
al	742	744	O
.	744	745	O
,	745	746	O
2001	747	751	O
)	751	752	O
,	752	753	O
to	754	756	O
determine	757	766	O
whether	767	774	O
Ca2	775	778	O
+	778	779	O
participates	780	792	O
in	793	795	O
Slob57	796	802	O
modulation	803	813	O
of	814	816	O
dSlo	817	821	O
.	821	822	O

This	823	827	O
mutated	828	835	O
channel	836	843	O
,	843	844	O
dSloD5N5	845	853	O
,	853	854	O
still	855	860	O
binds	861	866	O
to	867	869	O
full	870	874	O
-	874	875	O
length	875	881	O
and	882	885	O
truncated	886	895	O
Slobs	896	901	O
(	902	903	O
Fig	903	906	O
.	906	907	O
1	908	909	O
B	910	911	O
,	911	912	O
lanes	913	918	O
4	919	920	O
-	920	921	O
6	921	922	O
)	922	923	O
.	923	924	O

During	925	931	O
a	932	933	O
350	934	937	O
-	937	938	O
ms	938	940	O
test	941	945	O
pulse	946	951	O
(	952	953	O
Fig	953	956	O
.	956	957	O
7	958	959	O
E	960	961	O
)	961	962	O
,	962	963	O
Slob57	964	970	O
causes	971	977	O
dSloD5N5	978	986	O
inactivation	987	999	O
(	1000	1001	O
Fig	1001	1004	O
.	1004	1005	O
7	1006	1007	O
B	1008	1009	O
)	1009	1010	O
,	1010	1011	O
consistent	1012	1022	O
with	1023	1027	O
our	1028	1031	O
previous	1032	1040	O
finding	1041	1048	O
that	1049	1053	O
the	1054	1057	O
inactivation	1058	1070	O
caused	1071	1077	O
by	1078	1080	O
Slob57	1081	1087	O
is	1088	1090	O
Ca2	1091	1094	O
+	1094	1095	O
independent	1096	1107	O
(	1108	1109	O
Zeng	1109	1113	O
et	1114	1116	O
al	1117	1119	O
.	1119	1120	O
,	1120	1121	O
2005a	1122	1127	O
)	1127	1128	O
.	1128	1129	O

After	1130	1135	O
deletion	1136	1144	O
of	1145	1147	O
the	1148	1151	O
amino	1152	1157	O
-	1157	1158	O
terminal	1158	1166	O
residues	1167	1175	O
2	1176	1177	O
-	1177	1178	O
6	1178	1179	O
of	1180	1182	O
Slob57	1183	1189	O
,	1189	1190	O
the	1191	1194	O
inactivation	1195	1207	O
of	1208	1210	O
dSloD5N5	1211	1219	O
is	1220	1222	O
eliminated	1223	1233	O
(	1234	1235	O
Fig	1235	1238	O
.	1238	1239	O
7	1240	1241	O
C	1242	1243	O
)	1243	1244	O
,	1244	1245	O
and	1246	1249	O
further	1250	1257	O
truncation	1258	1268	O
of	1269	1271	O
Slob57	1272	1278	O
to	1279	1281	O
Arg16	1282	1287	O
also	1288	1292	O
eliminates	1293	1303	O
the	1304	1307	O
inactivation	1308	1320	O
(	1321	1322	O
Fig	1322	1325	O
.	1325	1326	O
7	1327	1328	O
D	1329	1330	O
)	1330	1331	O
,	1331	1332	O
just	1333	1337	O
as	1338	1340	O
observed	1341	1349	O
with	1350	1354	O
wild	1355	1359	O
-	1359	1360	O
type	1360	1364	O
dSlo	1365	1369	O
(	1370	1371	O
Fig	1371	1374	O
.	1374	1375	O
2	1376	1377	O
,	1377	1378	O
C	1379	1380	O
and	1381	1384	O
D	1385	1386	O
)	1386	1387	O
.	1387	1388	O

Figure	1389	1395	O
7	1396	1397	O
.	1397	1398	O

Slob57	1399	1405	O
causes	1406	1412	O
inactivation	1413	1425	O
of	1426	1428	O
dSloD5N5	1429	1437	O
.	1437	1438	O

Same	1439	1443	O
as	1444	1446	O
Fig	1447	1450	O
.	1450	1451	O

2	1452	1453	O
,	1453	1454	O
except	1455	1461	O
that	1462	1466	O
the	1467	1470	O
mutated	1471	1478	O
channel	1479	1486	O
dSloD5N5	1487	1495	O
was	1496	1499	O
used	1500	1504	O
instead	1505	1512	O
of	1513	1515	O
wild	1516	1520	O
-	1520	1521	O
type	1521	1525	O
dSlo	1526	1530	O
.	1530	1531	O

(	1532	1533	O
A	1533	1534	O
)	1534	1535	O
dSloD5N5	1536	1544	O
alone	1545	1550	O
,	1550	1551	O
(	1552	1553	O
B	1553	1554	O
)	1554	1555	O
dSloD5N5	1556	1564	O
together	1565	1573	O
with	1574	1578	O
Slob57	1579	1585	O
,	1585	1586	O
(	1587	1588	O
C	1588	1589	O
)	1589	1590	O
dSloD5N5	1591	1599	O
together	1600	1608	O
with	1609	1613	O
Slob57DeltaN5	1614	1627	O
,	1627	1628	O
(	1629	1630	O
D	1630	1631	O
)	1631	1632	O
dSloD5N5	1633	1641	O
together	1642	1650	O
with	1651	1655	O
Slob57DeltaN15	1656	1670	O
,	1670	1671	O
(	1672	1673	O
E	1673	1674	O
)	1674	1675	O
pulse	1676	1681	O
protocol	1682	1690	O
.	1690	1691	O

We	1692	1694	O
next	1695	1699	O
used	1700	1704	O
a	1705	1706	O
100	1707	1710	O
-	1710	1711	O
ms	1711	1713	O
test	1714	1718	O
pulse	1719	1724	O
(	1725	1726	O
during	1726	1732	O
which	1733	1738	O
no	1739	1741	O
inactivation	1742	1754	O
occurs	1755	1761	O
)	1761	1762	O
to	1763	1765	O
measure	1766	1773	O
the	1774	1777	O
voltage	1778	1785	O
dependence	1786	1796	O
of	1797	1799	O
activation	1800	1810	O
of	1811	1813	O
dSloD5N5	1814	1822	O
in	1823	1825	O
the	1826	1829	O
presence	1830	1838	O
of	1839	1841	O
110	1842	1845	O
muM	1846	1849	O
free	1850	1854	O
Ca2	1855	1858	O
+	1858	1859	O
,	1859	1860	O
as	1861	1863	O
only	1864	1868	O
at	1869	1871	O
high	1872	1876	O
concentrations	1877	1891	O
of	1892	1894	O
free	1895	1899	O
Ca2	1900	1903	O
+	1903	1904	O
can	1905	1908	O
tail	1909	1913	O
current	1914	1921	O
saturation	1922	1932	O
be	1933	1935	O
achieved	1936	1944	O
with	1945	1949	O
the	1950	1953	O
mutant	1954	1960	O
channel	1961	1968	O
(	1969	1970	O
Fig	1970	1973	O
.	1973	1974	O
8	1975	1976	O
)	1976	1977	O
.	1977	1978	O

As	1979	1981	O
shown	1982	1987	O
in	1988	1990	O
Fig	1991	1994	O
.	1994	1995	O

8	1996	1997	O
,	1997	1998	O
Slob57	1999	2005	O
does	2006	2010	O
not	2011	2014	O
rightward	2015	2024	O
shift	2025	2030	O
the	2031	2034	O
conductance	2035	2046	O
-	2046	2047	O
voltage	2047	2054	O
relationship	2055	2067	O
of	2068	2070	O
dSloD5N5	2071	2079	O
.	2079	2080	O

Because	2081	2088	O
dSloD5N5	2089	2097	O
can	2098	2101	O
still	2102	2107	O
respond	2108	2115	O
to	2116	2118	O
an	2119	2121	O
increment	2122	2131	O
of	2132	2134	O
free	2135	2139	O
Ca2	2140	2143	O
+	2143	2144	O
at	2145	2147	O
high	2148	2152	O
concentration	2153	2166	O
(	2167	2168	O
Bian	2168	2172	O
et	2173	2175	O
al	2176	2178	O
.	2178	2179	O
,	2179	2180	O
2001	2181	2185	O
)	2185	2186	O
,	2186	2187	O
we	2188	2190	O
then	2191	2195	O
increased	2196	2205	O
the	2206	2209	O
concentration	2210	2223	O
of	2224	2226	O
free	2227	2231	O
Ca2	2232	2235	O
+	2235	2236	O
to	2237	2239	O
300	2240	2243	O
muM	2244	2247	O
.	2247	2248	O

As	2249	2251	O
shown	2252	2257	O
in	2258	2260	O
Fig	2261	2264	O
.	2264	2265	O

8	2266	2267	O
,	2267	2268	O
the	2269	2272	O
conductance	2273	2284	O
-	2284	2285	O
voltage	2285	2292	O
relationship	2293	2305	O
of	2306	2308	O
dSloD5N5	2309	2317	O
shifts	2318	2324	O
to	2325	2327	O
less	2328	2332	O
depolarized	2333	2344	O
voltages	2345	2353	O
when	2354	2358	O
the	2359	2362	O
concentration	2363	2376	O
of	2377	2379	O
free	2380	2384	O
Ca2	2385	2388	O
+	2388	2389	O
is	2390	2392	O
increased	2393	2402	O
from	2403	2407	O
110	2408	2411	O
to	2412	2414	O
300	2415	2418	O
muM	2419	2422	O
,	2422	2423	O
but	2424	2427	O
again	2428	2433	O
the	2434	2437	O
V1	2438	2440	O
/	2440	2441	O
2	2441	2442	O
is	2443	2445	O
not	2446	2449	O
modulated	2450	2459	O
by	2460	2462	O
Slob57	2463	2469	O
.	2469	2470	O

Figure	2471	2477	O
8	2478	2479	O
.	2479	2480	O

Conductance	2481	2492	O
-	2492	2493	O
voltage	2493	2500	O
relationships	2501	2514	O
for	2515	2518	O
dSloD5N5	2519	2527	O
.	2527	2528	O

Same	2529	2533	O
protocol	2534	2542	O
as	2543	2545	O
Fig	2546	2549	O
.	2549	2550	O

6	2551	2552	O
,	2552	2553	O
except	2554	2560	O
that	2561	2565	O
the	2566	2569	O
mutated	2570	2577	O
channel	2578	2585	O
dSloD5N5	2586	2594	O
was	2595	2598	O
used	2599	2603	O
in	2604	2606	O
the	2607	2610	O
presence	2611	2619	O
(	2620	2621	O
circles	2621	2628	O
)	2628	2629	O
or	2630	2632	O
absence	2633	2640	O
(	2641	2642	O
squares	2642	2649	O
)	2649	2650	O
of	2651	2653	O
Slob57	2654	2660	O
,	2660	2661	O
and	2662	2665	O
the	2666	2669	O
concentration	2670	2683	O
of	2684	2686	O
free	2687	2691	O
Ca2	2692	2695	O
+	2695	2696	O
was	2697	2700	O
either	2701	2707	O
110	2708	2711	O
muM	2712	2715	O
(	2716	2717	O
filled	2717	2723	O
symbols	2724	2731	O
)	2731	2732	O
or	2733	2735	O
300	2736	2739	O
muM	2740	2743	O
(	2744	2745	O
open	2745	2749	O
symbols	2750	2757	O
)	2757	2758	O
.	2758	2759	O

We	2760	2762	O
next	2763	2767	O
measured	2768	2776	O
the	2777	2780	O
voltage	2781	2788	O
dependence	2789	2799	O
of	2800	2802	O
activation	2803	2813	O
of	2814	2816	O
wild	2817	2821	O
-	2821	2822	O
type	2822	2826	O
dSlo	2827	2831	O
,	2831	2832	O
in	2833	2835	O
the	2836	2839	O
presence	2840	2848	O
or	2849	2851	O
absence	2852	2859	O
of	2860	2862	O
Slob57	2863	2869	O
,	2869	2870	O
at	2871	2873	O
free	2874	2878	O
Ca2	2879	2882	O
+	2882	2883	O
concentrations	2884	2898	O
ranging	2899	2906	O
from	2907	2911	O
20	2912	2914	O
to	2915	2917	O
300	2918	2921	O
muM	2922	2925	O
.	2925	2926	O

As	2927	2929	O
shown	2930	2935	O
in	2936	2938	O
Fig	2939	2942	O
.	2942	2943	O

9	2944	2945	O
A	2946	2947	O
(	2948	2949	O
and	2949	2952	O
by	2953	2955	O
many	2956	2960	O
previous	2961	2969	O
investigators	2970	2983	O
)	2983	2984	O
,	2984	2985	O
in	2986	2988	O
the	2989	2992	O
absence	2993	3000	O
of	3001	3003	O
Slob57	3004	3010	O
,	3010	3011	O
the	3012	3015	O
voltage	3016	3023	O
-	3023	3024	O
conductance	3024	3035	O
relationship	3036	3048	O
of	3049	3051	O
dSlo	3052	3056	O
shifts	3057	3063	O
to	3064	3066	O
less	3067	3071	O
depolarized	3072	3083	O
voltages	3084	3092	O
as	3093	3095	O
the	3096	3099	O
free	3100	3104	O
Ca2	3105	3108	O
+	3108	3109	O
concentration	3110	3123	O
is	3124	3126	O
increased	3127	3136	O
in	3137	3139	O
this	3140	3144	O
range	3145	3150	O
.	3150	3151	O

The	3152	3155	O
V1	3156	3158	O
/	3158	3159	O
2	3159	3160	O
decreases	3161	3170	O
from	3171	3175	O
85	3176	3178	O
to	3179	3181	O
-	3182	3183	O
22	3183	3185	O
mV	3186	3188	O
,	3188	3189	O
a	3190	3191	O
change	3192	3198	O
of	3199	3201	O
107	3202	3205	O
mV	3206	3208	O
,	3208	3209	O
when	3210	3214	O
the	3215	3218	O
concentration	3219	3232	O
of	3233	3235	O
free	3236	3240	O
Ca2	3241	3244	O
+	3244	3245	O
is	3246	3248	O
increased	3249	3258	O
from	3259	3263	O
20	3264	3266	O
to	3267	3269	O
300	3270	3273	O
muM	3274	3277	O
.	3277	3278	O

In	3279	3281	O
contrast	3282	3290	O
,	3290	3291	O
when	3292	3296	O
dSlo	3297	3301	O
is	3302	3304	O
coexpressed	3305	3316	O
with	3317	3321	O
Slob57	3322	3328	O
,	3328	3329	O
this	3330	3334	O
increment	3335	3344	O
of	3345	3347	O
free	3348	3352	O
Ca2	3353	3356	O
+	3356	3357	O
concentration	3358	3371	O
shifts	3372	3378	O
the	3379	3382	O
V1	3383	3385	O
/	3385	3386	O
2	3386	3387	O
to	3388	3390	O
a	3391	3392	O
much	3393	3397	O
lesser	3398	3404	O
extent	3405	3411	O
(	3412	3413	O
Fig	3413	3416	O
.	3416	3417	O
9	3418	3419	O
B	3420	3421	O
and	3422	3425	O
Fig	3426	3429	O
.	3429	3430	O
10	3431	3433	O
A	3434	3435	O
)	3435	3436	O
.	3436	3437	O

Note	3438	3442	O
also	3443	3447	O
that	3448	3452	O
the	3453	3456	O
effect	3457	3463	O
of	3464	3466	O
Slob57	3467	3473	O
on	3474	3476	O
the	3477	3480	O
V1	3481	3483	O
/	3483	3484	O
2	3484	3485	O
is	3486	3488	O
more	3489	3493	O
apparent	3494	3502	O
at	3503	3505	O
higher	3506	3512	O
free	3513	3517	O
Ca2	3518	3521	O
+	3521	3522	O
concentrations	3523	3537	O
(	3538	3539	O
Fig	3539	3542	O
.	3542	3543	O
10	3544	3546	O
A	3547	3548	O
)	3548	3549	O
.	3549	3550	O

To	3551	3553	O
illustrate	3554	3564	O
this	3565	3569	O
better	3570	3576	O
,	3576	3577	O
we	3578	3580	O
plotted	3581	3588	O
the	3589	3592	O
V1	3593	3595	O
/	3595	3596	O
2	3596	3597	O
change	3598	3604	O
evoked	3605	3611	O
by	3612	3614	O
Slob57	3615	3621	O
(	3622	3623	O
DeltaV1	3623	3630	O
/	3630	3631	O
2	3631	3632	O
)	3632	3633	O
as	3634	3636	O
a	3637	3638	O
function	3639	3647	O
of	3648	3650	O
the	3651	3654	O
free	3655	3659	O
Ca2	3660	3663	O
+	3663	3664	O
concentration	3665	3678	O
(	3679	3680	O
Fig	3680	3683	O
.	3683	3684	O
10	3685	3687	O
B	3688	3689	O
)	3689	3690	O
to	3691	3693	O
demonstrate	3694	3705	O
that	3706	3710	O
the	3711	3714	O
magnitude	3715	3724	O
of	3725	3727	O
the	3728	3731	O
modulatory	3732	3742	O
shift	3743	3748	O
in	3749	3751	O
V1	3752	3754	O
/	3754	3755	O
2	3755	3756	O
evoked	3757	3763	O
by	3764	3766	O
Slob57	3767	3773	O
itself	3774	3780	O
is	3781	3783	O
calcium	3784	3791	O
dependent	3792	3801	O
.	3801	3802	O

Figure	3803	3809	O
9	3810	3811	O
.	3811	3812	O

Effect	3813	3819	O
of	3820	3822	O
calcium	3823	3830	O
on	3831	3833	O
dSlo	3834	3838	O
voltage	3839	3846	O
dependence	3847	3857	O
of	3858	3860	O
activation	3861	3871	O
in	3872	3874	O
the	3875	3878	O
absence	3879	3886	O
or	3887	3889	O
presence	3890	3898	O
of	3899	3901	O
Slob57	3902	3908	O
.	3908	3909	O

Same	3910	3914	O
as	3915	3917	O
Fig	3918	3921	O
.	3921	3922	O

6	3923	3924	O
,	3924	3925	O
except	3926	3932	O
that	3933	3937	O
the	3938	3941	O
measurements	3942	3954	O
of	3955	3957	O
dSlo	3958	3962	O
expressed	3963	3972	O
alone	3973	3978	O
(	3979	3980	O
A	3980	3981	O
)	3981	3982	O
or	3983	3985	O
together	3986	3994	O
with	3995	3999	O
Slob57	4000	4006	O
(	4007	4008	O
B	4008	4009	O
)	4009	4010	O
were	4011	4015	O
performed	4016	4025	O
in	4026	4028	O
the	4029	4032	O
presence	4033	4041	O
of	4042	4044	O
different	4045	4054	O
concentrations	4055	4069	O
of	4070	4072	O
free	4073	4077	O
Ca2	4078	4081	O
+	4081	4082	O
:	4082	4083	O
20	4084	4086	O
muM	4087	4090	O
(	4091	4092	O
diamonds	4092	4100	O
)	4100	4101	O
,	4101	4102	O
40	4103	4105	O
muM	4106	4109	O
(	4110	4111	O
inverted	4111	4119	O
triangles	4120	4129	O
)	4129	4130	O
,	4130	4131	O
80	4132	4134	O
muM	4135	4138	O
(	4139	4140	O
triangles	4140	4149	O
)	4149	4150	O
,	4150	4151	O
110	4152	4155	O
muM	4156	4159	O
(	4160	4161	O
squares	4161	4168	O
)	4168	4169	O
,	4169	4170	O
and	4171	4174	O
300	4175	4178	O
muM	4179	4182	O
(	4183	4184	O
circles	4184	4191	O
)	4191	4192	O
.	4192	4193	O

Figure	4194	4200	O
10	4201	4203	O
.	4203	4204	O

Interaction	4205	4216	O
between	4217	4224	O
Slob57	4225	4231	O
and	4232	4235	O
calcium	4236	4243	O
.	4243	4244	O

The	4245	4248	O
V1	4249	4251	O
/	4251	4252	O
2	4252	4253	O
(	4254	4255	O
A	4255	4256	O
)	4256	4257	O
of	4258	4260	O
the	4261	4264	O
conductance	4265	4276	O
-	4276	4277	O
voltage	4277	4284	O
relationship	4285	4297	O
for	4298	4301	O
dSlo	4302	4306	O
expressed	4307	4316	O
alone	4317	4322	O
(	4323	4324	O
O	4324	4325	O
)	4325	4326	O
or	4327	4329	O
together	4330	4338	O
with	4339	4343	O
Slob57	4344	4350	O
(	4351	4352	O
*	4352	4353	O
)	4353	4354	O
,	4354	4355	O
taken	4356	4361	O
from	4362	4366	O
Fig	4367	4370	O
.	4370	4371	O

9	4372	4373	O
,	4373	4374	O
and	4375	4378	O
the	4379	4382	O
difference	4383	4393	O
in	4394	4396	O
V1	4397	4399	O
/	4399	4400	O
2	4400	4401	O
(	4402	4403	O
DeltaV1	4403	4410	O
/	4410	4411	O
2	4411	4412	O
)	4412	4413	O
evoked	4414	4420	O
by	4421	4423	O
Slob57	4424	4430	O
(	4431	4432	O
B	4432	4433	O
)	4433	4434	O
are	4435	4438	O
plotted	4439	4446	O
as	4447	4449	O
a	4450	4451	O
function	4452	4460	O
of	4461	4463	O
the	4464	4467	O
concentration	4468	4481	O
of	4482	4484	O
free	4485	4489	O
Ca2	4490	4493	O
+	4493	4494	O
.	4494	4495	O

Authors	0	7	O
'	7	8	O
contributions	9	22	O

OK	23	25	O
and	26	29	O
MG	30	32	O
analyzed	33	41	O
and	42	45	O
interpreted	46	57	O
the	58	61	O
patient	62	69	O
data	70	74	O
regarding	75	84	O
his	85	88	O
hospitalization	89	104	O
.	104	105	O

SP	106	108	O
and	109	112	O
PK	113	115	O
performed	116	125	O
the	126	129	O
coronary	130	138	B-Multi-tissue_structure
angiography	139	150	O
,	150	151	O
and	152	155	O
were	156	160	O
the	161	164	O
major	165	170	O
contributors	171	183	O
in	184	186	O
writing	187	194	O
the	195	198	O
manuscript	199	209	O
.	209	210	O

All	211	214	O
authors	215	222	O
read	223	227	O
and	228	231	O
approved	232	240	O
the	241	244	O
final	245	250	O
manuscript	251	261	O
.	261	262	O

Authors	0	7	O
'	7	8	O
contributions	9	22	O

CM	23	25	O
,	25	26	O
JRH	27	30	O
,	30	31	O
HJP	32	35	O
,	35	36	O
and	37	40	O
JH	41	43	O
carried	44	51	O
animal	52	58	O
studies	59	66	O
.	66	67	O

CM	68	70	O
performed	71	80	O
the	81	84	O
statistical	85	96	O
analysis	97	105	O
.	105	106	O

JLK	107	110	O
conceived	111	120	O
of	121	123	O
the	124	127	O
study	128	133	O
,	133	134	O
participated	135	147	O
in	148	150	O
its	151	154	O
design	155	161	O
and	162	165	O
coordination	166	178	O
,	178	179	O
and	180	183	O
drafted	184	191	O
and	192	195	O
edited	196	202	O
the	203	206	O
manuscript	207	217	O
.	217	218	O

All	219	222	O
authors	223	230	O
read	231	235	O
and	236	239	O
approved	240	248	O
the	249	252	O
final	253	258	O
manuscript	259	269	O
.	269	270	O

Disk	0	4	O
preparation	5	16	O
phase	17	22	O

o	23	24	O
Adoption	25	33	O
of	34	36	O
a	37	38	O
two	39	42	O
-	42	43	O
stage	43	48	O
sampling	49	57	O
scheme	58	64	O
.	64	65	O

o	66	67	O
Careful	68	75	O
planning	76	84	O
and	85	88	O
choice	89	95	O
of	96	98	O
representative	99	113	O
sampling	114	122	O
groups	123	129	O
and	130	133	O
sites	134	139	O
according	140	149	O
to	150	152	O
the	153	156	O
adopted	157	164	O
network	165	172	O
sampling	173	181	O
technique	182	191	O
,	191	192	O
and	193	196	O
determining	197	208	O
certain	209	216	O
criteria	217	225	O
such	226	230	O
as	231	233	O
control	234	241	O
sites	242	247	O
where	248	253	O
major	254	259	O
sampling	260	268	O
groups	269	275	O
exist	276	281	O
(	282	283	O
i	283	284	O
.	284	285	O
e	285	286	O
.	286	287	O
surface	288	295	O
water	296	301	O
points	302	308	O
,	308	309	O
valleys	310	317	O
,	317	318	O
and	319	322	O
wells	323	328	O
)	328	329	O
,	329	330	O
impact	331	337	O
sites	338	343	O
where	344	349	O
contamination	350	363	O
is	364	366	O
expected	367	375	O
,	375	376	O
such	377	381	O
as	382	384	O
polygons	385	393	O
,	393	394	O
and	395	398	O
outlets	399	406	O
(	407	408	O
e	408	409	O
.	409	410	O
g	410	411	O
.	411	412	O
treated	413	420	O
water	421	426	O
discharges	427	437	O
site	438	442	O
)	442	443	O
to	444	446	O
maximise	447	455	O
understanding	456	469	O
the	470	473	O
quality	474	481	O
of	482	484	O
urban	485	490	O
water	491	496	O
sources	497	504	O
,	504	505	O
and	506	509	O
with	510	514	O
the	515	518	O
least	519	524	O
risk	525	529	O
of	530	532	O
missing	533	540	O
the	541	544	O
correct	545	552	O
representative	553	567	O
sampling	568	576	O
groups	577	583	O
and	584	587	O
sites	588	593	O
.	593	594	O

o	595	596	O
Attention	597	606	O
paid	607	611	O
to	612	614	O
ensure	615	621	O
inclusion	622	631	O
in	632	634	O
the	635	638	O
sampling	639	647	O
frame	648	653	O
of	654	656	O
all	657	660	O
groups	661	667	O
and	668	671	O
locations	672	681	O
(	682	683	O
sites	683	688	O
,	688	689	O
roads	690	695	O
,	695	696	O
venues	697	703	O
,	703	704	O
and	705	708	O
so	709	711	O
on	712	714	O
)	714	715	O
via	716	719	O
screening	720	729	O
,	729	730	O
browsing	731	739	O
,	739	740	O
and	741	744	O
delineation	745	756	O
from	757	761	O
a	762	763	O
satellite	764	773	O
digital	774	781	O
map	782	785	O
of	786	788	O
the	789	792	O
Khamis	793	799	O
Mushait	800	807	O
Governorate	808	819	O
zone	820	824	O
,	824	825	O
because	826	833	O
local	834	839	O
pre	840	843	O
-	843	844	O
knowledge	844	853	O
was	854	857	O
preferred	858	867	O
with	868	872	O
regard	873	879	O
to	880	882	O
accessibility	883	896	O
,	896	897	O
safety	898	904	O
,	904	905	O
and	906	909	O
permission	910	920	O
.	920	921	O

o	922	923	O
Approximation	924	937	O
of	938	940	O
the	941	944	O
number	945	951	O
of	952	954	O
the	955	958	O
target	959	965	O
study	966	971	O
population	972	982	O
in	983	985	O
each	986	990	O
group	991	996	O
and	997	1000	O
sampling	1001	1009	O
location	1010	1018	O
.	1018	1019	O

o	1020	1021	O
Determination	1022	1035	O
of	1036	1038	O
the	1039	1042	O
proportional	1043	1055	O
allocation	1056	1066	O
of	1067	1069	O
samples	1070	1077	O
between	1078	1085	O
different	1086	1095	O
groups	1096	1102	O
and	1103	1106	O
locations	1107	1116	O
.	1116	1117	O

o	1118	1119	O
Training	1120	1128	O
of	1129	1131	O
interviewers	1132	1144	O
\	1144	1145	O
sample	1145	1151	O
collectors	1152	1162	O
to	1163	1165	O
follow	1166	1172	O
and	1173	1176	O
to	1177	1179	O
use	1180	1183	O
the	1184	1187	O
sampling	1188	1196	O
strategy	1197	1205	O
and	1206	1209	O
procedures	1210	1220	O
.	1220	1221	O

o	1222	1223	O
Implementation	1224	1238	O
of	1239	1241	O
ways	1242	1246	O
to	1247	1249	O
boost	1250	1255	O
participation	1256	1269	O
rates	1270	1275	O
in	1276	1278	O
the	1279	1282	O
screening	1283	1292	O
and	1293	1296	O
core	1297	1301	O
interviews	1302	1312	O
and	1313	1316	O
sample	1317	1323	O
collection	1324	1334	O
.	1334	1335	O

o	1336	1337	O
Planning	1338	1346	O
of	1347	1349	O
logistic	1350	1358	O
needs	1359	1364	O
of	1365	1367	O
timing	1368	1374	O
,	1374	1375	O
gathering	1376	1385	O
,	1385	1386	O
handling	1387	1395	O
samples	1396	1403	O
,	1403	1404	O
and	1405	1408	O
laboratory	1409	1419	O
.	1419	1420	O

o	1421	1422	O
Producing	1423	1432	O
sampling	1433	1441	O
cards	1442	1447	O
to	1448	1450	O
be	1451	1453	O
completed	1454	1463	O
to	1464	1466	O
record	1467	1473	O
observations	1474	1486	O
at	1487	1489	O
scene	1490	1495	O
(	1496	1497	O
sample	1497	1503	O
ID	1504	1506	O
and	1507	1510	O
data	1511	1515	O
/	1515	1516	O
information	1516	1527	O
:	1527	1528	O
date	1529	1533	O
,	1533	1534	O
time	1535	1539	O
,	1539	1540	O
temperature	1541	1552	O
,	1552	1553	O
group	1554	1559	O
,	1559	1560	O
locality	1561	1569	O
,	1569	1570	O
problems	1571	1579	O
in	1580	1582	O
the	1583	1586	O
area	1587	1591	O
,	1591	1592	O
sketch	1593	1599	O
map	1600	1603	O
)	1603	1604	O
.	1604	1605	O

o	1606	1607	O
Selection	1608	1617	O
of	1618	1620	O
an	1621	1623	O
appropriate	1624	1635	O
major	1636	1641	O
sampling	1642	1650	O
method	1651	1657	O
[	1658	1659	O
52	1659	1661	O
]	1661	1662	O
(	1663	1664	O
i	1664	1665	O
.	1665	1666	O
e	1666	1667	O
.	1667	1668	O
simple	1669	1675	O
random	1676	1682	O
sample	1683	1689	O
;	1689	1690	O
network	1691	1698	O
sampling	1699	1707	O
)	1707	1708	O
.	1708	1709	O

o	1710	1711	O
Planning	1712	1720	O
of	1721	1723	O
pilot	1724	1729	O
visits	1730	1736	O
to	1737	1739	O
samples	1740	1747	O
of	1748	1750	O
each	1751	1755	O
group	1756	1761	O
in	1762	1764	O
the	1765	1768	O
field	1769	1774	O
to	1775	1777	O
review	1778	1784	O
strategy	1785	1793	O
.	1793	1794	O

Results	0	7	O

In	8	10	O
the	11	14	O
established	15	26	O
adult	27	32	O
rat	33	36	O
NSC	37	40	B-Cell
culture	41	48	O
,	48	49	O
FGF	50	53	O
-	53	54	O
2	54	55	O
promotes	56	64	O
self	65	69	O
-	69	70	O
renewal	70	77	O
by	78	80	O
increasing	81	91	O
proliferation	92	105	O
and	106	109	O
inhibiting	110	120	O
spontaneous	121	132	O
differentiation	133	148	O
of	149	151	O
adult	152	157	O
NSCs	158	162	B-Cell
,	162	163	O
accompanied	164	175	O
with	176	180	O
activation	181	191	O
of	192	194	O
MAPK	195	199	O
and	200	203	O
PLC	204	207	O
pathways	208	216	O
.	216	217	O

Using	218	223	O
a	224	225	O
molecular	226	235	O
genetic	236	243	O
approach	244	252	O
,	252	253	O
we	254	256	O
demonstrate	257	268	O
that	269	273	O
activation	274	284	O
of	285	287	O
FGF	288	291	O
receptor	292	300	O
1	301	302	O
(	303	304	O
FGFR1	304	309	O
)	309	310	O
,	310	311	O
largely	312	319	O
through	320	327	O
two	328	331	O
key	332	335	O
cytoplasmic	336	347	B-Organism_substance
amino	348	353	O
acid	354	358	O
residues	359	367	O
that	368	372	O
are	373	376	O
linked	377	383	O
to	384	386	O
MAPK	387	391	O
and	392	395	O
PLC	396	399	O
activation	400	410	O
,	410	411	O
suffices	412	420	O
to	421	423	O
promote	424	431	O
adult	432	437	O
NSC	438	441	B-Cell
self	442	446	O
-	446	447	O
renewal	447	454	O
.	454	455	O

The	456	459	O
canonical	460	469	O
MAPK	470	474	O
,	474	475	O
Erk1	476	480	O
/	480	481	O
2	481	482	O
activation	483	493	O
,	493	494	O
is	495	497	O
both	498	502	O
required	503	511	O
and	512	515	O
sufficient	516	526	O
for	527	530	O
the	531	534	O
NSC	535	538	B-Cell
expansion	539	548	O
and	549	552	O
anti	553	557	O
-	557	558	O
differentiation	558	573	O
effects	574	581	O
of	582	584	O
FGF	585	588	O
-	588	589	O
2	589	590	O
.	590	591	O

In	592	594	O
contrast	595	603	O
,	603	604	O
PLC	605	608	O
activation	609	619	O
is	620	622	O
integral	623	631	O
to	632	634	O
the	635	638	O
maintenance	639	650	O
of	651	653	O
adult	654	659	O
NSC	660	663	B-Cell
characteristics	664	679	O
,	679	680	O
including	681	690	O
the	691	694	O
full	695	699	O
capacity	700	708	O
for	709	712	O
neuronal	713	721	B-Cell
and	722	725	O
oligodendroglial	726	742	B-Cell
differentiation	743	758	O
.	758	759	O

Stochastic	0	10	O
models	11	17	O

Stochasticity	18	31	O
inevitably	32	42	O
emerges	43	50	O
when	51	55	O
molecular	56	65	O
components	66	76	O
are	77	80	O
present	81	88	O
at	89	91	O
low	92	95	O
cellular	96	104	B-Cell
concentrations	105	119	O
(	120	121	O
McAdams	121	128	O
&	129	130	O
Arkin	131	136	O
,	136	137	O
1997	138	142	O
;	142	143	O
Kierzek	144	151	O
et	152	154	O
al	155	157	O
.	157	158	O
,	158	159	O
2001	160	164	O
)	164	165	O
.	165	166	O

This	167	171	O
physical	172	180	O
phenomenon	181	191	O
generates	192	201	O
noise	202	207	O
in	208	210	O
synthetic	211	220	O
and	221	224	O
natural	225	232	O
circuits	233	241	O
(	242	243	O
Paulsson	243	251	O
,	251	252	O
2004	253	257	O
;	257	258	O
Mettetal	259	267	O
et	268	270	O
al	271	273	O
.	273	274	O
,	274	275	O
2006	276	280	O
)	280	281	O
,	281	282	O
and	283	286	O
its	287	290	O
consequences	291	303	O
over	304	308	O
the	309	312	O
phenotype	313	322	O
are	323	326	O
starting	327	335	O
to	336	338	O
be	339	341	O
explored	342	350	O
(	351	352	O
Suel	352	356	O
et	357	359	O
al	360	362	O
.	362	363	O
,	363	364	O
2006	365	369	O
)	369	370	O
.	370	371	O

For	372	375	O
example	376	383	O
,	383	384	O
noise	385	390	O
constitutes	391	402	O
the	403	406	O
driving	407	414	O
force	415	420	O
behind	421	427	O
differentiation	428	443	O
in	444	446	O
isogenetic	447	457	O
colonies	458	466	O
(	467	468	O
Colman	468	474	O
-	474	475	O
Lerner	475	481	O
et	482	484	O
al	485	487	O
.	487	488	O
,	488	489	O
2005	490	494	O
)	494	495	O
.	495	496	O

Biological	497	507	O
and	508	511	O
theoretical	512	523	O
studies	524	531	O
have	532	536	O
aided	537	542	O
to	543	545	O
delineate	546	555	O
the	556	559	O
regulatory	560	570	O
mechanism	571	580	O
by	581	583	O
which	584	589	O
the	590	593	O
cell	594	598	B-Cell
handles	599	606	O
noise	607	612	O
efficiently	613	624	O
and	625	628	O
effectively	629	640	O
to	641	643	O
carry	644	649	O
out	650	653	O
its	654	657	O
biological	658	668	O
functions	669	678	O
(	679	680	O
Gardner	680	687	O
&	688	689	O
Collins	690	697	O
,	697	698	O
2000	699	703	O
;	703	704	O
Orrell	705	711	O
&	712	713	O
Bolouri	714	721	O
,	721	722	O
2004	723	727	O
;	727	728	O
Raser	729	734	O
&	735	736	O
O	737	738	O
'	738	739	O
Shea	739	743	O
,	743	744	O
2005	745	749	O
)	749	750	O
.	750	751	O

From	752	756	O
a	757	758	O
theoretical	759	770	O
point	771	776	O
of	777	779	O
view	780	784	O
,	784	785	O
stochastic	786	796	O
models	797	803	O
are	804	807	O
the	808	811	O
most	812	816	O
challenging	817	828	O
but	829	832	O
also	833	837	O
the	838	841	O
most	842	846	O
realistic	847	856	O
ones	857	861	O
:	861	862	O
there	863	868	O
is	869	871	O
a	872	873	O
precise	874	881	O
counting	882	890	O
of	891	893	O
how	894	897	O
,	897	898	O
through	899	906	O
individual	907	917	O
chemical	918	926	O
reactions	927	936	O
,	936	937	O
the	938	941	O
populations	942	953	O
of	954	956	O
every	957	962	O
chemical	963	971	O
species	972	979	O
change	980	986	O
.	986	987	O

The	988	991	O
milestone	992	1001	O
to	1002	1004	O
simulate	1005	1013	O
stochastic	1014	1024	O
processes	1025	1034	O
is	1035	1037	O
the	1038	1041	O
Gillespie	1042	1051	O
algorithm	1052	1061	O
(	1062	1063	O
Gillespie	1063	1072	O
,	1072	1073	O
1992	1074	1078	O
)	1078	1079	O
.	1079	1080	O

Because	1081	1088	O
of	1089	1091	O
their	1092	1097	O
analytical	1098	1108	O
and	1109	1112	O
computational	1113	1126	O
complexity	1127	1137	O
,	1137	1138	O
the	1139	1142	O
present	1143	1150	O
models	1151	1157	O
do	1158	1160	O
not	1161	1164	O
surpass	1165	1172	O
a	1173	1174	O
handful	1175	1182	O
of	1183	1185	O
chemical	1186	1194	O
species	1195	1202	O
.	1202	1203	O

Two	1204	1207	O
immediate	1208	1217	O
problems	1218	1226	O
must	1227	1231	O
be	1232	1234	O
solved	1235	1241	O
to	1242	1244	O
model	1245	1250	O
systems	1251	1258	O
with	1259	1263	O
several	1264	1271	O
dozens	1272	1278	O
of	1279	1281	O
genetic	1282	1289	O
components	1290	1300	O
:	1300	1301	O
the	1302	1305	O
systematic	1306	1316	O
determination	1317	1330	O
of	1331	1333	O
kinetic	1334	1341	O
constants	1342	1351	O
and	1352	1355	O
the	1356	1359	O
efficient	1360	1369	O
computation	1370	1381	O
of	1382	1384	O
thousands	1385	1394	O
of	1395	1397	O
chemical	1398	1406	O
stochastic	1407	1417	O
equations	1418	1427	O
(	1428	1429	O
Kuwahara	1429	1437	O
et	1438	1440	O
al	1441	1443	O
.	1443	1444	O
,	1444	1445	O
2006	1446	1450	O
;	1450	1451	O
Sanchez	1452	1459	O
&	1460	1461	O
Kondev	1462	1468	O
,	1468	1469	O
2008	1470	1474	O
)	1474	1475	O
.	1475	1476	O

Model	0	5	O
of	6	8	O
how	9	12	O
estrogen	13	21	O
induces	22	29	O
DNA	30	33	O
damage	34	40	O
.	40	41	O

Estrogen	42	50	O
enters	51	57	O
the	58	61	O
cell	62	66	B-Cell
and	67	70	O
is	71	73	O
bound	74	79	O
by	80	82	O
the	83	86	O
ER	87	89	O
.	89	90	O

The	91	94	O
dimeric	95	102	O
ER	103	105	O
-	105	106	O
estrogen	106	114	O
complex	115	122	O
enters	123	129	O
the	130	133	O
nucleus	134	141	B-Cellular_component
and	142	145	O
induces	146	153	O
AID	154	157	O
expression	158	168	O
.	168	169	O

This	170	174	O
leads	175	180	O
to	181	183	O
an	184	186	O
increase	187	195	O
in	196	198	O
mutations	199	208	O
and	209	212	O
translocations	213	227	O
,	227	228	O
and	229	232	O
potentially	233	244	O
cancer	245	251	B-Pathological_formation

Results	0	7	O
:	7	8	O

In	9	11	O
the	12	15	O
total	16	21	O
population	22	32	O
(	33	34	O
N	34	35	O
=	35	36	O
95	36	38	O
)	38	39	O
,	39	40	O
median	41	47	O
OS	48	50	O
was	51	54	O
significantly	55	68	O
longer	69	75	O
in	76	78	O
patients	79	87	O
with	88	92	O
baseline	93	101	O
CA	102	104	O
19	105	107	O
-	107	108	O
9	108	109	O
values	110	116	O
at	117	119	O
or	120	122	O
below	123	128	O
the	129	132	O
median	133	139	O
than	140	144	O
in	145	147	O
those	148	153	O
with	154	158	O
values	159	165	O
above	166	171	O
it	172	174	O
(	175	176	O
12	176	178	O
.	178	179	O
2	179	180	O
months	181	187	O
[	188	189	O
95	189	191	O
%	191	192	O
confidence	193	203	O
interval	204	212	O
(	213	214	O
CI	214	216	O
)	216	217	O
,	217	218	O
8	219	220	O
.	220	221	O
6	221	222	O
-	222	223	O
16	223	225	O
.	225	226	O
6	226	227	O
%	227	228	O
]	228	229	O
vs	230	232	O
5	233	234	O
.	234	235	O
0	235	236	O
months	237	243	O
[	244	245	O
95	245	247	O
%	247	248	O
CI	249	251	O
,	251	252	O
3	253	254	O
.	254	255	O
9	255	256	O
-	256	257	O
5	257	258	O
.	258	259	O
7	259	260	O
%	260	261	O
]	261	262	O
;	262	263	O
P	264	265	O
<	265	266	O
0	266	267	O
.	267	268	O
0001	268	272	O
)	272	273	O
.	273	274	O

This	275	279	O
also	280	284	O
reached	285	292	O
significance	293	305	O
in	306	308	O
the	309	312	O
Gem	313	316	O
+	316	317	O
A	317	318	O
arm	319	322	O
(	323	324	O
median	324	330	O
OS	331	333	O
,	333	334	O
12	335	337	O
.	337	338	O
5	338	339	O
months	340	346	O
[	347	348	O
95	348	350	O
%	350	351	O
CI	352	354	O
,	354	355	O
8	356	357	O
.	357	358	O
6	358	359	O
-	359	360	O
16	360	362	O
.	362	363	O
6	363	364	O
%	364	365	O
]	365	366	O
vs	367	369	O
4	370	371	O
.	371	372	O
9	372	373	O
months	374	380	O
[	381	382	O
95	382	384	O
%	384	385	O
CI	386	388	O
,	388	389	O
3	390	391	O
.	391	392	O
6	392	393	O
-	393	394	O
5	394	395	O
.	395	396	O
6	396	397	O
%	397	398	O
]	398	399	O
;	399	400	O
P	401	402	O
<	402	403	O
0	403	404	O
.	404	405	O
0001	405	409	O
)	409	410	O
.	410	411	O

Patients	412	420	O
with	421	425	O
any	426	429	O
dBP	430	433	O
>	433	434	O
90	434	436	O
mmHg	437	441	O
had	442	445	O
significantly	446	459	O
longer	460	466	O
OS	467	469	O
than	470	474	O
those	475	480	O
who	481	484	O
did	485	488	O
not	489	492	O
.	492	493	O

However	494	501	O
,	501	502	O
there	503	508	O
was	509	512	O
no	513	515	O
predictive	516	526	O
significance	527	539	O
of	540	542	O
CA	543	545	O
19	546	548	O
-	548	549	O
9	549	550	O
.	550	551	O

Percentage	0	10	O
reported	11	19	O
purchasing	20	30	O
intentions	31	41	O
,	41	42	O
comparing	43	52	O
ITN	53	56	O
-	56	57	O
owning	57	63	O
to	64	66	O
non	67	70	O
-	70	71	O
owning	71	77	O
households	78	88	O

School	0	6	O
environment	7	18	O

At	19	21	O
the	22	25	O
majority	26	34	O
of	35	37	O
the	38	41	O
schools	42	49	O
a	50	51	O
soft	52	56	O
drink	57	62	O
vending	63	70	O
machine	71	78	O
(	79	80	O
91	80	82	O
%	82	83	O
,	83	84	O
n	85	86	O
=	87	88	O
446	89	92	O
)	92	93	O
and	94	97	O
/	97	98	O
or	98	100	O
a	101	102	O
vending	103	110	O
machine	111	118	O
containing	119	129	O
sweets	130	136	O
and	137	140	O
candy	141	146	O
bars	147	151	O
(	152	153	O
81	153	155	O
%	155	156	O
,	156	157	O
n	158	159	O
=	160	161	O
413	162	165	O
)	165	166	O
is	167	169	O
present	170	177	O
(	178	179	O
Table	179	184	O
2	185	186	O
)	186	187	O
.	187	188	O

At	189	191	O
78	192	194	O
%	194	195	O
(	196	197	O
n	197	198	O
=	199	200	O
393	201	204	O
)	204	205	O
of	206	208	O
the	209	212	O
schools	213	220	O
there	221	226	O
is	227	229	O
a	230	231	O
supermarket	232	243	O
,	243	244	O
gas	245	248	O
station	249	256	O
or	257	259	O
a	260	261	O
fast	262	266	O
food	267	271	O
restaurant	272	282	O
in	283	285	O
the	286	289	O
neighbourhood	290	303	O
(	304	305	O
within	305	311	O
1	312	313	O
km	314	316	O
of	317	319	O
the	320	323	O
school	324	330	O
)	330	331	O
.	331	332	O

At	333	335	O
68	336	338	O
%	338	339	O
(	340	341	O
n	341	342	O
=	343	344	O
345	345	348	O
)	348	349	O
of	350	352	O
the	353	356	O
schools	357	364	O
there	365	370	O
are	371	374	O
facilities	375	385	O
at	386	388	O
or	389	391	O
around	392	398	O
the	399	402	O
school	403	409	O
property	410	418	O
where	419	424	O
the	425	428	O
students	429	437	O
can	438	441	O
be	442	444	O
physically	445	455	O
active	456	462	O
,	462	463	O
for	464	467	O
example	468	475	O
a	476	477	O
soccer	478	484	O
field	485	490	O
or	491	493	O
a	494	495	O
basketball	496	506	O
field	507	512	O
.	512	513	O

Table	514	519	O
2	520	521	O

The	522	525	O
school	526	532	O
environment	533	544	O

Total	545	550	O
School	551	557	O
level	558	563	O

Vocational	564	574	O
education	575	584	O
schools	585	592	O
Mixed	593	598	O
schools	599	606	O
Higher	607	613	O
education	614	623	O
schools	624	631	O
Vocational	632	642	O
education	643	652	O
schools	653	660	O
versus	661	667	O
higher	668	674	O
education	675	684	O
schools	685	692	O
#	692	693	O
Mixed	694	699	O
schools	700	707	O
versus	708	714	O
higher	715	721	O
education	722	731	O
schools	732	739	O
#	739	740	O

n	741	742	O
=	743	744	O
515	745	748	O
n	749	750	O
=	751	752	O
216	753	756	O
n	757	758	O
=	759	760	O
232	761	764	O
n	765	766	O
=	767	768	O
67	769	771	O

%	772	773	O
(	774	775	O
n	775	776	O
)	776	777	O
%	778	779	O
(	780	781	O
n	781	782	O
)	782	783	O
%	784	785	O
(	786	787	O
n	787	788	O
)	788	789	O
%	790	791	O
(	792	793	O
n	793	794	O
)	794	795	O
OR	796	798	O
(	799	800	O
95	800	802	O
%	802	803	O
CI	803	805	O
)	805	806	O
OR	807	809	O
(	810	811	O
95	811	813	O
%	813	814	O
CI	814	816	O
)	816	817	O

Soft	818	822	O
drink	823	828	O
vending	829	836	O
machine	837	844	O
present	845	852	O
at	853	855	O
school	856	862	O
91	863	865	O
.	865	866	O
4	866	867	O
(	868	869	O
466	869	872	O
)	872	873	O
90	874	876	O
.	876	877	O
2	877	878	O
(	879	880	O
194	880	883	O
)	883	884	O
91	885	887	O
.	887	888	O
3	888	889	O
(	890	891	O
209	891	894	O
)	894	895	O
95	896	898	O
.	898	899	O
5	899	900	O
(	901	902	O
63	902	904	O
)	904	905	O
1	906	907	O
.	907	908	O
0	908	909	O
(	910	911	O
0	911	912	O
.	912	913	O
9	913	914	O
;	914	915	O
1	915	916	O
.	916	917	O
1	917	918	O
)	918	919	O
1	920	921	O
.	921	922	O
0	922	923	O
(	924	925	O
0	925	926	O
.	926	927	O
9	927	928	O
;	928	929	O
1	929	930	O
.	930	931	O
0	931	932	O
)	932	933	O

Percentage	934	944	O
of	945	947	O
soft	948	952	O
drink	953	958	O
vending	959	966	O
machines	967	975	O
present	976	983	O
at	984	986	O
school	987	993	O
that	994	998	O
contain	999	1006	O
light	1007	1012	O
soft	1013	1017	O
drinks	1018	1024	O
79	1025	1027	O
.	1027	1028	O
8	1028	1029	O
(	1030	1031	O
372	1031	1034	O
)	1034	1035	O
75	1036	1038	O
.	1038	1039	O
4	1039	1040	O
(	1041	1042	O
147	1042	1045	O
)	1045	1046	O
82	1047	1049	O
.	1049	1050	O
2	1050	1051	O
(	1052	1053	O
171	1053	1056	O
)	1056	1057	O
85	1058	1060	O
.	1060	1061	O
7	1061	1062	O
(	1063	1064	O
54	1064	1066	O
)	1066	1067	O
0	1068	1069	O
.	1069	1070	O
9	1070	1071	O
(	1072	1073	O
0	1073	1074	O
.	1074	1075	O
8	1075	1076	O
;	1076	1077	O
1	1077	1078	O
.	1078	1079	O
0	1079	1080	O
)	1080	1081	O
1	1082	1083	O
.	1083	1084	O
0	1084	1085	O
(	1086	1087	O
0	1087	1088	O
.	1088	1089	O
9	1089	1090	O
;	1090	1091	O
1	1091	1092	O
.	1092	1093	O
1	1093	1094	O
)	1094	1095	O

Soft	1096	1100	O
drink	1101	1106	O
vending	1107	1114	O
machines	1115	1123	O
contain	1124	1131	O
more	1132	1136	O
unhealthy	1137	1146	O
drinks	1147	1153	O
than	1154	1158	O
healthy	1159	1166	O
drinks	1167	1173	O
57	1174	1176	O
.	1176	1177	O
9	1177	1178	O
(	1179	1180	O
268	1180	1183	O
)	1183	1184	O
61	1185	1187	O
.	1187	1188	O
9	1188	1189	O
(	1190	1191	O
120	1191	1194	O
)	1194	1195	O
58	1196	1198	O
.	1198	1199	O
5	1199	1200	O
(	1201	1202	O
121	1202	1205	O
)	1205	1206	O
43	1207	1209	O
.	1209	1210	O
6	1210	1211	O
(	1212	1213	O
27	1213	1215	O
)	1215	1216	O
1	1217	1218	O
.	1218	1219	O
4	1219	1220	O
(	1221	1222	O
1	1222	1223	O
.	1223	1224	O
0	1224	1225	O
;	1225	1226	O
1	1226	1227	O
.	1227	1228	O
9	1228	1229	O
)	1229	1230	O
1	1231	1232	O
.	1232	1233	O
4	1233	1234	O
(	1235	1236	O
1	1236	1237	O
.	1237	1238	O
0	1238	1239	O
;	1239	1240	O
1	1240	1241	O
.	1241	1242	O
9	1242	1243	O
)	1243	1244	O
*	1244	1245	O

Vending	1246	1253	O
machine	1254	1261	O
present	1262	1269	O
at	1270	1272	O
school	1273	1279	O
that	1280	1284	O
contains	1285	1293	O
sweets	1294	1300	O
/	1300	1301	O
candy	1301	1306	O
bars	1307	1311	O
80	1312	1314	O
.	1314	1315	O
7	1315	1316	O
(	1317	1318	O
413	1318	1321	O
)	1321	1322	O
75	1323	1325	O
.	1325	1326	O
6	1326	1327	O
(	1328	1329	O
161	1329	1332	O
)	1332	1333	O
84	1334	1336	O
.	1336	1337	O
9	1337	1338	O
(	1339	1340	O
197	1340	1343	O
)	1343	1344	O
82	1345	1347	O
.	1347	1348	O
1	1348	1349	O
(	1350	1351	O
55	1351	1353	O
)	1353	1354	O
1	1355	1356	O
.	1356	1357	O
1	1357	1358	O
(	1359	1360	O
0	1360	1361	O
.	1361	1362	O
9	1362	1363	O
;	1363	1364	O
1	1364	1365	O
.	1365	1366	O
2	1366	1367	O
)	1367	1368	O
1	1369	1370	O
.	1370	1371	O
1	1371	1372	O
(	1373	1374	O
1	1374	1375	O
.	1375	1376	O
0	1376	1377	O
;	1377	1378	O
1	1378	1379	O
.	1379	1380	O
2	1380	1381	O
)	1381	1382	O

Sweets	1383	1389	O
/	1389	1390	O
candy	1390	1395	O
bars	1396	1400	O
vending	1401	1408	O
machines	1409	1417	O
contain	1418	1425	O
more	1426	1430	O
unhealthy	1431	1440	O
than	1441	1445	O
healthy	1446	1453	O
foods	1454	1459	O
63	1460	1462	O
.	1462	1463	O
7	1463	1464	O
(	1465	1466	O
260	1466	1469	O
)	1469	1470	O
70	1471	1473	O
.	1473	1474	O
6	1474	1475	O
(	1476	1477	O
113	1477	1480	O
)	1480	1481	O
64	1482	1484	O
.	1484	1485	O
4	1485	1486	O
(	1487	1488	O
125	1488	1491	O
)	1491	1492	O
40	1493	1495	O
.	1495	1496	O
7	1496	1497	O
(	1498	1499	O
22	1499	1501	O
)	1501	1502	O
1	1503	1504	O
.	1504	1505	O
7	1505	1506	O
(	1507	1508	O
1	1508	1509	O
.	1509	1510	O
2	1510	1511	O
;	1511	1512	O
2	1512	1513	O
.	1513	1514	O
4	1514	1515	O
)	1515	1516	O
*	1516	1517	O
1	1518	1519	O
.	1519	1520	O
6	1520	1521	O
(	1522	1523	O
1	1523	1524	O
.	1524	1525	O
1	1525	1526	O
;	1526	1527	O
2	1527	1528	O
.	1528	1529	O
3	1529	1530	O
)	1530	1531	O
*	1531	1532	O

There	1533	1538	O
is	1539	1541	O
a	1542	1543	O
supermarket	1544	1555	O
,	1555	1556	O
gas	1557	1560	O
station	1561	1568	O
,	1568	1569	O
or	1570	1572	O
fast	1573	1577	O
food	1578	1582	O
restaurant	1583	1593	O
in	1594	1596	O
the	1597	1600	O
neighbourhood	1601	1614	O
of	1615	1617	O
the	1618	1621	O
school	1622	1628	O
78	1629	1631	O
.	1631	1632	O
3	1632	1633	O
(	1634	1635	O
393	1635	1638	O
)	1638	1639	O
76	1640	1642	O
.	1642	1643	O
7	1643	1644	O
(	1645	1646	O
161	1646	1649	O
)	1649	1650	O
79	1651	1653	O
.	1653	1654	O
7	1654	1655	O
(	1656	1657	O
181	1657	1660	O
)	1660	1661	O
78	1662	1664	O
.	1664	1665	O
5	1665	1666	O
(	1667	1668	O
51	1668	1670	O
)	1670	1671	O
1	1672	1673	O
.	1673	1674	O
1	1674	1675	O
(	1676	1677	O
0	1677	1678	O
.	1678	1679	O
9	1679	1680	O
;	1680	1681	O
1	1681	1682	O
.	1682	1683	O
2	1683	1684	O
)	1684	1685	O
1	1686	1687	O
.	1687	1688	O
1	1688	1689	O
(	1690	1691	O
0	1691	1692	O
.	1692	1693	O
9	1693	1694	O
;	1694	1695	O
1	1695	1696	O
.	1696	1697	O
2	1697	1698	O
)	1698	1699	O

The	1700	1703	O
students	1704	1712	O
are	1713	1716	O
allowed	1717	1724	O
to	1725	1727	O
leave	1728	1733	O
the	1734	1737	O
school	1738	1744	O
property	1745	1753	O
during	1754	1760	O
school	1761	1767	O
hours	1768	1773	O
57	1774	1776	O
.	1776	1777	O
4	1777	1778	O
(	1779	1780	O
295	1780	1783	O
)	1783	1784	O
42	1785	1787	O
.	1787	1788	O
6	1788	1789	O
(	1790	1791	O
92	1791	1793	O
)	1793	1794	O
65	1795	1797	O
.	1797	1798	O
8	1798	1799	O
(	1800	1801	O
152	1801	1804	O
)	1804	1805	O
76	1806	1808	O
.	1808	1809	O
1	1809	1810	O
(	1811	1812	O
51	1812	1814	O
)	1814	1815	O
0	1816	1817	O
.	1817	1818	O
6	1818	1819	O
(	1820	1821	O
0	1821	1822	O
.	1822	1823	O
5	1823	1824	O
;	1824	1825	O
0	1825	1826	O
.	1826	1827	O
8	1827	1828	O
)	1828	1829	O
*	1829	1830	O
0	1831	1832	O
.	1832	1833	O
9	1833	1834	O
(	1835	1836	O
0	1836	1837	O
.	1837	1838	O
8	1838	1839	O
;	1839	1840	O
1	1840	1841	O
.	1841	1842	O
0	1842	1843	O
)	1843	1844	O

There	1845	1850	O
are	1851	1854	O
facilities	1855	1865	O
at	1866	1868	O
and	1869	1872	O
around	1873	1879	O
the	1880	1883	O
school	1884	1890	O
property	1891	1899	O
where	1900	1905	O
the	1906	1909	O
students	1910	1918	O
can	1919	1922	O
be	1923	1925	O
physically	1926	1936	O
active	1937	1943	O
68	1944	1946	O
.	1946	1947	O
1	1947	1948	O
(	1949	1950	O
345	1950	1953	O
)	1953	1954	O
63	1955	1957	O
.	1957	1958	O
1	1958	1959	O
(	1960	1961	O
135	1961	1964	O
)	1964	1965	O
70	1966	1968	O
.	1968	1969	O
3	1969	1970	O
(	1971	1972	O
161	1972	1975	O
)	1975	1976	O
76	1977	1979	O
.	1979	1980	O
6	1980	1981	O
(	1982	1983	O
49	1983	1985	O
)	1985	1986	O
0	1987	1988	O
.	1988	1989	O
8	1989	1990	O
(	1991	1992	O
0	1992	1993	O
.	1993	1994	O
7	1994	1995	O
;	1995	1996	O
1	1996	1997	O
.	1997	1998	O
0	1998	1999	O
)	1999	2000	O
0	2001	2002	O
.	2002	2003	O
9	2003	2004	O
(	2005	2006	O
0	2006	2007	O
.	2007	2008	O
8	2008	2009	O
;	2009	2010	O
1	2010	2011	O
.	2011	2012	O
1	2012	2013	O
)	2013	2014	O

#	2015	2016	O
Associations	2017	2029	O
are	2030	2033	O
adjusted	2034	2042	O
for	2043	2046	O
school	2047	2053	O
size	2054	2058	O

*	2059	2060	O
p	2061	2062	O
<	2063	2064	O
0	2065	2066	O
.	2066	2067	O
05	2067	2069	O

The	2070	2073	O
vocational	2074	2084	O
education	2085	2094	O
schools	2095	2102	O
did	2103	2106	O
not	2107	2110	O
differ	2111	2117	O
from	2118	2122	O
the	2123	2126	O
higher	2127	2133	O
education	2134	2143	O
schools	2144	2151	O
with	2152	2156	O
regard	2157	2163	O
to	2164	2166	O
the	2167	2170	O
presence	2171	2179	O
of	2180	2182	O
vending	2183	2190	O
machines	2191	2199	O
and	2200	2203	O
a	2204	2205	O
canteen	2206	2213	O
,	2213	2214	O
but	2215	2218	O
the	2219	2222	O
vending	2223	2230	O
machines	2231	2239	O
and	2240	2243	O
the	2244	2247	O
canteen	2248	2255	O
contained	2256	2265	O
a	2266	2267	O
less	2268	2272	O
favourable	2273	2283	O
selection	2284	2293	O
of	2294	2296	O
foods	2297	2302	O
and	2303	2306	O
drinks	2307	2313	O
.	2313	2314	O

The	2315	2318	O
vocational	2319	2329	O
education	2330	2339	O
schools	2340	2347	O
indicated	2348	2357	O
more	2358	2362	O
often	2363	2368	O
that	2369	2373	O
the	2374	2377	O
vending	2378	2385	O
machines	2386	2394	O
and	2395	2398	O
the	2399	2402	O
canteen	2403	2410	O
contained	2411	2420	O
more	2421	2425	O
unhealthy	2426	2435	O
foods	2436	2441	O
and	2442	2445	O
drinks	2446	2452	O
than	2453	2457	O
healthy	2458	2465	O
foods	2466	2471	O
and	2472	2475	O
drinks	2476	2482	O
.	2482	2483	O

Vocational	2484	2494	O
education	2495	2504	O
schools	2505	2512	O
had	2513	2516	O
fewer	2517	2522	O
facilities	2523	2533	O
at	2534	2536	O
and	2537	2540	O
around	2541	2547	O
the	2548	2551	O
school	2552	2558	O
property	2559	2567	O
to	2568	2570	O
be	2571	2573	O
physical	2574	2582	O
than	2583	2587	O
the	2588	2591	O
higher	2592	2598	O
education	2599	2608	O
schools	2609	2616	O
.	2616	2617	O

Most	2618	2622	O
associations	2623	2635	O
were	2636	2640	O
attenuated	2641	2651	O
after	2652	2657	O
adjustment	2658	2668	O
for	2669	2672	O
school	2673	2679	O
size	2680	2684	O
.	2684	2685	O

For	2686	2689	O
example	2690	2697	O
,	2697	2698	O
the	2699	2702	O
association	2703	2714	O
between	2715	2722	O
school	2723	2729	O
level	2730	2735	O
and	2736	2739	O
content	2740	2747	O
of	2748	2750	O
the	2751	2754	O
soft	2755	2759	O
drink	2760	2765	O
vending	2766	2773	O
machines	2774	2782	O
was	2783	2786	O
OR	2787	2789	O
=	2790	2791	O
1	2792	2793	O
.	2793	2794	O
42	2794	2796	O
,	2796	2797	O
95	2798	2800	O
%	2800	2801	O
CI	2801	2803	O
:	2803	2804	O
1	2805	2806	O
.	2806	2807	O
05	2807	2809	O
-	2809	2810	O
1	2810	2811	O
.	2811	2812	O
93	2812	2814	O
in	2815	2817	O
the	2818	2821	O
crude	2822	2827	O
analysis	2828	2836	O
and	2837	2840	O
OR	2841	2843	O
=	2844	2845	O
1	2846	2847	O
.	2847	2848	O
35	2848	2850	O
,	2850	2851	O
95	2852	2854	O
%	2854	2855	O
CI	2855	2857	O
:	2857	2858	O
0	2859	2860	O
.	2860	2861	O
99	2861	2863	O
-	2863	2864	O
1	2864	2865	O
.	2865	2866	O
85	2866	2868	O
in	2869	2871	O
the	2872	2875	O
adjusted	2876	2884	O
analysis	2885	2893	O
.	2893	2894	O

Background	0	10	O

Over	11	15	O
the	16	19	O
past	20	24	O
decades	25	32	O
,	32	33	O
extensive	34	43	O
comparative	44	55	O
mapping	56	63	O
research	64	72	O
has	73	76	O
been	77	81	O
performed	82	91	O
in	92	94	O
the	95	98	O
plant	99	104	O
family	105	111	O
Solanaceae	112	122	O
.	122	123	O

The	124	127	O
recent	128	134	O
identification	135	149	O
of	150	152	O
a	153	154	O
large	155	160	O
set	161	164	O
of	165	167	O
single	168	174	O
-	174	175	O
copy	175	179	O
conserved	180	189	O
orthologous	190	201	O
(	202	203	O
COSII	203	208	O
)	208	209	O
markers	210	217	O
has	218	221	O
greatly	222	229	O
accelerated	230	241	O
comparative	242	253	O
mapping	254	261	O
studies	262	269	O
among	270	275	O
major	276	281	O
solanaceous	282	293	O
species	294	301	O
including	302	311	O
tomato	312	318	O
,	318	319	O
potato	320	326	O
,	326	327	O
eggplant	328	336	O
,	336	337	O
pepper	338	344	O
and	345	348	O
diploid	349	356	O
Nicotiana	357	366	O
species	367	374	O
(	375	376	O
as	376	378	O
well	379	383	O
as	384	386	O
tetraploid	387	397	O
tobacco	398	405	O
)	405	406	O
.	406	407	O

The	408	411	O
large	412	417	O
amount	418	424	O
of	425	427	O
comparative	428	439	O
data	440	444	O
now	445	448	O
available	449	458	O
for	459	462	O
these	463	468	O
species	469	476	O
provides	477	485	O
the	486	489	O
opportunity	490	501	O
to	502	504	O
describe	505	513	O
the	514	517	O
overall	518	525	O
patterns	526	534	O
of	535	537	O
chromosomal	538	549	B-Cellular_component
evolution	550	559	O
in	560	562	O
this	563	567	O
important	568	577	O
plant	578	583	O
family	584	590	O
.	590	591	O

The	592	595	O
results	596	603	O
of	604	606	O
this	607	611	O
investigation	612	625	O
are	626	629	O
described	630	639	O
herein	640	646	O
.	646	647	O

Introduction	0	12	O

Tea	13	16	O
(	17	18	O
Camellia	18	26	O
sinensis	27	35	O
L	36	37	O
.	37	38	O
)	38	39	O
is	40	42	O
one	43	46	O
of	47	49	O
the	50	53	O
most	54	58	O
widely	59	65	O
consumed	66	74	O
beverages	75	84	O
in	85	87	O
the	88	91	O
world	92	97	O
.	97	98	O

(	99	100	O
-	100	101	O
)	101	102	O
-	102	103	O
Epigallocatechin	103	119	O
-	119	120	O
3	120	121	O
-	121	122	O
O	122	123	O
-	123	124	O
gallate	124	131	O
(	132	133	O
EGCG	133	137	O
)	137	138	O
,	138	139	O
which	140	145	O
is	146	148	O
the	149	152	O
major	153	158	O
green	159	164	O
tea	165	168	O
catechin	169	177	O
present	178	185	O
in	186	188	O
the	189	192	O
leaves	193	199	B-Organ
,	199	200	O
is	201	203	O
believed	204	212	O
to	213	215	O
the	216	219	O
compound	220	228	O
most	229	233	O
responsible	234	245	O
for	246	249	O
the	250	253	O
health	254	260	O
benefits	261	269	O
attributed	270	280	O
to	281	283	O
tea	284	287	O
.	287	288	O

EGCG	289	293	O
was	294	297	O
reported	298	306	O
to	307	309	O
have	310	314	O
antioxidative	315	328	O
[	329	330	O
1	330	331	O
]	331	332	O
,	332	333	O
[	334	335	O
2	335	336	O
]	336	337	O
,	337	338	O
antimutagenic	339	352	O
[	353	354	O
3	354	355	O
]	355	356	O
,	356	357	O
anti	358	362	O
-	362	363	O
inflammatory	363	375	O
[	376	377	O
4	377	378	O
]	378	379	O
,	379	380	O
and	381	384	O
anticarcinogenic	385	401	O
activities	402	412	O
[	413	414	O
5	414	415	O
]	415	416	O
.	416	417	O

Although	418	426	O
the	427	430	O
EGCG	431	435	O
concentrations	436	450	O
required	451	459	O
to	460	462	O
elicit	463	469	O
the	470	473	O
anticancer	474	484	B-Pathological_formation
activity	485	493	O
have	494	498	O
been	499	503	O
shown	504	509	O
to	510	512	O
be	513	515	O
more	516	520	O
than	521	525	O
1	526	527	O
microM	528	534	O
,	534	535	O
the	536	539	O
blood	540	545	B-Organism_substance
level	546	551	O
of	552	554	O
EGCG	555	559	O
after	560	565	O
consuming	566	575	O
the	576	579	O
equivalent	580	590	O
of	591	593	O
2	594	595	O
-	595	596	O
3	596	597	O
cups	598	602	O
of	603	605	O
green	606	611	O
tea	612	615	O
was	616	619	O
0	620	621	O
.	621	622	O
1	622	623	O
-	623	624	O
0	624	625	O
.	625	626	O
6	626	627	O
microM	628	634	O
and	635	638	O
for	639	642	O
an	643	645	O
equivalent	646	656	O
of	657	659	O
7	660	661	O
-	661	662	O
9	662	663	O
cups	664	668	O
was	669	672	O
still	673	678	O
lower	679	684	O
than	685	689	O
1	690	691	O
microM	692	698	O
[	699	700	O
6	700	701	O
]	701	702	O
,	702	703	O
[	704	705	O
7	705	706	O
]	706	707	O
.	707	708	O

In	709	711	O
a	712	713	O
cohort	714	720	O
study	721	726	O
,	726	727	O
daily	728	733	O
consumption	734	745	O
of	746	748	O
ten	749	752	O
cups	753	757	O
of	758	760	O
green	761	766	O
tea	767	770	O
was	771	774	O
required	775	783	O
for	784	787	O
the	788	791	O
cancer	792	798	B-Pathological_formation
preventive	799	809	O
effect	810	816	O
[	817	818	O
8	818	819	O
]	819	820	O
.	820	821	O

Moreover	822	830	O
,	830	831	O
adverse	832	839	O
effects	840	847	O
of	848	850	O
green	851	856	O
tea	857	860	O
,	860	861	O
mainly	862	868	O
hepatitis	869	878	O
,	878	879	O
by	880	882	O
consumption	883	894	O
of	895	897	O
high	898	902	O
doses	903	908	O
of	909	911	O
green	912	917	O
tea	918	921	O
have	922	926	O
been	927	931	O
reported	932	940	O
[	941	942	O
9	942	943	O
]	943	944	O
.	944	945	O

Therefore	946	955	O
,	955	956	O
it	957	959	O
is	960	962	O
important	963	972	O
to	973	975	O
enhance	976	983	O
the	984	987	O
pharmacologic	988	1001	O
effect	1002	1008	O
of	1009	1011	O
EGCG	1012	1016	O
to	1017	1019	O
obtain	1020	1026	O
the	1027	1030	O
health	1031	1037	O
benefit	1038	1045	O
in	1046	1048	O
reasonable	1049	1059	O
concentration	1060	1073	O
in	1074	1076	O
daily	1077	1082	O
life	1083	1087	O
.	1087	1088	O

We	1089	1091	O
have	1092	1096	O
reported	1097	1105	O
that	1106	1110	O
the	1111	1114	O
cell	1115	1119	B-Cellular_component
-	1119	1120	I-Cellular_component
surface	1120	1127	I-Cellular_component
binding	1128	1135	O
of	1136	1138	O
EGCG	1139	1143	O
and	1144	1147	O
its	1148	1151	O
derivatives	1152	1163	O
is	1164	1166	O
involved	1167	1175	O
in	1176	1178	O
their	1179	1184	O
biological	1185	1195	O
activities	1196	1206	O
[	1207	1208	O
10	1208	1210	O
]	1210	1211	O
-	1211	1212	O
[	1212	1213	O
15	1213	1215	O
]	1215	1216	O
.	1216	1217	O

We	1218	1220	O
have	1221	1225	O
identified	1226	1236	O
the	1237	1240	O
67	1241	1243	O
-	1243	1244	O
kDa	1244	1247	O
laminin	1248	1255	O
receptor	1256	1264	O
(	1265	1266	O
67LR	1266	1270	O
)	1270	1271	O
as	1272	1274	O
a	1275	1276	O
cell	1277	1281	B-Cellular_component
surface	1282	1289	I-Cellular_component
receptor	1290	1298	O
for	1299	1302	O
EGCG	1303	1307	O
that	1308	1312	O
mediates	1313	1321	O
the	1322	1325	O
anticancer	1326	1336	O
activity	1337	1345	O
of	1346	1348	O
EGCG	1349	1353	O
[	1354	1355	O
16	1355	1357	O
]	1357	1358	O
.	1358	1359	O

67LR	1360	1364	O
has	1365	1368	O
been	1369	1373	O
shown	1374	1379	O
to	1380	1382	O
be	1383	1385	O
overexpressed	1386	1399	O
on	1400	1402	O
the	1403	1406	O
cell	1407	1411	B-Cellular_component
surface	1412	1419	I-Cellular_component
of	1420	1422	O
various	1423	1430	O
tumor	1431	1436	B-Cell
cells	1437	1442	I-Cell
[	1443	1444	O
17	1444	1446	O
]	1446	1447	O
.	1447	1448	O

It	1449	1451	O
was	1452	1455	O
postulated	1456	1466	O
that	1467	1471	O
67LR	1472	1476	O
plays	1477	1482	O
a	1483	1484	O
significant	1485	1496	O
role	1497	1501	O
in	1502	1504	O
the	1505	1508	O
tumor	1509	1514	B-Pathological_formation
progression	1515	1526	O
and	1527	1530	O
speculated	1531	1541	O
that	1542	1546	O
studies	1547	1554	O
conducted	1555	1564	O
to	1565	1567	O
define	1568	1574	O
the	1575	1578	O
function	1579	1587	O
of	1588	1590	O
67LR	1591	1595	O
could	1596	1601	O
provide	1602	1609	O
a	1610	1611	O
new	1612	1615	O
approach	1616	1624	O
to	1625	1627	O
cancer	1628	1634	B-Pathological_formation
prevention	1635	1645	O
.	1645	1646	O

Indeed	1647	1653	O
,	1653	1654	O
expression	1655	1665	O
of	1666	1668	O
67	1669	1671	O
LR	1672	1674	O
confers	1675	1682	O
EGCG	1683	1687	O
responsiveness	1688	1702	O
to	1703	1705	O
tumor	1706	1711	B-Cell
cells	1712	1717	I-Cell
in	1718	1720	O
vivo	1721	1725	O
[	1726	1727	O
18	1727	1729	O
]	1729	1730	O
.	1730	1731	O

Vitamin	1732	1739	O
A	1740	1741	O
,	1741	1742	O
also	1743	1747	O
known	1748	1753	O
as	1754	1756	O
retinol	1757	1764	O
,	1764	1765	O
participates	1766	1778	O
in	1779	1781	O
physiological	1782	1795	O
activities	1796	1806	O
related	1807	1814	O
to	1815	1817	O
the	1818	1821	O
immune	1822	1828	O
system	1829	1835	O
,	1835	1836	O
maintenance	1837	1848	O
of	1849	1851	O
epithelial	1852	1862	B-Tissue
and	1863	1866	O
mucosa	1867	1873	B-Tissue
tissues	1874	1881	I-Tissue
,	1881	1882	O
growth	1883	1889	O
,	1889	1890	O
reproduction	1891	1903	O
,	1903	1904	O
and	1905	1908	O
bone	1909	1913	B-Organ
development	1914	1925	O
.	1925	1926	O

It	1927	1929	O
comes	1930	1935	O
from	1936	1940	O
animal	1941	1947	O
sources	1948	1955	O
,	1955	1956	O
such	1957	1961	O
as	1962	1964	O
eggs	1965	1969	B-Organism_substance
,	1969	1970	O
meat	1971	1975	B-Organism_subdivision
,	1975	1976	O
milk	1977	1981	B-Organism_substance
,	1981	1982	O
cheese	1983	1989	O
,	1989	1990	O
cream	1991	1996	O
,	1996	1997	O
liver	1998	2003	B-Organ
,	2003	2004	O
kidney	2005	2011	B-Organ
,	2011	2012	O
cod	2013	2016	O
and	2017	2020	O
halibut	2021	2028	O
fish	2029	2033	O
oil	2034	2037	B-Organism_substance
.	2037	2038	O

In	2039	2041	O
vitro	2042	2047	O
and	2048	2051	O
in	2052	2054	O
animal	2055	2061	O
models	2062	2068	O
,	2068	2069	O
it	2070	2072	O
has	2073	2076	O
been	2077	2081	O
demonstrated	2082	2094	O
that	2095	2099	O
vitamin	2100	2107	O
A	2108	2109	O
is	2110	2112	O
involved	2113	2121	O
in	2122	2124	O
the	2125	2128	O
regulation	2129	2139	O
and	2140	2143	O
promotion	2144	2153	O
of	2154	2156	O
growth	2157	2163	O
and	2164	2167	O
differentiation	2168	2183	O
of	2184	2186	O
many	2187	2191	O
cells	2192	2197	B-Cell
[	2198	2199	O
19	2199	2201	O
]	2201	2202	O
.	2202	2203	O

The	2204	2207	O
visual	2208	2214	O
function	2215	2223	O
of	2224	2226	O
vitamin	2227	2234	O
A	2235	2236	O
depends	2237	2244	O
on	2245	2247	O
its	2248	2251	O
natural	2252	2259	O
and	2260	2263	O
synthetic	2264	2273	O
derivatives	2274	2285	O
,	2285	2286	O
retinoids	2287	2296	O
[	2297	2298	O
20	2298	2300	O
]	2300	2301	O
.	2301	2302	O

All	2303	2306	O
-	2306	2307	O
trans	2307	2312	O
-	2312	2313	O
retinoic	2313	2321	O
acid	2322	2326	O
(	2327	2328	O
ATRA	2328	2332	O
)	2332	2333	O
,	2333	2334	O
the	2335	2338	O
active	2339	2345	O
derivative	2346	2356	O
of	2357	2359	O
vitamin	2360	2367	O
A	2368	2369	O
,	2369	2370	O
has	2371	2374	O
been	2375	2379	O
well	2380	2384	O
documented	2385	2395	O
as	2396	2398	O
a	2399	2400	O
growth	2401	2407	O
and	2408	2411	O
differentiation	2412	2427	O
factor	2428	2434	O
in	2435	2437	O
many	2438	2442	O
tissues	2443	2450	B-Tissue
and	2451	2454	O
cells	2455	2460	B-Cell
,	2460	2461	O
and	2462	2465	O
proved	2466	2472	O
to	2473	2475	O
be	2476	2478	O
an	2479	2481	O
effective	2482	2491	O
treatment	2492	2501	O
to	2502	2504	O
many	2505	2509	O
diseases	2510	2518	O
including	2519	2528	O
cancers	2529	2536	B-Pathological_formation
[	2537	2538	O
21	2538	2540	O
]	2540	2541	O
,	2541	2542	O
[	2543	2544	O
22	2544	2546	O
]	2546	2547	O
.	2547	2548	O

Retinoids	2549	2558	O
exert	2559	2564	O
their	2565	2570	O
physiological	2571	2584	O
activities	2585	2595	O
through	2596	2603	O
retinoid	2604	2612	O
receptor	2613	2621	O
nuclear	2622	2629	B-Cellular_component
proteins	2630	2638	O
that	2639	2643	O
belong	2644	2650	O
to	2651	2653	O
the	2654	2657	O
superfamily	2658	2669	O
of	2670	2672	O
steroid	2673	2680	O
/	2680	2681	O
thyroid	2681	2688	O
hormone	2689	2696	O
receptors	2697	2706	O
,	2706	2707	O
of	2708	2710	O
which	2711	2716	O
there	2717	2722	O
are	2723	2726	O
two	2727	2730	O
classes	2731	2738	O
,	2738	2739	O
retinoic	2740	2748	O
acid	2749	2753	O
receptors	2754	2763	O
(	2764	2765	O
RARs	2765	2769	O
)	2769	2770	O
and	2771	2774	O
the	2775	2778	O
retinoic	2779	2787	O
-	2787	2788	O
X	2788	2789	O
receptors	2790	2799	O
(	2800	2801	O
RXRs	2801	2805	O
)	2805	2806	O
,	2806	2807	O
each	2808	2812	O
of	2813	2815	O
which	2816	2821	O
has	2822	2825	O
three	2826	2831	O
subtypes	2832	2840	O
,	2840	2841	O
alpha	2842	2847	O
,	2847	2848	O
beta	2849	2853	O
,	2853	2854	O
and	2855	2858	O
gamma	2859	2864	O
[	2865	2866	O
23	2866	2868	O
]	2868	2869	O
,	2869	2870	O
[	2871	2872	O
24	2872	2874	O
]	2874	2875	O
.	2875	2876	O

The	2877	2880	O
natural	2881	2888	O
ligands	2889	2896	O
for	2897	2900	O
the	2901	2904	O
RARs	2905	2909	O
are	2910	2913	O
ATRA	2914	2918	O
and	2919	2922	O
its	2923	2926	O
stereoisomers	2927	2940	O
9	2941	2942	O
-	2942	2943	O
cis	2943	2946	O
-	2946	2947	O
RA	2947	2949	O
and	2950	2953	O
13	2954	2956	O
-	2956	2957	O
cis	2957	2960	O
-	2960	2961	O
RA	2961	2963	O
,	2963	2964	O
whereas	2965	2972	O
RXRs	2973	2977	O
are	2978	2981	O
activated	2982	2991	O
by	2992	2994	O
9	2995	2996	O
-	2996	2997	O
cis	2997	3000	O
-	3000	3001	O
RA	3001	3003	O
only	3004	3008	O
.	3008	3009	O

ATRA	3010	3014	O
acts	3015	3019	O
through	3020	3027	O
RAR	3028	3031	O
to	3032	3034	O
transcriptionally	3035	3052	O
activate	3053	3061	O
target	3062	3068	O
genes	3069	3074	O
,	3074	3075	O
such	3076	3080	O
as	3081	3083	O
cytochrome	3084	3094	O
P450	3095	3099	O
and	3100	3103	O
CRABI	3104	3109	O
[	3110	3111	O
24	3111	3113	O
]	3113	3114	O
.	3114	3115	O

This	3116	3120	O
study	3121	3126	O
was	3127	3130	O
designed	3131	3139	O
to	3140	3142	O
identify	3143	3151	O
a	3152	3153	O
food	3154	3158	O
component	3159	3168	O
that	3169	3173	O
could	3174	3179	O
be	3180	3182	O
effectively	3183	3194	O
used	3195	3199	O
in	3200	3202	O
combination	3203	3214	O
with	3215	3219	O
EGCG	3220	3224	O
and	3225	3228	O
to	3229	3231	O
investigate	3232	3243	O
the	3244	3247	O
mechanism	3248	3257	O
of	3258	3260	O
action	3261	3267	O
of	3268	3270	O
this	3271	3275	O
combination	3276	3287	O
.	3287	3288	O

By	3289	3291	O
using	3292	3297	O
in	3298	3300	O
vitro	3301	3306	O
and	3307	3310	O
in	3311	3313	O
vivo	3314	3318	O
systems	3319	3326	O
involving	3327	3336	O
a	3337	3338	O
highly	3339	3345	O
metastatic	3346	3356	O
mouse	3357	3362	O
B16	3363	3366	B-Cell
melanoma	3367	3375	I-Cell
cell	3376	3380	I-Cell
line	3381	3385	I-Cell
[	3386	3387	O
25	3387	3389	O
]	3389	3390	O
,	3390	3391	O
we	3392	3394	O
found	3395	3400	O
that	3401	3405	O
ATRA	3406	3410	O
enhances	3411	3419	O
the	3420	3423	O
antitumor	3424	3433	B-Pathological_formation
activity	3434	3442	O
of	3443	3445	O
EGCG	3446	3450	O
by	3451	3453	O
upregulating	3454	3466	O
the	3467	3470	O
67	3471	3473	O
LR	3474	3476	O
expression	3477	3487	O
through	3488	3495	O
RAR	3496	3499	O
.	3499	3500	O

Titration	0	9	O
of	10	12	O
Ab	13	15	O
-	15	16	O
01	16	18	O
inhibition	19	29	O
of	30	32	O
ex	33	35	O
vivo	36	40	O
response	41	49	O
to	50	52	O
rhIL21	53	59	O

Samples	60	67	O
from	68	72	O
4	73	74	O
individual	75	85	O
healthy	86	93	O
human	94	99	O
donors	100	106	O
were	107	111	O
pre	112	115	O
-	115	116	O
incubated	116	125	O
for	126	129	O
2	130	131	O
hours	132	137	O
at	138	140	O
the	141	144	O
indicated	145	154	O
concentration	155	168	O
of	169	171	O
Ab	172	174	O
-	174	175	O
01	175	177	O
or	178	180	O
the	181	184	O
control	185	192	O
IgG1TM	193	199	O
prior	200	205	O
to	206	208	O
addition	209	217	O
of	218	220	O
10	221	223	O
ng	224	226	O
/	226	227	O
mL	227	229	O
rhIL21	230	236	O
and	237	240	O
2	241	242	O
hr	243	245	O
incubation	246	256	O
,	256	257	O
and	258	261	O
the	262	265	O
effect	266	272	O
on	273	275	O
the	276	279	O
6	280	281	O
biomarkers	282	292	O
was	293	296	O
then	297	301	O
assessed	302	310	O
(	311	312	O
Figures	312	319	O
4	320	321	O
and	322	325	O
5	326	327	O
)	327	328	O
.	328	329	O

For	330	333	O
the	334	337	O
first	338	343	O
2	344	345	O
donors	346	352	O
tested	353	359	O
,	359	360	O
even	361	365	O
the	366	369	O
lowest	370	376	O
concentration	377	390	O
of	391	393	O
Ab	394	396	O
-	396	397	O
01	397	399	O
(	400	401	O
0	401	402	O
.	402	403	O
1	403	404	O
mug	405	408	O
/	408	409	O
mL	409	411	O
,	411	412	O
0	413	414	O
.	414	415	O
66	415	417	O
nM	418	420	O
)	420	421	O
resulted	422	430	O
in	431	433	O
complete	434	442	O
inhibition	443	453	O
of	454	456	O
the	457	460	O
rhIL21	461	467	O
response	468	476	O
,	476	477	O
therefore	478	487	O
the	488	491	O
two	492	495	O
subsequent	496	506	O
donors	507	513	O
were	514	518	O
tested	519	525	O
at	526	528	O
increasing	529	539	O
concentrations	540	554	O
of	555	557	O
Ab	558	560	O
-	560	561	O
01	561	563	O
starting	564	572	O
at	573	575	O
0	576	577	O
.	577	578	O
003	578	581	O
mug	582	585	O
/	585	586	O
mL	586	588	O
.	588	589	O

Ab	590	592	O
-	592	593	O
01	593	595	O
inhibited	596	605	O
the	606	609	O
response	610	618	O
of	619	621	O
all	622	625	O
6	626	627	O
genes	628	633	O
in	634	636	O
all	637	640	O
4	641	642	O
donors	643	649	O
.	649	650	O

IC50	651	655	O
values	656	662	O
ranged	663	669	O
between	670	677	O
0	678	679	O
.	679	680	O
003	680	683	O
and	684	687	O
0	688	689	O
.	689	690	O
015	690	693	O
mug	694	697	O
/	697	698	O
mL	698	700	O
Ab	701	703	O
-	703	704	O
01	704	706	O
(	706	707	O
Figure	707	713	O
5	714	715	O
)	715	716	O
.	716	717	O

Control	718	725	O
IgG1TM	726	732	O
had	733	736	O
no	737	739	O
significant	740	751	O
effect	752	758	O
on	759	761	O
rhIL21	762	768	O
response	769	777	O
(	778	779	O
Figure4B	779	787	O
)	787	788	O
.	788	789	O

Figure	790	796	O
4	797	798	O

Average	799	806	O
percent	807	814	O
inhibition	815	825	O
of	826	828	O
the	829	832	O
expression	833	843	O
level	844	849	O
of	850	852	O
6	853	854	O
IL21	855	859	O
-	859	860	O
responsive	860	870	O
genes	871	876	O
.	876	877	O

Percent	878	885	O
inhibition	886	896	O
values	897	903	O
were	904	908	O
calculated	909	919	O
based	920	925	O
on	926	928	O
RQ	929	931	O
(	932	933	O
relative	933	941	O
quantification	942	956	O
)	956	957	O
values	958	964	O
of	965	967	O
untreated	968	977	O
control	978	985	O
and	986	989	O
rhIL21	990	996	O
-	996	997	O
treated	997	1004	O
samples	1005	1012	O
for	1013	1016	O
each	1017	1021	O
of	1022	1024	O
the	1025	1028	O
4	1029	1030	O
donors	1031	1037	O
,	1037	1038	O
and	1039	1042	O
subsequently	1043	1055	O
the	1056	1059	O
mean	1060	1064	O
and	1065	1068	O
standard	1069	1077	O
deviation	1078	1087	O
were	1088	1092	O
determined	1093	1103	O
for	1104	1107	O
each	1108	1112	O
gene	1113	1117	O
shown	1118	1123	O
.	1123	1124	O

A	1125	1126	O
:	1126	1127	O
Percent	1128	1135	O
inhibition	1136	1146	O
in	1147	1149	O
presence	1150	1158	O
of	1159	1161	O
Ab	1162	1164	O
-	1164	1165	O
01	1165	1167	O
.	1167	1168	O

B	1169	1170	O
:	1170	1171	O
Percent	1172	1179	O
inhibition	1180	1190	O
in	1191	1193	O
presence	1194	1202	O
of	1203	1205	O
control	1206	1213	O
IgG1TM	1214	1220	O
.	1220	1221	O

Data	1222	1226	O
for	1227	1230	O
the	1231	1234	O
0	1235	1236	O
.	1236	1237	O
1	1237	1238	O
mug	1239	1242	O
/	1242	1243	O
mL	1243	1245	O
,	1246	1247	O
0	1248	1249	O
.	1249	1250	O
3	1250	1251	O
mug	1252	1255	O
/	1255	1256	O
mL	1256	1258	O
and	1259	1262	O
1	1263	1264	O
mug	1265	1268	O
/	1268	1269	O
mL	1269	1271	O
concentrations	1272	1286	O
were	1287	1291	O
generated	1292	1301	O
using	1302	1307	O
4	1308	1309	O
donors	1310	1316	O
.	1316	1317	O

Data	1318	1322	O
for	1323	1326	O
the	1327	1330	O
higher	1331	1337	O
and	1338	1341	O
the	1342	1345	O
lower	1346	1351	O
concentrations	1352	1366	O
were	1367	1371	O
generated	1372	1381	O
using	1382	1387	O
2	1388	1389	O
donors	1390	1396	O
.	1396	1397	O

Figure	1398	1404	O
5	1405	1406	O

Inhibition	1407	1417	O
by	1418	1420	O
Ab	1421	1423	O
-	1423	1424	O
01	1424	1426	O
at	1427	1429	O
the	1430	1433	O
indicated	1434	1443	O
concentration	1444	1457	O
is	1458	1460	O
shown	1461	1466	O
for	1467	1470	O
6	1471	1472	O
IL21	1473	1477	O
-	1477	1478	O
responsive	1478	1488	O
genes	1489	1494	O
.	1494	1495	O

IC50	1496	1500	O
values	1501	1507	O
of	1508	1510	O
inhibition	1511	1521	O
curves	1522	1528	O
shown	1529	1534	O
in	1535	1537	O
Figure	1538	1544	O
4A	1545	1547	O
were	1548	1552	O
calculated	1553	1563	O
using	1564	1569	O
curve	1570	1575	O
fit	1576	1579	O
(	1580	1581	O
XLfit	1581	1586	O
)	1586	1587	O
program	1588	1595	O
for	1596	1599	O
each	1600	1604	O
of	1605	1607	O
the	1608	1611	O
referred	1612	1620	O
biomarker	1621	1630	O
genes	1631	1636	O
.	1636	1637	O

Values	1638	1644	O
for	1645	1648	O
the	1649	1652	O
0	1653	1654	O
.	1654	1655	O
1	1655	1656	O
mug	1657	1660	O
/	1660	1661	O
mL	1661	1663	O
,	1663	1664	O
0	1665	1666	O
.	1666	1667	O
3	1667	1668	O
mug	1669	1672	O
/	1672	1673	O
mL	1673	1675	O
and	1676	1679	O
1	1680	1681	O
mug	1682	1685	O
/	1685	1686	O
mL	1686	1688	O
concentrations	1689	1703	O
were	1704	1708	O
generated	1709	1718	O
using	1719	1724	O
4	1725	1726	O
donors	1727	1733	O
.	1733	1734	O

Data	1735	1739	O
for	1740	1743	O
the	1744	1747	O
higher	1748	1754	O
and	1755	1758	O
the	1759	1762	O
lower	1763	1768	O
concentrations	1769	1783	O
were	1784	1788	O
generated	1789	1798	O
using	1799	1804	O
2	1805	1806	O
donors	1807	1813	O
each	1814	1818	O
.	1818	1819	O

INTRODUCTION	0	12	O

For	13	16	O
several	17	24	O
years	25	30	O
now	31	34	O
,	34	35	O
virtual	36	43	O
microscopy	44	54	O
has	55	58	O
been	59	63	O
utilized	64	72	O
in	73	75	O
medical	76	83	O
teaching	84	92	O
,	92	93	O
research	94	102	O
,	102	103	O
proficiency	104	115	O
testing	116	123	O
,	123	124	O
American	125	133	O
Board	134	139	O
of	140	142	O
Pathology	143	152	O
examinations	153	165	O
,	165	166	O
pathology	167	176	O
meetings	177	185	O
and	186	189	O
conferences	190	201	O
,	201	202	O
and	203	206	O
quality	207	214	O
assurance	215	224	O
programs	225	233	O
.	233	234	O

In	235	237	O
diagnostic	238	248	O
practice	249	257	O
,	257	258	O
it	259	261	O
is	262	264	O
most	265	269	O
widely	270	276	O
and	277	280	O
routinely	281	290	O
used	291	295	O
in	296	298	O
image	299	304	O
analysis	305	313	O
.	313	314	O

Some	315	319	O
practices	320	329	O
are	330	333	O
beginning	334	343	O
to	344	346	O
use	347	350	O
it	351	353	O
internally	354	364	O
(	365	366	O
within	366	372	O
their	373	378	O
group	379	384	O
)	384	385	O
for	386	389	O
frozen	390	396	O
section	397	404	O
intraoperative	405	419	O
consultations	420	433	O
and	434	437	O
subspecialty	438	450	O
consultations	451	464	O
due	465	468	O
to	469	471	O
geographic	472	482	O
and	483	486	O
time	487	491	O
constrains	492	502	O
.	502	503	O

Although	504	512	O
diagnostic	513	523	O
consultation	524	536	O
for	537	540	O
expert	541	547	O
second	548	554	O
opinion	555	562	O
is	563	565	O
a	566	567	O
well	568	572	O
-	572	573	O
established	573	584	O
practice	585	593	O
in	594	596	O
pathology	597	606	O
for	607	610	O
glass	611	616	O
slides	617	623	O
,	623	624	O
similar	625	632	O
consultation	633	645	O
via	646	649	O
virtual	650	657	O
microscopy	658	668	O
poses	669	674	O
multiple	675	683	O
controversial	684	697	O
issues	698	704	O
such	705	709	O
as	710	712	O
licensing	713	722	O
,	722	723	O
liability	724	733	O
,	733	734	O
security	735	743	O
,	743	744	O
reimbursement	745	758	O
,	758	759	O
and	760	763	O
scanning	764	772	O
quality	773	780	O
and	781	784	O
its	785	788	O
validation	789	799	O
.	799	800	O

Regulations	801	812	O
and	813	816	O
standardization	817	832	O
are	833	836	O
not	837	840	O
yet	841	844	O
in	845	847	O
place	848	853	O
that	854	858	O
pathologists	859	871	O
can	872	875	O
use	876	879	O
to	880	882	O
allay	883	888	O
these	889	894	O
fears	895	900	O
.	900	901	O

Nevertheless	902	914	O
,	914	915	O
if	916	918	O
the	919	922	O
virtual	923	930	O
microscopy	931	941	O
scans	942	947	O
are	948	951	O
of	952	954	O
optimal	955	962	O
quality	963	970	O
,	970	971	O
these	972	977	O
can	978	981	O
be	982	984	O
simply	985	991	O
substituted	992	1003	O
for	1004	1007	O
glass	1008	1013	O
slides	1014	1020	O
and	1021	1024	O
a	1025	1026	O
microscope	1027	1037	O
while	1038	1043	O
maintaining	1044	1055	O
all	1056	1059	O
other	1060	1065	O
practice	1066	1074	O
guidelines	1075	1085	O
for	1086	1089	O
second	1090	1096	O
opinion	1097	1104	O
consultation	1105	1117	O
.	1117	1118	O

Additionally	1119	1131	O
,	1131	1132	O
the	1133	1136	O
cost	1137	1141	O
and	1142	1145	O
maintenance	1146	1157	O
of	1158	1160	O
scanning	1161	1169	O
equipment	1170	1179	O
is	1180	1182	O
not	1183	1186	O
currently	1187	1196	O
affordable	1197	1207	O
to	1208	1210	O
most	1211	1215	O
practitioners	1216	1229	O
and	1230	1233	O
consultants	1234	1245	O
.	1245	1246	O

A	1247	1248	O
practice	1249	1257	O
model	1258	1263	O
that	1264	1268	O
offers	1269	1275	O
tertiary	1276	1284	O
consultation	1285	1297	O
in	1298	1300	O
gastrointestinal	1301	1317	B-Organism_subdivision
(	1318	1319	O
GI	1319	1321	B-Organism_subdivision
)	1321	1322	O
and	1323	1326	O
liver	1327	1332	B-Organ
pathology	1333	1342	O
is	1343	1345	O
presented	1346	1355	O
that	1356	1360	O
eliminates	1361	1371	O
the	1372	1375	O
cost	1376	1380	O
and	1381	1384	O
maintenance	1385	1396	O
of	1397	1399	O
scanners	1400	1408	O
by	1409	1411	O
the	1412	1415	O
consultants	1416	1427	O
and	1428	1431	O
clients	1432	1439	O
,	1439	1440	O
minimizes	1441	1450	O
the	1451	1454	O
need	1455	1459	O
for	1460	1463	O
review	1464	1470	O
of	1471	1473	O
glass	1474	1479	O
slides	1480	1486	O
,	1486	1487	O
facilitates	1488	1499	O
clinicopathological	1500	1519	O
and	1520	1523	O
radiological	1524	1536	O
correlation	1537	1548	O
and	1549	1552	O
serves	1553	1559	O
the	1560	1563	O
need	1564	1568	O
of	1569	1571	O
clients	1572	1579	O
who	1580	1583	O
need	1584	1588	O
timely	1589	1595	O
help	1596	1600	O
with	1601	1605	O
challenging	1606	1617	O
liver	1618	1623	B-Organ
and	1624	1627	O
GI	1628	1630	B-Organism_subdivision
cases	1631	1636	O
and	1637	1640	O
to	1641	1643	O
obtain	1644	1650	O
expert	1651	1657	O
opinion	1658	1665	O
for	1666	1669	O
dysplasia	1670	1679	O
in	1680	1682	O
Barrett	1683	1690	O
'	1690	1691	O
s	1691	1692	O
and	1693	1696	O
ulcerative	1697	1707	O
colitis	1708	1715	O
surveillance	1716	1728	O
biopsies	1729	1737	O
required	1738	1746	O
by	1747	1749	O
the	1750	1753	O
American	1754	1762	O
Gastroenterology	1763	1779	O
Association	1780	1791	O
(	1792	1793	O
AGA	1793	1796	O
)	1796	1797	O
.	1797	1798	O

This	1799	1803	O
model	1804	1809	O
has	1810	1813	O
been	1814	1818	O
practiced	1819	1828	O
for	1829	1832	O
3	1833	1834	O
years	1835	1840	O
and	1841	1844	O
applied	1845	1852	O
to	1853	1855	O
over	1856	1860	O
2000	1861	1865	O
cases	1866	1871	O
by	1872	1874	O
small	1875	1880	O
pathology	1881	1890	O
practices	1891	1900	O
in	1901	1903	O
the	1904	1907	O
50	1908	1910	O
United	1911	1917	O
States	1918	1924	O
and	1925	1928	O
a	1929	1930	O
single	1931	1937	O
consultant	1938	1948	O
GI	1949	1951	B-Organism_subdivision
and	1952	1955	O
liver	1956	1961	B-Organ
pathologist	1962	1973	O
.	1973	1974	O

Click	0	5	O
here	6	10	O
for	11	14	O
file	15	19	O

The	0	3	O
right	4	9	O
eye	10	13	B-Organ
of	14	16	O
a	17	18	O
50	19	21	O
-	21	22	O
year	22	26	O
-	26	27	O
old	27	30	O
patient	31	38	O
with	39	43	O
severe	44	50	O
hypertension	51	63	O
at	64	66	O
the	67	70	O
first	71	76	O
visit	77	82	O
.	82	83	O

(	84	85	O
a	85	86	O
)	86	87	O
Fundus	88	94	O
photograph	95	105	O
shows	106	111	O
serous	112	118	O
retinal	119	126	B-Multi-tissue_structure
detachment	127	137	O
.	137	138	O

The	139	142	O
optic	143	148	O
disc	149	153	O
is	154	156	O
pale	157	161	O
at	162	164	O
the	165	168	O
temporal	169	177	O
side	178	182	O
.	182	183	O

(	184	185	O
b	185	186	O
)	186	187	O
Optical	188	195	O
coherence	196	205	O
tomography	206	216	O
(	217	218	O
OCT	218	221	O
)	221	222	O
shows	223	228	O
retinal	229	236	B-Multi-tissue_structure
detachment	237	247	O
involving	248	257	O
the	258	261	O
fovea	262	267	O
and	268	271	O
cystic	272	278	O
change	279	285	O
of	286	288	O
inner	289	294	B-Multi-tissue_structure
retina	295	301	I-Multi-tissue_structure
.	301	302	O

(	303	304	O
c	304	305	O
)	305	306	O
Early	307	312	O
phase	313	318	O
images	319	325	O
of	326	328	O
fluorescein	329	340	O
angiography	341	352	O
(	353	354	O
FA	354	356	O
)	356	357	O
(	358	359	O
left	359	363	O
)	363	364	O
and	365	368	O
indocyanine	369	380	O
green	381	386	O
angiography	387	398	O
(	399	400	O
IA	400	402	O
)	402	403	O
(	404	405	O
right	405	410	O
)	410	411	O
.	411	412	O

(	413	414	O
d	414	415	O
)	415	416	O
Late	417	421	O
phase	422	427	O
images	428	434	O
of	435	437	O
FA	438	440	O
(	441	442	O
left	442	446	O
)	446	447	O
and	448	451	O
IA	452	454	O
(	455	456	O
right	456	461	O
)	461	462	O
.	462	463	O

FA	464	466	O
shows	467	472	O
window	473	479	O
defect	480	486	O
associated	487	497	O
with	498	502	O
macular	503	510	B-Tissue
cystic	511	517	O
change	518	524	O
.	524	525	O

Note	526	530	O
that	531	535	O
no	536	538	O
active	539	545	O
leakage	546	553	O
is	554	556	O
observed	557	565	O
in	566	568	O
the	569	572	O
area	573	577	O
with	578	582	O
serous	583	589	O
retinal	590	597	B-Multi-tissue_structure
detachment	598	608	O
or	609	611	O
cystoid	612	619	B-Pathological_formation
edema	620	625	I-Pathological_formation
.	625	626	O

IA	627	629	O
shows	630	635	O
decreased	636	645	O
perfusion	646	655	O
of	656	658	O
the	659	662	O
choroid	663	670	O
at	671	673	O
the	674	677	O
macula	678	684	B-Tissue
and	685	688	O
window	689	695	O
defect	696	702	O
with	703	707	O
the	708	711	O
damaged	712	719	O
RPE	720	723	O
.	723	724	O

Hypofluorescence	725	741	O
(	742	743	O
arrow	743	748	O
)	748	749	O
along	750	755	O
the	756	759	O
retinal	760	767	B-Tissue
artery	768	774	I-Tissue
are	775	778	O
observed	779	787	O
.	787	788	O

These	789	794	O
are	795	798	O
unique	799	805	O
findings	806	814	O
.	814	815	O

5	0	1	O
.	1	2	O

Conclusion	3	13	O

RLs	14	17	O
are	18	21	O
new	22	25	O
actors	26	32	O
in	33	35	O
animal	36	42	O
and	43	46	O
plant	47	52	O
defense	53	60	O
and	61	64	O
their	65	70	O
low	71	74	O
toxicity	75	83	O
and	84	87	O
biodegradability	88	104	O
make	105	109	O
them	110	114	O
promising	115	124	O
molecules	125	134	O
to	135	137	O
be	138	140	O
used	141	145	O
against	146	153	O
pathogens	154	163	O
.	163	164	O

In	165	167	O
this	168	172	O
respect	173	180	O
,	180	181	O
there	182	187	O
are	188	191	O
some	192	196	O
clues	197	202	O
now	203	206	O
available	207	216	O
for	217	220	O
the	221	224	O
success	225	232	O
of	233	235	O
RL	236	238	O
applications	239	251	O
in	252	254	O
greenhouses	255	266	O
to	267	269	O
fight	270	275	O
phytopathogens	276	290	O
.	290	291	O

A	292	293	O
better	294	300	O
understanding	301	314	O
of	315	317	O
RL	318	320	O
mode	321	325	O
of	326	328	O
action	329	335	O
,	335	336	O
especially	337	347	O
their	348	353	O
perception	354	364	O
and	365	368	O
the	369	372	O
signaling	373	382	O
pathways	383	391	O
activated	392	401	O
,	401	402	O
will	403	407	O
be	408	410	O
very	411	415	O
important	416	425	O
to	426	428	O
potentiate	429	439	O
their	440	445	O
beneficial	446	456	O
effects	457	464	O
in	465	467	O
plants	468	474	O
.	474	475	O

RLs	476	479	O
have	480	484	O
a	485	486	O
dual	487	491	O
mode	492	496	O
of	497	499	O
action	500	506	O
:	506	507	O
they	508	512	O
are	513	516	O
antimicrobial	517	530	O
and	531	534	O
also	535	539	O
stimulate	540	549	O
plant	550	555	O
defense	556	563	O
responses	564	573	O
.	573	574	O

This	575	579	O
dual	580	584	O
property	585	593	O
is	594	596	O
probably	597	605	O
very	606	610	O
important	611	620	O
for	621	624	O
the	625	628	O
efficiency	629	639	O
of	640	642	O
new	643	646	O
biopesticides	647	660	O
.	660	661	O

In	662	664	O
animals	665	672	O
,	672	673	O
the	674	677	O
use	678	681	O
of	682	684	O
RLs	685	688	O
is	689	691	O
also	692	696	O
at	697	699	O
an	700	702	O
advanced	703	711	O
stage	712	717	O
.	717	718	O

RLs	719	722	O
are	723	726	O
successfully	727	739	O
used	740	744	O
as	745	747	O
antimicrobial	748	761	O
agents	762	768	O
,	768	769	O
especially	770	780	O
for	781	784	O
skin	785	789	B-Organ
disease	790	797	O
treatment	798	807	O
.	807	808	O

Deep	809	813	O
insight	814	821	O
into	822	826	O
the	827	830	O
physiochemical	831	845	O
effects	846	853	O
of	854	856	O
RLs	857	860	O
and	861	864	O
their	865	870	O
biological	871	881	O
importance	882	892	O
would	893	898	O
reveal	899	905	O
new	906	909	O
dimensions	910	920	O
in	921	923	O
the	924	927	O
fields	928	934	O
of	935	937	O
research	938	946	O
like	947	951	O
agriculture	952	963	O
and	964	967	O
medicine	968	976	O
,	976	977	O
precisely	978	987	O
in	988	990	O
plant	991	996	O
defense	997	1004	O
,	1004	1005	O
disease	1006	1013	O
control	1014	1021	O
and	1022	1025	O
pathogenesis	1026	1038	O
.	1038	1039	O

An	1040	1042	O
understanding	1043	1056	O
of	1057	1059	O
bacterial	1060	1069	O
genera	1070	1076	O
producing	1077	1086	O
RLs	1087	1090	O
that	1091	1095	O
are	1096	1099	O
not	1100	1103	O
yet	1104	1107	O
well	1108	1112	O
studied	1113	1120	O
would	1121	1126	O
provide	1127	1134	O
light	1135	1140	O
on	1141	1143	O
these	1144	1149	O
fascinating	1150	1161	O
aspects	1162	1169	O
.	1169	1170	O

Objectives	0	10	O

Evaluate	11	19	O
relationships	20	33	O
between	34	41	O
MRI	42	45	O
and	46	49	O
clinical	50	58	O
/	58	59	O
laboratory	59	69	O
/	69	70	O
radiographic	70	82	O
findings	83	91	O
in	92	94	O
rheumatoid	95	105	O
arthritis	106	115	O
(	116	117	O
RA	117	119	O
)	119	120	O
.	120	121	O

Assessment	0	10	O
instruments	11	22	O

The	23	26	O
SCID	27	31	O
-	31	32	O
I	32	33	O
/	33	34	O
P	34	35	O
was	36	39	O
administered	40	52	O
by	53	55	O
psychiatrists	56	69	O
trained	70	77	O
and	78	81	O
certified	82	91	O
in	92	94	O
the	95	98	O
use	99	102	O
of	103	105	O
all	106	109	O
instruments	110	121	O
in	122	124	O
this	125	129	O
study	130	135	O
.	135	136	O

The	137	140	O
ICG	141	144	O
is	145	147	O
a	148	149	O
self	150	154	O
-	154	155	O
report	155	161	O
instrument	162	172	O
that	173	177	O
can	178	181	O
be	182	184	O
used	185	189	O
to	190	192	O
identify	193	201	O
CG	202	204	O
when	205	209	O
the	210	213	O
total	214	219	O
score	220	225	O
is	226	228	O
>	229	230	O
25	231	233	O
,	233	234	O
that	235	239	O
demonstrated	240	252	O
high	253	257	O
internal	258	266	O
consistency	267	278	O
(	279	280	O
Cronbach	280	288	O
'	288	289	O
s	289	290	O
alpha	291	296	O
=	297	298	O
0	299	300	O
.	300	301	O
94	301	303	O
)	303	304	O
,	304	305	O
and	306	309	O
convergent	310	320	O
and	321	324	O
criterion	325	334	O
validity	335	343	O
[	344	345	O
27	345	347	O
]	347	348	O
.	348	349	O

The	350	353	O
ICG	354	357	O
total	358	363	O
score	364	369	O
also	370	374	O
showed	375	381	O
a	382	383	O
fairly	384	390	O
high	391	395	O
association	396	407	O
with	408	412	O
the	413	416	O
Beck	417	421	O
Depression	422	432	O
Inventory	433	442	O
(	443	444	O
BDI	444	447	O
)	447	448	O
[	449	450	O
32	450	452	O
]	452	453	O
total	454	459	O
score	460	465	O
(	466	467	O
r	467	468	O
=	469	470	O
0	471	472	O
.	472	473	O
67	473	475	O
,	475	476	O
P	477	478	O
<	479	480	O
0	481	482	O
.	482	483	O
001	483	486	O
)	486	487	O
,	487	488	O
the	489	492	O
Texas	493	498	O
Revised	499	506	O
Inventory	507	516	O
of	517	519	O
Grief	520	525	O
(	526	527	O
TRIG	527	531	O
)	531	532	O
[	533	534	O
33	534	536	O
]	536	537	O
score	538	543	O
(	544	545	O
r	545	546	O
=	547	548	O
0	549	550	O
.	550	551	O
87	551	553	O
,	553	554	O
P	555	556	O
<	557	558	O
0	559	560	O
.	560	561	O
001	561	564	O
)	564	565	O
,	565	566	O
and	567	570	O
the	571	574	O
Grief	575	580	O
Measurement	581	592	O
Scale	593	598	O
(	599	600	O
GMS	600	603	O
)	603	604	O
[	605	606	O
34	606	608	O
]	608	609	O
score	610	615	O
(	616	617	O
r	617	618	O
=	619	620	O
0	621	622	O
.	622	623	O
70	623	625	O
,	625	626	O
P	627	628	O
<	629	630	O
0	631	632	O
.	632	633	O
001	633	636	O
)	636	637	O
.	637	638	O

The	639	642	O
ASA	643	646	O
-	646	647	O
27	647	649	O
is	650	652	O
a	653	654	O
self	655	659	O
-	659	660	O
report	660	666	O
measure	667	674	O
developed	675	684	O
to	685	687	O
rate	688	692	O
separation	693	703	O
anxiety	704	711	O
symptoms	712	720	O
in	721	723	O
adult	724	729	O
life	730	734	O
(	735	736	O
from	736	740	O
18	741	743	O
years	744	749	O
of	750	752	O
age	753	756	O
)	756	757	O
.	757	758	O

Principal	759	768	O
components	769	779	O
analysis	780	788	O
revealed	789	797	O
a	798	799	O
coherent	800	808	O
construct	809	818	O
of	819	821	O
adult	822	827	O
separation	828	838	O
anxiety	839	846	O
with	847	851	O
high	852	856	O
internal	857	865	O
consistency	866	877	O
(	878	879	O
Cronbach	879	887	O
'	887	888	O
s	888	889	O
alpha	890	895	O
=	896	897	O
0	898	899	O
.	899	900	O
95	900	902	O
)	902	903	O
and	904	907	O
sound	908	913	O
test	914	918	O
-	918	919	O
retest	919	925	O
reliability	926	937	O
(	938	939	O
r	939	940	O
=	941	942	O
0	943	944	O
.	944	945	O
86	945	947	O
;	947	948	O
P	949	950	O
<	951	952	O
0	953	954	O
.	954	955	O
001	955	958	O
)	958	959	O
.	959	960	O

Further	961	968	O
,	968	969	O
a	970	971	O
receiver	972	980	O
operation	981	990	O
characteristic	991	1005	O
(	1006	1007	O
ROC	1007	1010	O
)	1010	1011	O
analysis	1012	1020	O
against	1021	1028	O
the	1029	1032	O
semistructured	1033	1047	O
interview	1048	1057	O
yielded	1058	1065	O
a	1066	1067	O
high	1068	1072	O
area	1073	1077	O
under	1078	1083	O
the	1084	1087	O
curve	1088	1093	O
(	1094	1095	O
AUC	1095	1098	O
)	1098	1099	O
index	1100	1105	O
of	1106	1108	O
0	1109	1110	O
.	1110	1111	O
9	1111	1112	O
,	1112	1113	O
suggesting	1114	1124	O
that	1125	1129	O
the	1130	1133	O
questionnaire	1134	1147	O
is	1148	1150	O
an	1151	1153	O
adequate	1154	1162	O
alternative	1163	1174	O
measure	1175	1182	O
of	1183	1185	O
adult	1186	1191	O
separation	1192	1202	O
anxiety	1203	1210	O
[	1211	1212	O
29	1212	1214	O
]	1214	1215	O
.	1215	1216	O

The	1217	1220	O
WSAS	1221	1225	O
is	1226	1228	O
a	1229	1230	O
self	1231	1235	O
-	1235	1236	O
report	1236	1242	O
scale	1243	1248	O
of	1249	1251	O
functional	1252	1262	O
impairment	1263	1273	O
that	1274	1278	O
includes	1279	1287	O
five	1288	1292	O
questions	1293	1302	O
rating	1303	1309	O
interference	1310	1322	O
of	1323	1325	O
psychiatric	1326	1337	O
symptoms	1338	1346	O
in	1347	1349	O
work	1350	1354	O
,	1354	1355	O
home	1356	1360	O
management	1361	1371	O
,	1371	1372	O
social	1373	1379	O
or	1380	1382	O
private	1383	1390	O
leisure	1391	1398	O
activities	1399	1409	O
,	1409	1410	O
and	1411	1414	O
ability	1415	1422	O
to	1423	1425	O
form	1426	1430	O
and	1431	1434	O
maintain	1435	1443	O
close	1444	1449	O
relationships	1450	1463	O
with	1464	1468	O
others	1469	1475	O
.	1475	1476	O

Each	1477	1481	O
question	1482	1490	O
is	1491	1493	O
rated	1494	1499	O
on	1500	1502	O
a	1503	1504	O
0	1505	1506	O
to	1507	1509	O
8	1510	1511	O
scale	1512	1517	O
with	1518	1522	O
0	1523	1524	O
indicating	1525	1535	O
no	1536	1538	O
impairment	1539	1549	O
at	1550	1552	O
all	1553	1556	O
and	1557	1560	O
8	1561	1562	O
indicating	1563	1573	O
very	1574	1578	O
severe	1579	1585	O
impairment	1586	1596	O
.	1596	1597	O

The	1598	1601	O
Cronbach	1602	1610	O
'	1610	1611	O
s	1611	1612	O
alpha	1613	1618	O
measure	1619	1626	O
of	1627	1629	O
internal	1630	1638	O
scale	1639	1644	O
consistency	1645	1656	O
ranged	1657	1663	O
from	1664	1668	O
0	1669	1670	O
.	1670	1671	O
70	1671	1673	O
to	1674	1676	O
0	1677	1678	O
.	1678	1679	O
94	1679	1681	O
,	1681	1682	O
the	1683	1686	O
test	1687	1691	O
-	1691	1692	O
retest	1692	1698	O
correlation	1699	1710	O
was	1711	1714	O
0	1715	1716	O
.	1716	1717	O
73	1717	1719	O
,	1719	1720	O
and	1721	1724	O
the	1725	1728	O
WSAS	1729	1733	O
interactive	1734	1745	O
voice	1746	1751	O
response	1752	1760	O
administrations	1761	1776	O
gave	1777	1781	O
correlations	1782	1794	O
of	1795	1797	O
0	1798	1799	O
.	1799	1800	O
81	1800	1802	O
and	1803	1806	O
0	1807	1808	O
.	1808	1809	O
86	1809	1811	O
with	1812	1816	O
clinician	1817	1826	O
interviews	1827	1837	O
[	1838	1839	O
30	1839	1841	O
]	1841	1842	O
.	1842	1843	O

Correlations	1844	1856	O
of	1857	1859	O
WSAS	1860	1864	O
with	1865	1869	O
severity	1870	1878	O
of	1879	1881	O
depression	1882	1892	O
and	1893	1896	O
obsessive	1897	1906	O
-	1906	1907	O
compulsive	1907	1917	O
disorder	1918	1926	O
symptoms	1927	1935	O
were	1936	1940	O
0	1941	1942	O
.	1942	1943	O
76	1943	1945	O
and	1946	1949	O
0	1950	1951	O
.	1951	1952	O
61	1952	1954	O
,	1954	1955	O
respectively	1956	1968	O
,	1968	1969	O
and	1970	1973	O
the	1974	1977	O
scores	1978	1984	O
were	1985	1989	O
sensitive	1990	1999	O
to	2000	2002	O
patient	2003	2010	O
differences	2011	2022	O
in	2023	2025	O
disorder	2026	2034	O
severity	2035	2043	O
and	2044	2047	O
treatment	2048	2057	O
-	2057	2058	O
related	2058	2065	O
change	2066	2072	O
[	2073	2074	O
30	2074	2076	O
]	2076	2077	O
.	2077	2078	O

The	2079	2082	O
MOODS	2083	2088	O
-	2088	2089	O
SR	2089	2091	O
is	2092	2094	O
an	2095	2097	O
instrument	2098	2108	O
developed	2109	2118	O
and	2119	2122	O
validated	2123	2132	O
to	2133	2135	O
assess	2136	2142	O
lifetime	2143	2151	O
mood	2152	2156	O
spectrum	2157	2165	O
symptoms	2166	2174	O
[	2175	2176	O
35	2176	2178	O
]	2178	2179	O
,	2179	2180	O
including	2181	2190	O
manic	2191	2196	O
and	2197	2200	O
depressive	2201	2211	O
features	2212	2220	O
,	2220	2221	O
rhythmicity	2222	2233	O
and	2234	2237	O
vegetative	2238	2248	O
functions	2249	2258	O
.	2258	2259	O

The	2260	2263	O
manic	2264	2269	O
and	2270	2273	O
depressive	2274	2284	O
components	2285	2295	O
are	2296	2299	O
subtyped	2300	2308	O
into	2309	2313	O
mood	2314	2318	O
,	2318	2319	O
energy	2320	2326	O
and	2327	2330	O
cognition	2331	2340	O
domains	2341	2348	O
,	2348	2349	O
focusing	2350	2358	O
on	2359	2361	O
manic	2362	2367	O
or	2368	2370	O
depressive	2371	2381	O
symptoms	2382	2390	O
,	2390	2391	O
respectively	2392	2404	O
.	2404	2405	O

The	2406	2409	O
rhythmicity	2410	2421	O
and	2422	2425	O
vegetative	2426	2436	O
functions	2437	2446	O
domain	2447	2453	O
include	2454	2461	O
changes	2462	2469	O
in	2470	2472	O
energy	2473	2479	O
,	2479	2480	O
physical	2481	2489	O
wellbeing	2490	2499	O
,	2499	2500	O
mental	2501	2507	O
and	2508	2511	O
physical	2512	2520	O
efficiency	2521	2531	O
,	2531	2532	O
related	2533	2540	O
to	2541	2543	O
the	2544	2547	O
weather	2548	2555	O
and	2556	2559	O
season	2560	2566	O
,	2566	2567	O
and	2568	2571	O
changes	2572	2579	O
in	2580	2582	O
appetite	2583	2591	O
,	2591	2592	O
sleep	2593	2598	O
and	2599	2602	O
sexual	2603	2609	O
activities	2610	2620	O
.	2620	2621	O

The	2622	2625	O
sum	2626	2629	O
of	2630	2632	O
the	2633	2636	O
scores	2637	2643	O
on	2644	2646	O
the	2647	2650	O
3	2651	2652	O
manic	2653	2658	O
domains	2659	2666	O
(	2667	2668	O
mood	2668	2672	O
,	2672	2673	O
energy	2674	2680	O
,	2680	2681	O
cognition	2682	2691	O
)	2691	2692	O
constitutes	2693	2704	O
the	2705	2708	O
'	2709	2710	O
manic	2710	2715	O
component	2716	2725	O
'	2725	2726	O
(	2727	2728	O
62	2728	2730	O
items	2731	2736	O
)	2736	2737	O
and	2738	2741	O
that	2742	2746	O
of	2747	2749	O
the	2750	2753	O
3	2754	2755	O
depressive	2756	2766	O
domains	2767	2774	O
the	2775	2778	O
'	2779	2780	O
depressive	2780	2790	O
component	2791	2800	O
'	2800	2801	O
(	2802	2803	O
63	2803	2805	O
items	2806	2811	O
)	2811	2812	O
.	2812	2813	O

The	2814	2817	O
rhythmicity	2818	2829	O
and	2830	2833	O
vegetative	2834	2844	O
functions	2845	2854	O
domain	2855	2861	O
includes	2862	2870	O
29	2871	2873	O
items	2874	2879	O
.	2879	2880	O

The	2881	2884	O
instrument	2885	2895	O
can	2896	2899	O
be	2900	2902	O
downloaded	2903	2913	O
from	2914	2918	O
http	2919	2923	O
:	2923	2924	O
/	2924	2925	O
/	2925	2926	O
www	2926	2929	O
.	2929	2930	O
spectrum	2930	2938	O
-	2938	2939	O
project	2939	2946	O
.	2946	2947	O
org	2947	2950	O
.	2950	2951	O

